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ABSTRACT 
This thesis describes the development and application of a rapid and sensitive 
electrospray ionization-mass spectrometry (ESI-MS) method to study the weak 
hydrophobic interactions seen in many Ub-Ub-binding domain (UBD) 
complexes. A range of UBDs has been screened against mono-Ub, di-Ub (Ub2) and 
tetra-Ub (Ub4). Affinities in the 2-200 J.lM range were found to be in excellent 
agreement with data obtained from other biophysical techniques. Insights into 
the UBD's preference for poly-Ub chain linkage and length are also provided by 
this methodology. Detection of a ternary complex involving Ub interacting 
simultaneously with two different UBDs demonstrated the co-existence of multi-
site interactions. A simple, clean and effective method for reducing charge states 
observed in ESI-MS without the use of any solution additives or instrumental 
modifications is also reported; with the charge reduction method ultimately 
promoting the investigation ofthe Ub-UBD interactions. 
Moreover, the development and application of a top-down proteomics approach 
to characterize the topology of an unanchored Ub dimer purified from rat skeletal 
muscle is also described in this thesis. This study has identified the topology of 
the Ub2 to be Lys48-linked. In addition, ESI-MS of endogenous Ub2 species has 
revealed the presence of cyclic Lys48-linked Ub2 and demonstrates for the first 
time that cyclisation of poly-Ub can also occur in vivo. 
Further to these studies, the inhibitory activity of small peptides against the 
complex formed by Ub with the ZnF domain of isopeptidase T (IsoT) is also 
investigated. Finally, the unusual effects of cation adduction upon the gas-phase 
conformation of three-helix bundle UBDs are revealed by ESI-IMS-MS and 
reported in this thesis. 
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CHAPTER 1 
INTRODUCTION 
1.1 MASS SPECTROMETRY 
Mass spectrometry (MS) has evolved into a powerful analytical tool that is used 
for measuring the molecular mass of a sample molecule, for the determination of 
elemental composition, for protein sequencing, and many other applications. The 
fundamental basis of MS is the generation of gas-phase ions and their separation 
driven by differences in their mass-to-charge ratio (m/z). 
The development of MS can be mainly attributed to the work of J.J. Thomson and 
of his student, Fransis Aston. Thomson discovered the electron and determined 
its mass-to-charge ratio (m/z) in 1897 (Nobel Prize in physics, 1906) and then 
he constructed the first mass spectrometer in 1912 [1] with which he managed to 
obtain mass spectra of various gases. A few years later, in 1919, Aston designed a 
significantly improved apparatus and used it to discover isotopes of the non-
radioactive elements [2]. In 1922, Aston received the Nobel Prize in chemistry for 
his pioneering work. Today, more than 70 years after the launch of the first 
commercial instrument, several improvements including development of 
revolutionary mass analysers and ionization techniques, have extended the use of 
MS in a very broad scientific field; from the analysis of single elements up to the 
analysis of complex biomolecular assemblies. 
Several types of MS instruments are currently available; however, all of them 
consist of three basic components, which are the ion source, the mass analyser(s) 
1 
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and the detector. Figure 1.1.1 illustrates a typical configuration of a mass 
spectrometer composed of these three units together with a controlling/data 
system. While the mass analyser(s) and detector are held under vacuum, ion 
source, depending on the ionization process, may be held either under vacuum or 
at atmospheric pressure. 
Mass Spectrometer 
Detector 
Mass nalyzer 1 
Figure 1.1.1 A typical configuration of a mass spectrometry platform, consist of 
an inlet system, the mass spectrometer and the data system. 
An inlet system, such as a gas chromatograph (GC), liquid chromatograph (LC) or 
a solids probe, or simple syringe pump, is frequently used to subject sample to 
MS analysis. Sample ionization followed by ion separation according to their m/z 
ratio and finally ion detection, are the three key steps that are followed in every 
MS experiment. Finally, a data processing system such as a computer, also 
frequently used to control the whole instrument, will produce a mass spectrum. 
1.1.1 ION SOURCE 
Ionization of the analyte can be achieved using several different techniques. Ions 
can be generated thermally, by electric fields or by collisions between analyte 
molecules and other "particles", such as energetic electrons, ions, photons and 
energetic neutral atoms. Choice of the appropriate ionization technique depends 
2 
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on the nature of the analyte, principally its physical and chemical properties. For 
example, thermally labile compounds are very challenging, and usually not 
feasible, for some ionization techniques such as electron ionization (EI), chemical 
ionization (eI) and field ionization (FI), largely due to the need to vaporize them 
by heating. Another factor that has to be taken into account, when selecting an 
ion source, is the amount of internal energy that is transferred during ionization. 
While high energetic ionization techniques, like EI, transfer large amounts of 
energy to the analyte that result in its extensive fragmentation, other approaches, 
such as matrix assisted laser desorption ionization (MALDI) and electrospray 
ionization (ESI) usually produce dominant ions of the molecular species. Brief 
descriptions of the principles governing the aforementioned ionization 
techniques are given below. ESI is discussed in more details in section 1.1.2. 
1.1.1.1 ELECTRON IONIZATION (El) 
In an EI source, a heated filament produces highly energetic electrons (a 
procedure known as thermionic emission), which are accelerated towards an 
anode. When neutral gaseous analytes are injected into the source, they collide 
with these energetic electrons. The collision results in energy transfer to the 
neutral molecules, and if this energy is sufficient to expel an electron it leads to 
the formation of a radical cation (M+·). The energy of the electrons and the 
chemistry of the analyte regulate the ionization efficiency (i.e. the ratio of the 
number of formed ions to the number of electrons used) and its fragmentation 
level. 
When an electron is accelerated, it behaves as a wave. Therefore, each electron 
has a characteristic wavelength A, known as de Broglie wavelength (eq. 1.1), and 
its value is determined by its mass (m), its velocity (v) and the Planck (h) 
constant. 
3 
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Equation 1.1 
The wavelength is inversely proportional to the kinetic energy of electrons. For 
example, when the kinetic energy of the electrons is increased from 20 eV to 70 
eV, the wavelength is decreased from 2.7 A to 1.4 A, respectively. The ionization 
efficiency of a given sample at a constant temperature depends on the kinetic 
energy of the electrons. While the energy transferred to the analyte molecules by 
"slow" electrons it can be insufficient to cause their ionization, electrons with 
very high kinetic energy exhibit very small wavelengths and as a consequence the 
analyte molecules become "transparent" to them. In case of organiC molecules, 
maximum ionization efficiency is achieved when electrons are accelerated 
around 70 eV. Under these conditions, between 10 and 20 eV is transferred to the 
analyte molecule resulting in its ionization. However, since 10 eV or less is 
usually sufficient to cause ionization, the excess energy is used to fragment the 
molecular ion [3]. 
1.1.1.2 CHEMICAL IONIZATION (CI) 
In the CI technique, in contrast to EI, sample ionization is achieved via ion-
molecule collisions instead of energetic electron-molecule collisions. CI is a lower 
energy process, compared to EI, therefore it induces less analyte fragmentation. 
During a CI experiment, a reagent gas present in the CI chamber is ionised via EI, 
which leads to the formation of ionization plasma through a series of ion-
molecule reactions. Subsequent reactions between analyte molecules and this 
plasma leads to the ionization of the former [3]. Ionization occurs via different 
chemical reactions, including proton transfer from the reagent ion to the analyte 
molecule, hydride abstraction with the transfer of a hydride ion from the analyte 
molecule to the reagent gas, charge transfer from the rea.gent ion to the analyte 
molecule and adduct formation [3]. 
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1.1.1.3 FIELD IONIZATION AND FIELD DESORPTION (FI AND FD) 
FI uses strong electric fields to ionize gas-phase molecules. The electric field is 
created by a filament called the emitter and a counter-electrode held at a 
potential difference of 8-12 kY. As sample molecules approach the surface ofthe 
emitter, an electron is transferred to the emitter by quantum tunnelling resulting 
in the formation of a radical cation, which is then repelled by the emitter. Ions 
travel towards the negative counter-electrode and pass into the mass analyser 
through a hole located on counter-electrode's surface. Similar to EI and Cl 
processes, FI can be used for the ionization of sufficiently volatile and thermally 
stable compounds. Due to the very low energy that is transferred to the analyte 
molecules, FI is a much softer ionization method compared to EI and CI. In reality, 
the energy is so low that only the molecular ion is generated. The main 
drawbacks for the FI are its very low ionization efficiency and that thermal 
decomposition of the analyte can occur prior its ionization [3]. 
Field desorption (FD) is an ionization method that is basically governed by the 
same principles as FI; in FD ionization is driven by the application of high electric 
fields [4]. However, in contrast to FI, in FD, evaporation of the analyte prior to 
ionization is not required. Instead, the analyte is deposited on a tungsten or 
rhenium filament covered with carbon microneedles. Contrary to FI, FD can be 
used in the analysis of thermally labile compounds. While the filament is kept 
under the influence of a high electric field of approximately 108 Vern-I, is 
simultaneously heated by the application of a high current, causing the melting of 
the sample. At the tip of the micro needles, the ions are desorbed, carrying along 
molecules of the sample. The analyte molecules interact with the high electric 
field and they are ionised in a similar to FI mechanism being described above. 
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1.1.1.4 FAST ATOM BOMBARDMENT (FAB) 
FAB was introduce in 1981 by Barber et al. [5] and it became a popular technique 
mainly for its capability to ionise polar and higher molecular weight compounds 
such as peptides and nuc1eotides. In FAB the sample is mixed with a low volatility 
liquid matrix; the most often used liquid matrix is glycerol. Subsequently, the 
dissolved sample is "bombarded" under vacuum with a high energy beam of 
neutral atoms which is produced by the ionization of an inert gas, usually argon. 
A similar approach is used in liquid secondary-ion mass spectrometry (LSIMS) 
with the difference that the beam of neutral atoms is replaced by a beam of 
caesium (Cs+) ions [6]. In both ionization methods the energetic particles (neutral 
atoms or ions) collide with analyte molecules in solution. Such a collision results 
in the formation of a shock wave which ejects ions and molecules present in 
solution. The resultant ions are accelerated towards the mass analyser by means 
of a potential difference. 
1.1.1.5 MATRIX ASSISTED LASER DESORPTION IONIZATION (MALDI) 
Although the MALOI technique was introduced in 1988 [7, 8], the use of laser 
beams in the ionization of organic molecules, dates back to 1978, when 
Posthumus et al introduced the laser desorption ionization (LOI) technique [9]. 
In LOI method, ionization occurs by directly irradiating the sample with a laser 
beam. However, the levels of energy transferred to the analyte molecules is 
usually very high and result in extensive fragmentation. In contrast to LOI, during 
the MALDI process the analyte is deposited in a matrix containing small organic 
molecules. The mixture is then irradiated with intense short duration laser 
pulses. The exact mechanism of this desorption-ionization procedure is not fully 
understood [10-13]. Regarding desorption process, however, it is thought that 
the energy transferred by the laser beam to the matrix, results in the excitation of 
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matrix molecules. In turn, the excited molecules cause the rapid heating of the 
crystals, which leads to localized sublimation of the matrix crystals, ablation of 
the crystal surface and transfer of matrix particles containing the analyte to the 
gas-phase [14]. Moreover, the most widely accepted ionization mechanism 
involves proton transfer reactions either in the solid phase prior desorption or in 
the gas-phase [3]. The MALDI desorption ionization process is illustrated in 
Figure 1.1.2. 
IRRADIATION 
DESORPTION 
MATRIX 0 
PRODUCT. 
DESOLVATATION 
c?t .. 
~ ~ / 
~ ~ H+ •• ] 
PROTON TRANSFER 
o 
o • 
o 0 
Figure 1.1.2 A diagram of the MALO I desorption ionization process. Adapted 
from reference [3]. 
1.1.2 ELECTROSPRAY IONIZATION 
Electrospray is the consequence of the application of electricity to an ion-
containing liquid, which lead to its dispersion into a fine aerosol. ESI in turn, is a 
soft ionization technique that is very well known for its use in the analysis of 
large, non-volatile molecules such as biomolecules. The work of a number of 
researchers has successfully demonstrated the ability of ESI-MS to measure non-
covalently bound protein assemblies, like the ribosome, a 2 MDa protein-RNA 
complex [15], the tetradecameric GroEL [16] and the 20S proteasome, a 690 kDa 
28-mer [17]. The development of ESI in combination with instrumental 
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improvements (better sensitivity, resolving power and mass accuracy) has led to 
a revolution in biological mass spectrometry. 
1.1.2.1 HISTORICAL ORIGINS 
In 1882, Lord Rayleigh, published, "On the Equilibrium of Liquid Conducting 
Masses charged with Electricity", which is the study that established the theories 
of charged droplets, balancing the forces of surface tension and coulomb 
repulsion to determine charged droplet stability [18]. The first experimental 
demonstrations of electrospray process were reported by John Zeleny, in 1916-
1917 [19, 20]. His research on the electrified liquid surfaces became the first 
study that investigated the effects of the application of electric field on a liquid, 
and revealed that the electric field can cause droplet instability-disintegration, 
when it is applied to a conductive liquid. Fifty years later, in 1968, Malcolm Dole, 
published, "Molecular beams of Macroions", which is the first study that 
demonstrates the usage of electrospray as a potential ionization source, for the 
ionization of large nonvolatile molecules [21]. However the breakthrough and the 
establishment of electrospray ionization, as a potential ion source for the analysis 
of biomolecules by mass spectrometry, started in 1989, when John Fenn, 
published "Electrospray Ionization for Mass-Spectrometry of Large Biomolecules" 
[22]. It was the first study that reported a successful combination of ESI and MS 
that was used for the analysis of biological macromolecules (Figure 1.1.3). The 
importance of Fenn's work was recognised with the award of the Nobel Prize in 
Chemistry in 2002 [23]. 
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Figure 1.1.3 The electrospray ionization Instrument used by Fenn, which was 
also coupled to liquid chromatography. Adapted from [22]. 
1.1.2.2 FORMATION OF GAS-PHASE IONS IN ELECTROSPRAY IONIZATION 
The sample liquid, which consists of the analyte of interest in a suitable solvent, 
passes through a needle at a rate of 1-20 J.ll.min·1, which is held at a high 
potential of 3-4 kV. As the liquid reaches the open end of the needle it is exposed 
to a strong electric field (-106 V.m·l). This causes the expansion of the liquid into 
a Taylor cone [24] and the creation of a fine jet of liquid from its tip (Figure 
1.1.4). The generated liquid jet is enriched in ions of a particular charge sign [25] 
(either positively or negatively charged, depending on the applied potential) 
(Figure 1.1.4). Two opposite forces govern the stability of these charged droplets 
forming the liquid jet. On one hand is the surface tension, which holds the 
droplets together and on the other hand is the coulomb repulsion (or 
electrostatic repulsion) due to like-charges at the surface. During the process, 
solvent evaporates from the droplets surface and as a result the charge density 
increases and thus the coulomb repulsion also increases. 
9 
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a 
Reduction 
b 
Oxidation 
Electrons 
Figure 1.1.4 a) Effect of electrospray potential on the drop at the tip of the 
capillary as the voltage is increased from left to right. At the end the shape of 
the drop changes to a Taylor cone and small droplets are released. Adapted from 
reference [3]. b) Charge flow is maintained by an electrochemical oxidation 
reaction at the positive electrode in contact with the solution. Adapted from 
reference [25]. 
At the point, known as Rayleigh limit, where the coulomb repulsion overcomes 
surface tension, the fine liquid jet disperses into a fine spray of charged droplets, 
which are driven apart due to Coulomb repulsion. 
The Rayleigh equation (Eq. 1.2) describes the relationship between the charge of 
the droplet (QRy), droplet radius (R), surface tension (y) and the electrical 
permittivity of the atmosphere (EO) under which the droplet is present. 
Equation 1.2 
Initially it was believed that at the Rayleigh limit, a Coulomb fission (or Coulomb 
explosion) was taking place, and the droplets were "exploding" continuously, 
until a fine spray of droplets was produced. Although this theory remains 
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partially correct, later work has revealed that the shape of the droplets is more 
like a "tail" than a sphere [26] (Figure 1.1.5). This results in the ejection of 
smaller (compared to the parent) droplets from the end of the tail, thus the 
generation of daughter droplets before the Rayleigh limit i.e. charged droplets, 
can also occur "mechanically" instead of deriving from a Coulomb fission. Each 
daughter droplet generated "mechanically" carries -2% of the mass and -15% of 
the charge of the parent droplet [26], which actually promotes coulomb fission. 
The discovery of a precise mechanism for the formation of gas-phase ions by 
charged droplets had proven to be a very difficult task, and was the subject of a 
long-lasting debate. Even today, the mechanism remains unclear and the debate 
is still ongoing. Our current understanding is concentrated around two theories. 
The two prevailing models are the charged-residue model (CRM) and the ion 
evaporation model (lEM). 
N .. 51250 
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Figure 1.1.5 Droplet evolution scheme due to solvent evaporation at constant 
charge. Adapted from reference [25]. 
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Charged-Residue Model (CRM) and Ion Evaporation Model (IEM) 
The CRM theory was proposed by Dole during his work with electrospray. 
According to this theory, the charged droplets are entering in a Coulomb fission-
reduction cycle until no further evaporation of the solvent can occur. At this 
point, each droplet contains only one analyte molecule, and the charges are 
transferred onto it [27]. Contrary, IEM theory [28, 29] suggests that charged 
analyte ions can directly evaporate from the charged droplets, when the size of 
the charged droplet reaches a certain radius RE before reaching radius RR (Figure 
1.1.6). 
The RR is the radius at which the droplet becomes disrupted due to Rayleigh 
instability [18]. Figure 1.1.7 shows a simplistic diagram of CRM and IEM ion 
formation processes. 
84 100 134 150 200 
R(1) 
Figure 1.1.6 Critical droplet radius (RE'; for large clusters, RE.; for small clusters) 
and Rayleigh instability (RR). N: the number of elementary charges in the drop; 
A: the evaporating drop reaches ion evaporation limit first; B: the evaporating 
drop reaches Rayleigh limit first and therefore Is disrupted. Adapted from [28]. 
12 
Introduction 
EV APORA TlON 
• • SUBDIVISION 
•••••• ~ ~ DESORPTION 
o 1 ~ ' ' ' ' ' ' ' c ' ' ' J J
+ + 
Chapter 1 
A ~ ~ 0 
~ O O
Figure 1.1.7 A simplistic diagram showing CRM (top) and IEM (bottom) ion 
formation processes. Adapted from reference [30] . 
Evidence for both, IEM [28,30,31] and CRM [32,33] ion formation mechanisms, 
has been provided. These studies suggested that relatively small ions such as 
peptide ions are formed by ion evaporation, i.e. the IEM mechanism, whereas 
ionization of large molecules, such as proteins, most probably proceeds via the 
CRM pathway. A study from Fernadez de la Mora [33] has provided evidence that 
ionization of native globular proteins and naturally compact starburst 
dendrimers (with a mass greater than 3.3 kDa at least), follows the logic 
developed by Dole, i.e. CRM pathway. The same study has also suggested that 
relatively small ions, particularly small PEG (polyethylene glycols) ions, may be 
formed by ion evaporation. 
Recently, Konermann and co-workers have suggested a different mechanism for 
the ESI process, referred to as the chain ejection model (CEM), which applies to 
unfolded proteins that are partially hydrophobic and also capable of 
accommodating excess charges [34]. According to the authors, when unfolded 
proteins are placed in a Rayleigh-charged nanodroplet, they immediately migrate 
to the droplet surface. This is attributed to the highly hydrophobic character of 
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disordered proteins, which makes it unfavourable to reside within the droplet 
interior. Therefore, as the unfolded protein chains move towards the droplet 
surface, the protein terminus is expelled to the vapour phase followed by 
stepwise ejection of the remaining protein from the droplet (Figure 1.1.8). 
Figure 1.1.8 A simplistic diagram showing an unfolded protein (red) that 
separates from a charged nanodroplet (blue) during CEM. Reproduced 
(modified) from reference [34]. 
1.1.3 MASS ANALYSERS 
The separation of the generated gas-phase analyte ions is based on their mass-
to-charge ratio (m/z). The gas-phase ions can be analysed and separated using 
either fields (static, magnetic, dynamic or electric) or in a field free region as it is 
the case of Time-of-flight (TOF) mass spectrometer (although the reflectron-if 
used-provides a field). Several different types of mass analysers, which are 
based on different principles, have been developed (Table 1.1.1). 
Table 1.1.1 Types of mass analysers 
Type of analyser Symbol Principle of 
separation 
Electric sector E or ESA Kinetic energy 
Magnetic sector B Momentum 
Quadrupole Q Trajectory stability 
Ion Trap IT Resonance frequency 
Time-of-flight TOF Velocity (flight time) 
Fourier transform ion cyclotron FT-ICR Resonance frequency 
resonance 
Fourier transform orbitrap FT-OT Resonance frequency 
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A mass analyser can be generally described by the following parameters, which 
are also used to demonstrate its performance. 
a) Mass range: The m/z range over which the analyser can be used to 
separate and analyse gas-phase analyte ions. 
b) Analysis speed: The rate at which the analyser measures over a 
particular mass range and is usually expressed in mass units per second 
(u·s· l ) or in mass units per millisecond (u·ms·1). 
c) Transmission: This is a measure of ion lose during mass analysis. It is 
defined as the ratio of the ions reaching the detector over the total ions 
entering the mass analyser. 
d) Mass accuracy: It is given by the difference observed between the 
measured m/z (m measured) and the theoretical mass m/z (m theoretical) and it 
is often expressed in parts per million (ppm). 
e) Resolution/resolving power: A parameter that is used to describe the 
ability of a mass analyser to differentiate signals deriving from two 
distinct ions with slightly different m/z values. The resolution R, of a mass 
analyser that is capable to resolve two peaks with masses m and m+Am, is 
R=m/ Am. This definition requires the use of two peaks that are well 
resolved; for ICR and magnetic sector instruments, two peaks are 
considered to be resolved if the valley between them is 10 % of the 
weaker peak intensity; for other mass analysers the valley between two 
peaks has to be at least 50 %. Further to the above method, the 
estimation of resolution can be achieved by using the peak width Am of 
an isolated peak with mass m. The peak width is measured at height x %, 
which is commonly be 50 %, which is known as FWHM (Full Width at Half 
Maximum). 
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1.1.3.1 QUADRUPOLE 
The principles of quadrupole mass analyser was first described by Paul and 
Steinwedel in 1953 [35]. A quadrupole analyser consists of four cylindrically or 
ideally, hyperbolically shaped metal rod electrodes arranged parallel to each 
other, in a square configuration (Figure 1.1.9). 
+ 
z - axis 
- <1>0= - (U - V COS wt) 
<1>0 = (U - V COS wt) 
Figure 1.1.9 Top: Schematic representation of a quadrupole mass analyser. 
Bottom: Circuit diagram showing the four rods with alternative field applied by 
RF voltage (V cos cot), superposed on a constant field applied by DC voltage (U). 
<1> 0 represents the potential and co is the angular frequency in radians per second 
= 2n v, where v is the frequency of RF field. 
Its operation is based upon the application of an oscillating electric field to the 
rods, which influences the stability of ion trajectories, resulting in separation of 
ions according to their m/z ratios. Ions are accelerated at the entrance of the 
quadrupole filter and travel along its z-axis. Their movement is influenced by an 
oscillating electric field which continuously forces ions towards the centre of the 
analyser. 
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The field is created by application of DC and RF voltages to the four electrodes 
and is applied along the x and y axes (2D field) of the mass analyzer (circuit 
diagram in Figure 1.1.9). Therefore, ions travel along a field free pathway (z-axis). 
The 2D field quadrupole potential (<1>0) is described by the following equation. 
Equation 1.3 
The motion of ions in the x and y directions of a quadrupole field is determined 
by 
iN)o -2% ( ) 
-A-=- U-Vcoswt iJx rg Equation 1.4 
o <Po +2y 
-A- = -(U - Vcoswt) iJy rg Equation 1.5 
where A is the amplitude of the quadrupole field, U is the applied DC voltage, V is 
the applied RF voltage and OJ is the angular frequency of the RF (OJ = 2rrvwhere v 
is frequency in Hz). Ions motion in quadrupole fields can be described by second-
order Mathieu differential equations, 
Equation 1.6 
Equation 1.7 
where the variables are aX. ay, qx. qy and ~ ~ are given by: 
Equation 1.8 -1.9 
{ = ~ ~
2 Equation 1.10 
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where e is the electronic charge, m is the mass, ro is the quadrupole radius [36]. 
Solutions of Mathieu equations can be classified as being either bounded 
solutions or unbounded solutions. A bounded solution corresponds to stable ion 
trajectory while unbounded solutions result in unstable ion trajectories. Figure 
1.1.10 shows a stability diagram for a quadrupole mass analyser as a function of 
ax and qx variables. 
O.Z5 1.0 
a. 
00 02 o. 06 08 
Figure 1.1.10 Stability region of a quadrupole mass filter as a function of ax and 
qx variables. ~ ~ is a function of a and q. Taken from [36] 
Considering the variables of Mathieu equation (ax. ay, qx and qy), we can deduce 
the following equations, where u is either x or y. 
Equations 1.11 - 1.12 
These equations describe the relationship of U and V parameters with mjz values. 
Figure 1.1.11 is a graphical representation of this relationship. 
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Figure 1.1.11 Stability diagram of a quadrupole mass filter as a function of U and 
V for ions with different masses (ml <m2<m3). Reproduced (modified) from [3]. 
The scan line or operating line results from the linear change of U as a function of 
V. Ions of a given mass will possess a stable trajectory, as long as the scan line 
goes through their stability area (shaded). Therefore, a scan line with higher 
slope will result in higher resolution. Contrary, removal of DC voltage (U = 0), 
allows the transmission of all ions as long as the V value relies on their stability 
region. 
1.1.3.2 TIME OF FLIGHT 
The concept of an analyser that could discriminate ions based on their velocity in 
. a field free environment, was first proposed by W. E. Stephens in 1946 [37]. Two 
years later, Cameron and Eggers published the design of a time-of-flight (TOF) 
mass spectrometer [38]. In 1955, Wiley and McLaren, have made significant 
improvements on the design of the TOF analyser [39]. Three years later, Bendix 
Corporation introduced the first commercial TOF mass spectrometer [40]. The 
principle that governs ion separation by a TOF analyser is quite simple; ions are 
separated on the basis of their velocity difference into a field free drift region 
(flight tube). Ions are accelerated by a source region that operates at high electric 
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field and all ions gain the same nominal kinetic energy, which is given by 
equation 1.16, 
mv2 KE = zeVacc = -2- Equation 1.16 
where z = the charge upon the ion, e = fundamental unit of charge (1.602 x 10-19 
C), Vace = accelerating voltage, m = mass of the ion and v = velocity of the ion. 
Consequently, the velocity of ions travel towards the detector, is given by 
(
2ZeVacc)1/z 
v= --
m 
Equation 1.17 
It is clear from the above equations that the higher the mass of an ion the lower 
its velocity is within the field free drift region, and hence high mass ions will hit 
the detector later than low mass ions. 
The time it takes for an ion to hit the detector plate that is located at the end of a 
flight tube of length L, is known as the flight time (t) and is given by 
L t=-
v 
Equation 1.18 
Substituting v by equation 1.17, and rearranging, the following is obtained: 
2 m ( L2 ) t =--
z 2eVacc 
Solving the above equation for mlz, we obtain: 
Equation 1.19 
Equation 1.20 
The above equation describes the operation principle of the linear TOF mass 
filters; m/z value of an ion can be determined by its flight time in a field free 
region. 
20 
Introduction Chapter 1 
When TOF analysers are compared to other mass filters, they demonstrate some 
key advantages, such as the theoretically unlimited mass range, high 
transmission efficiency, compatibility with pulsed ionization techniques and high 
sensitivity; detection limits of 100-200 amol quantities have been reported [41]. 
The performance of the early TOF designs, however, delivered very poor 
resolution. That was mainly attributed to variations of the initial kinetic energy of 
the ions of the same m/z, result in peak broadening and therefore poor 
resolution. The introduction of two main techniques, the delayed pulsed 
extraction [39] and the inclusion of an electrostatic reflector (reflectron), has 
substantially improved the resolving power ofTOF analysers. 
Delay pulse extraction 
Delay pulse, originally known as time-lag focusing, is used to reduce kinetic 
energy spread of the ions. In delayed pulse extraction, the acceleration voltage is 
pulsed rather than continually applied. This introduces a delay between ion 
formation and ion extraction, which allows ions to expand into a field free region 
in the source. Ions of the same m/z ratio are distributed in the source region 
according to their kinetic energy; high energy ions move further towards the 
detector than lower energy ions which remain in the source for longer time. 
When the extraction pulse is applied, the less energetic ions, which have 
remained in the source for a longer time, receive more kinetic energy than the 
more energetic ions of the same m/z ratio. In this way, differences in initial 
kinetic energies are compensated and as a consequence ions of the same m/z, 
reach the detector in a narrow time distribution. 
Reflectron 
The electrostatic reflectror, known as reflectron, was originally proposed by 
Alikhanov, in 1957 [42] and was build a few years later, in 1973, by Mamyrin 
[43]. A reflectron is fundamentally an ion mirror, positioned after the field-free 
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region opposed to the ion source. It is usually consisted of a series of equally 
spaced, usually ring electrodes, which generate a retarding electric field that 
decelerates the ions and deflects them back into the flight tube. Ions with high 
kinetic energies penetrate further into the electrostatic field, thus they spend 
longer time in the reflectron than lower kinetic energy ions. Therefore, ions of the 
same m/z ratio with different kinetic energies, exhibit different flight paths-high 
energetic ions exhibit longer flight paths than low energetic ions-which 
compensates for any velocity differences between the ions (Figure 1.1.12). Thus, 
ions of the same m/z ratio, strike detector almost simultaneously, improving the 
resolving power of the analyser. 
Figure 1.1.12 Schematic representation of a reflectron time-of-flight mass 
analyser; • = ions of a given mass with a given kinetic energy; • = ions of the arne 
mass but with a lower kinetic energy. The former penetrate the field created by the 
reflectron more deeply and thereby have longer flight path than the slower (less 
energetic) ions. At the end both , fast and slow ions reach the detector at the arne 
time. 
Ions of a given m/z ratio and kinetic energy, will fly towards the reflectron with a 
constant velocity v 1 and will penetrate the electrostatic field at depth d before 
their velocity becomes zero (vo). At this point the direction of movement will be 
reversed and the ions will be forced out of the reflectron towards the detector. 
Ions will enter the field free region with the same velocity (Vi). The mean velocity 
of ions within the reflectron is vi/2, and total flight length inside the reflectron is 
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2d. Therefore, the total time inside the reflectron (tR) is determined by equation 
1.21. 
t - ~ ~R - VI Equation 1.21 
If Ll and Lz are the distances from source to reflectron and reflectron to detector, 
respectively, then the total time in the field free region (tF) is given by equation 
1.22. 
Lt +L2 t ---F - VI Equation 1.22 
The total flight time of ions in a reflectron TOF analyser (tT), is given by the sum 
of tF and tR. Therefore, for reflectron TOF analysers, the equation 1.20 is altered 
to 
~ ~ = 2ev' tr ( )
2 
z ace Ll +Lz+4d 
Equation 1.23 
Today, the TOF analysers are widely used, either as part of hybrid instruments 
(see section 1.1.3.4) or as single mass analysers, particularly in combination with 
MALDI or even ESI sources. 
Orthogonal acceleration Time-of-Flight 
Although the combination of a TOF analyser with a pulsed ionization technique, 
such as MALDI is directly compatible, their key advantages over the other mass 
analysers, has stimulated the development of techniques that allow the use of 
TOF analysers with continuous ion beam sources such as ESI. These involved the 
use of a narrow slit to sweep the ion beam and the use of pulsed ion extraction. 
Currently, the well established orthogonal acceleration technique is used with 
success to couple a TOF analyser with a continuous ionization source. A device, 
known as orthogonal accelerator is situated between the continuous ion beam 
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source and the TOF analyser. The ion accelerator operates in two phases; load 
stage at which the device is filled with ions and injection stage at which ions are 
transferred to the field-free region of the TOF analyser in a direction orthogonal 
to their original trajectory. 
1.1.3.3 FOURIER TRANSFORM ION CYCLOTRON RESONANCE (FT-ICR) 
The fundamental basis ofthe FT-ICR mass analyser relies on the circular motion 
of ions moving perpendicular to a homogeneous magnetic field [3]. The ions are 
injected into a cell, located in a magnetic field of 3 to 9.4 T that is produced by a 
superconducting magnet (Figure 1.1.13). Ions are trapped along the z axis, where 
the magnetic field is oriented, by a trapping voltage (typically 1 V) applied to the 
front and back plates. The ions are then excited by a RF pulse, which increases 
the radius of the ions spiral trajectories and induces an alternating current that 
can be detected and converted into a spectrum by the Fourier transform [44,45]. 
Receiver 
plate 
Emitter 
plate 
~ ~
'WI 
Figure 1.1.13 Diagram of an ICR cell. 
1.1.3.4 HYBRID INSTRUMENTS 
VTrap 
Hybrid mass spectrometers have been developed, also. These instruments 
combine different types of mass analysers in a single configuration. One of the 
most common hybrid instruments is the quadrupole Time-of-flight CQTof), 
which consists of a quadrupole filter, a collision cell and a TOF analyser (Figure 
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1.1.14). The quadrupole can be operated in two modes; a) RF only mode allows 
all ions to pass through filter and analysed by the TOF analyser, thus full scan 
spectrum is recorder and b) resolving mode allows the selection of ions of a 
specific m/z ratio (precursor ions), which undergo fragmentation, usually due to 
collisional induced dissociation (CID), in the collision cell. Remaining precursor 
and its fragments are further separated and detected by the TOF analyser. 
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Figure 1.1.14 Diagram of a QTof instrument. 
I 
Another example of a hybrid instrument is the L TQ FT ULTRA by Thermo 
Scientific, which combines linear ion trap (LIT) analyser with fourier transfer-ion 
cyclotron resonance (FT -ICR) analyser. 
1.1.3.5 TANDEM MASS SPECTROMETRY 
Tandem mass spectrometry is a powerful technique used to gain structural 
information on a particular ionic species. The procedure involves at least two 
stages of mass analysis (MSjMS) that are linked by an intermediate stage which 
induces fragmentation of a preselected ion of a specific m/z ratio. When a tandem 
mass spectrometry experiment involves more than two stages it is usually 
referred as MSn experiment, where n refers to the number of mass analysis steps 
been involved. 
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Tandem mass spectrometry experiments can be carried out in two ways: tandem 
analysis in space and tandem analysis in time. The former involves the coupling 
of two mass spectrometers, either of the same (e.g. triple quadrupole, QqQ) or 
different (e.g. QTot) type, in series. Tandem mass spectrometry in time can be 
performed using ion trap devices, such as LIT, quadrupole ion trap (QIT), 
orbitrap and ICR. 
1.1.3.6 COLLISION-INDUCED DISSOCIATION 
Several activation techniques are used in tandem mass spectrometry 
experiments to fragment or dissociate precursor ions. The application of a 
specific fragmentation technique to a precursor ion leads to the generation of 
product ions in a predictable manner. For example, fragmentation of peptide ions 
will produce specific fragment ions generated by the cleavage of the Ca-C bond 
(an and Xn fragments), or C-N bond (bn and Yn fragments) or N-Ca (cn and Zn 
fragments) (Figure 1.1.15). 
G R R R ~ + +I I I H2N-CH-CO-(NH-CH CO)n NH CH-COOH + H 
Figure 1.1.15 Main fragmentation paths of peptides in MSjMS 
For example, electron transfer dissociation (ETD) and electron capture 
dissociation (ECD) generate Cn and Zn fragments, whereas collision-induced 
dissociation (CID) mainly creates bn any Yn fragment ions. 
The CID technique is based on the collisions of the precursor ion with neutral gas 
atoms (e.g N2 or Ar) in a collision cell. During the collision, a part of the initial 
kinetic energy of ions, is converted into internal energy [46]. The maximum 
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amount of energy converted into internal energy from the collision in the centre 
of mass frame of reference (Ecm) is given in equation 1.24 
Equation 1.24 
where Elab is the ion's kinetic energy, Me is the mass of the buffer gas and M is the 
mass of the precursor ion [47]. cm experiments can be categorised as either low-
energy or high-energy, with the barrier between these two categories defined as 
100 eV. Generally, low energy em favours facile bond cleavage resulting in a 
limited variety and quantity of product ions, whereas high energy cm induces 
significant fragmentation resulting to more complex spectra. 
1.2 ION MOBILITY - MASS SPECTROMETRY 
Ion mobility spectrometry (IMS) refers to the analytical technique that separates 
gas-phase ions based on their different mobility through a buffer gas at a 
(normally) uniformly applied electric field. In contrast to MS, IMS separates ions 
based on their charge and shape rather than their m/z ratio. The combination of 
IMS with MS, usually abbreviated as IM-MS, provides a platform capable of 
addressing a wide variety of analytical challenges. The complimentarily of these 
individual techniques affords 2D separation of analytes on the size-to-charge 
and mass-to-charge axes, respectively [48]. Relatively recent studies on highly 
complex mixtures have shown that IM-MS gives far greater resolution and 
information than is possible by either method alone [49, SO]. A particularly 
powerful application of IM-MS lies in its ability to size particles of defined m/z 
values through measurement of their collisional cross section (CCS) [48]. When it 
is combined with ESI, in particular, this technique may be utilised to study the 
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conformation of biomolecules in the gas-phase [51-56] with the potential to 
provide low resolution structural information [57,58]. 
There is much debate on the structure of protein ions in gas-phase [59]. Whilst it 
appears probable that surface side-chain collapse occurs within picoseconds of 
dehydration, some elements of gross structural rearrangement may require 
milliseconds. Thus, there may be a window for the observation of species which 
are relatively similar to the solution structure. 
1.2.1.1 ION MOBILITY 
IMS is based on measurements of an ion's mobility in the gas-phase. The ions 
while passing through a 'drift tube', are accelerated by the applied static electric 
field and decelerated by the opposite flowing buffer gas (Figure 1.2.1) . 
•• 
•• 
•• 
Figure 1.2.1 A simplistic image of an ion mobility spectrometer. Analytes with 
increased mobility move quicker through the drift tube. 
Assuming the electric field is static and the pressure of the buffer gas is constant, 
the average 'drift velocity' (VD) of an ion that travels through a 'drift tube', is 
dependent on the applied electric field (E) and its mobility (K) and it can be 
calculated by the following equation. 
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Vo =K.E Equation 1.25 
]n addition, the 'drift velocity' is given by: 
L 
vo=-
to 
Equation 1.26 
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where L is length of the drift tube and tD is the 'drift time' i.e. the time it takes an 
ion to pass through the 'drift tube'. 
The ion's mobility at standard conditions (temperature and pressure) also known 
as reduced mobility, Ko, is given by the following equation: 
P 273.2 
Ko = 760 -T- K 
where P is the operating pressure in Torr. 
Equation 1.27 
The mobility of an ion can also be calculated by following equation: 
Equation 1.28 
where z is the integer ion's charge, e is the charge of an electron (i.e. 1.602x10· 
19C), N is the number density of the buffer gas, Jl is the reduced mass of the 
neutral ion, T is the operating temperature in Kelvin, kb is Boltzmann's constant 
and no is the ion's collision cross-section [60]. 
The mobility of an ion depends on the number of collisions between that ion and 
the buffer gas. Larger collision cross-sections undergo more collisions with the 
buffer gas, thus their velocity is reduced and as a consequence the drift time is 
increased. For example, an unfolded protein ("open" form) has larger rotationally 
averaged collision cross-section compared to its folded form ("compact" form) 
and as a result higher drift time (assuming that both fold and unfold form, are 
equally charged). 
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Combining equations 1.27 and 1.28 and rearrange to solve for f1: 
Equation 1.29 
But, 
where, MJ and MG are the masses of the neutral ion and buffer gas, respectively, 
and from equations 1.25 and 1.26, 
L 
K=-
tDE 
Thus, equation 1.29 can be re-written as, 
n = 
(18rr)1/2 z e (_1 +_1 )1/2tDE 760 __ T __ 1 
16 (kb T)l/z MJ MG L P 273.2 N 
Equation 1.30 
Equation 1.30, gives the collision cross-section of an ion, which can be directly 
calculated from the measured drift times (to). 
Clemmer's work [61], on the analysis of electrosprayed biomolecules by IM-MS 
in the late 90's, demonstrated that IM-MS can be applied to the analysis of 
biomolecules, and is especially beneficial for gas-phase conformational studies. 
Their studies played a central role in the development of the modern IM-MS 
instruments. For example, they showed that the usage of an ion trap in order to 
accumulate ions before entering the drift tubes, can increase the sensitive (in 
terms of SIN ratio) by factors of 10-30. 
1.2.1.2 TRAVELLING WAVE ION MOBILITY SPECTROMETRY 
A recently developed hybrid instrument, the Synapt HDMS by Waters (Figure 
1.2.2), which is a quadrupole-IMS-TOF instrument, has introduced the use of a 
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travelling wave-enabled stacked ring ion gUide [62] as an alternative to the 
classic drift tube IMS devices. In a TWIMS (travelling wave ion mobility 
spectrometry) device, the static gradient electric field (DC axial field) of the drift 
tube is replaced by high-speed travelling wave potential, which propagates along 
the drift tube at adjustable wave heights and velocities. The transmission of DC 
voltage in travelling waves is achieved with the application of RF voltage, of 
opposite phase, to the adjacent electrodes which produce a radial confinement 
for the transited DC voltage. 
Figure 1.2 .2 a) A sch ematic of the Waters Synapt HDMS . Adapted from re fe rence [5 2] . 
A comparative study [63] has shown that the efficiency of mobility separation of 
protein ions by TWIMS is similar to that of static-field drift tube devices. In 
addition, as has been concluded from the same study, the usage of the TWIMS 
device, does not compromise mass spectrometers sensitivity when the 
instrument is running in mobility mode. However, the use of TWIMS device 
instead, of a conventional drift tube, comes at the cost that ion CCS cannot be 
directly measured from the arrival time of the ions. Instead it is necessary to 
calibrate the instrument using a series of protein or peptide calibrants [57, 64, 
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65] (see Chapter 2). A number of databases containing the CCSs of these 
calibrants are available; including those from the Clemmer group 
(http://www.indiana.edu/-clemmer) the Bush Lab (http://depts.washington.edu/bushlab) 
and the McLean group (http://www.vanderbilt.edu/AnS/Chemistry/groups/mcleanlab/ccs.html). 
Several recent applications have successfully demonstrated the ability of IM-MS, 
including TWIM-MS, to study the conformation and stoichiometry of proteins 
and their complexes. For example, structural changes to amyloid and prion 
proteins, as well as the calcium-dependent conformational change in calmodulin 
have been probed by TWIM-MS [66-68]. Insights into the structures of large 
multi-protein complexes, such as the RNA-binding TRAP protein and the GroEL 
have also been provided by the same technique [64, 69]. The dynamic 
equilibrium between biologically-relevant compact and extended conformations 
of cytochrome P450 reductase has also been examined by TWIM-MS [70]. Steps 
in amyloid fibril assembly, the structure of the 20S proteasome as well as the 
relationship between tertiary structure and chemotactic activity in anti-bacterial 
peptides, have been studied using other IM-MS approaches [17,71,72]. 
1.2.1.3 THEORETICAL COLLISION CROSS SECTION CALCULATION 
Computational methods allowing the calculation of CCS from atomic coordinates 
derived from NMR spectroscopy, X-ray crystallography and molecular dynamics 
simulations are employed to evaluate the experimentally measured CCS obtained 
by IMS or IM-MS (including TWIM-MS) experiments. This can provide useful 
information about the maintenance or modification of the protein conformation 
upon transfer to the gas-phase [73]. In addition, in cases where the conformation 
of a protein or a protein assembly is unknown, combination of experimentally 
derived CCS data with those obtained by molecular modelling and/or molecular 
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dynamics simulations can provide a good prediction of the real structure or 
conformation. 
Three different algorithms are commonly used to calculate the theoretical CCS of 
a molecule; the projection approximation (PA), the trajectory method (TM) and 
the exact hard sphere scattering (EHSS). The PA approach averages the 
geometric projection areas over all possible orientations and measures the CCS of 
this averaged shape. The EHSS method treats the protein and the buffer gas as 
hard spheres, and calculates the scattering angles of the buffer gas upon collision 
[74, 75]. The TM model is considered to be the most realistic model for the 
theoretical calculation of protein CCS values. This approach simulates the 
collisions between the analyte molecule and the gas particle as a Lenard-Jones 
potential; this also accounts the contribution of mUltiple collisions and long range 
interactions in the CCS calculation. 
1.3 CONCEPTS OF PROTEIN STRUCTURE AND FUNCTION 
1.3.1 STRUCTURE AND FUNCTION OF PROTEINS 
Proteins or peptides are built by the assembly of small organic molecules, called 
amino acids. There are 20 proteinogenic amino acids, which are usually 
considered natural or canonical, since these correspond to 61 out of a total of 64 
codons within the triplet code. Figure 1.3.1 shows a general amino acid structure. 
Amino acids are amphoteric organic molecules, therefore they can either be 
positively charged (protonated) or negatively charged (deprotonated), or they 
can exhibit a zwitterion structure (Figure 1.3.2). Each amino acid is characterized 
by a unique R functional group -hydrogen in case of glycine (Gly)- that is 
attached to the a-carbon, and it is commonly referred as the side chain. With the 
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exception of Gly, all the amino acids are optically activity, however, only the L-
stereoisomer participates in the construction of polypeptide chains assembled by 
the ribosome. Moreover, the nature of the side chain, affects the electronic 
properties of the residue, which allows the classification of the 20 amino acids 
into four categories; basic residues, acidic residues, polar residues and non-polar 
residues (Table 1.3.1). The following subsections are dealing briefly with the 
im portant role of side chains in the construction of biologically functional protein 
structures. 
H H 0 
I I II 
H-N-C-C-OH 
I 
R 
Figure 1.3.1 Generalised structure of amino acids. R represents the side chain. 
H3
NEB
" 1 H3NEB" 1 e H,N" 1 e 
'I "OH 'I "0 'I "0 
R R R 
pH 
Figure 1.3.2 The amphoteric character of amino acids. 
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Table 1.3,1 The twenty amino acids 
Glycine 0 
Gly, G H 2 N ~ ~til OH til 0 Q) Q) lfOH til til (1j (1j Proline u 0 u ~ ~ ~ ~ Pro,P 
'u Cysteine H ~ { { 'u Q) Q) 0.. OH 0.. 
Vl Cys, C Vl SH 
Residue Side chain Residue Side chain 
name name 
Arginine ~ ~ r N H H Alanine 
-----
CH3 
Arg,R NH. Ala, A 
u Histidine 
-CNH Valine I 'iii I I (1j ~ ~ I I CQ ~ ~His,H N Val, V 
Lysine ~ N H 2 2 Isoleucine ~ ~..... Lys,K lie, I 
Aspartic OH Leucine ~ ~acid ~ o oAsp,D Leu,L u ;a 
'u Glutamic 
L. 
< OH (1j Methionine 
acid ~ o o "0 0. ~ s / /I Met,M c GJu, E 0 z 
Serine 
Phenylalani 
~ O H H ne ( ) Ser, S Phe,F 
Threonin OH Tyrosine 
e A -o-OH L. Thr, T Tyr, Y (1j 
"0 
Il. Asparagin 
e y N ~ ~ f" NH 
Asn,N 0 Tryptophan 
=-Trp, W 
Glutamine ~ N H 2 2 !J ~ ~
GIn, 
0 
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1.3.1.1 LEVELS OF PROTEIN STRUCTURE 
There are four structure levels involved in protein architecture: 
a) The primary structure refers to the linear sequence of the covalently 
attached amino acids in a protein. Each protein is characterized by a 
unique amino acid sequence, which can also define its structure. In 
addition, PTMs as phosphorylation, glycosylation and formation of 
disulfide bonds are also considered a part of the primary structure. 
b) The secondary structure refers to structural motifs occurring within the 
protein structure. These motifs are mediated by intermolecular and 
intramolecular hydrogen bonding of amide groups. For example, the a-
helix is a common secondary structure motif that is stabilized by 
hydrogen bonds formed between the backbone N-H group of one residue 
with the backbone c=o group of the fourth residue away from it (Figure 
1.3.3a). Another example, is the p-sheet which is stabilized by hydrogen 
bonds between N-H and C=O groups of adjacent anti parallel molecules 
(Figure 1.3.3b). 
c) The tertiary structure is the three-dimensional arrangement of all the 
amino acids that are included in a single polypeptide chain. Its stability is 
determined by non-covalent interactions, including hydrogen bonding, 
dispersion forces and salt bridges as well as by the entropic driving force, 
known as the hydrophobic effect. 
d) The quaternary structure refers to the three-dimensional structure of a 
biomolecular entity that consists of more than one polypeptide chain, 
and/or the addition of small molecule ligands. For example, the 
biologically active structure of haemoglobin, exhibits a quaternary 
structure since is consisted of 4 polypeptides chains and 4 iron-
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containing heme groups (Figure 1.3.4). The establishment of quaternary 
structures is driven by non-covalent forces similar to those stated above 
for the determination of the tertiary structure. 
a 
R 
b 
Figure 1.3.3 Two of the most commonly occurring secondary structures, (a) the 
a-helix and (b) the anti -parallel b-sheet. Hydrogen bonds are represented by the 
dotted lines. Figure adapted from htta:!(www.mun.calb;o[ogy(scarrIMGA2 03 -
18b.html 
Figure 1.3.4 The quaternary structure of haemoglobin showing the two alpha 
(light blue) and two beta (red) chains as well as the four heme groups (green). 
From POB 10: lGZX. 
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1.3.2 PROTEIN- PROTEIN INTERACTIONS 
Several vital cellular processes including, proteolysis, DNA repair, DNA 
replication and protein folding are carried out by large protein complexes. These 
biomolecular entities are established by protein-protein interactions, which are 
driven by non-covalent forces including hydrogen bonding, dispersion forces and 
salt bridges and by the hydrophobic effect. 
1.4 THE UBIQUITIN SYSTEM 
The functional diversity and dynamics of the eukaryotic proteome is mainly 
attributed to post-translational modifications (PTMs) of proteins such as 
phosphorylation, methylation, acetylation and ubiquitination (or ubiquitylation). 
The first three modifications involve a small chemical group (phosphate, methyl 
and acetyl group, respectively) whereas the latter entails the conjugation of a 
small protein, namely Ub (Ub) to a target protein. This conjugation was initially 
recognized as the trigger for proteasomal protein degradation; a protein 
degradation mechanism known as the Ub-proteasome proteolytic pathway. 
Today, almost 40 years after its discovery, the Ub system is known to be 
implicated in several pathways. It is also known that, crucial to the function of Ub 
as a signalling motif is its non-covalent association with modular protein 
domains known as Ub-binding domains (UBDs). The following subsections 
provide further details regarding Ub, ubiquitination, UBDs and Ub.UBD 
interactions. 
1.4.1 UBIQUITIN 
Ub is a 76-residue protein (- 8.5 kDa) that is ubiqUitously expressed in 
eukaryotic organisms and is highly conserved among the Eukaryota. Its 
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secondary structure is defined by a 3.5-turn a-helix, a 310 helix and as-stranded 
~ - s h e e t t (Figure 1.4.1a). The human and yeast Ub share 96% sequence homology, 
with 73 out of 76 amino acids are located at the same position [76] leading to the 
conclusion that the primary structure and thus the secondary structure of Ub, is 
essential for its biological functionality. Key features of Ub include its (-terminal 
and the seven lysine (Lys) residues, located at positions 6, 11, 27, 29, 33,48 and 
63, which permit the formation of poly-Ub chains, both homotypic and 
heterotypic [77]. As we will see later on, Ub's ability to utilize anyone of the 
seven Lys residues in order to form poly-Ub chains of specific topology and 
length is critical for its vital role as a signalling motif. Furthermore, three regions 
located on Ub's surface; the hydrophobic patch around Jle44, the polar patch 
Asp58 and the (-terminal Gly76 residue (Figure 1.4.1b), are known to promote 
the non-covalent interaction of Ub or ubiquitinated substrates with Ub receptor 
proteins Le. biomolecular assemblies that recognize and process Ub signals. 
a b 
Figure 1.4.1 a) The secondary structure of Ub is defined by a 3.S-turn a-helix, a 
31 0 helix and a 5-stranded ~ - s h e e t , , b) Surface representation of Ub showing the 
Ile44 hydrophobic patch (yellow), the polar patch AspS8 (light blue) and the C-
terminal Gly76 residue (pink). POB 10: 103Z 
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1.4.2 UBIQUITINATION 
The Ub conjugation pathway-ubiquitination-is a fundamental regulatory 
mechanism involved in several eukaryotic cellular processes. Protein 
degradation [78], vesicular trafficking [79], DNA repair [80], endocytosis [81], 
transcription and gene silencing [8Z] are all regulated by this important PTM. It is 
catalysed by a triplet of enzymes,-El, EZ, E3-and leads to the formation of an 
isopeptide bond between the C-terminal glycine carboxyl group of Ub and, 
usually, a Lys residue in the target protein (more details regarding the 
mechanism are given below). The attachment of Ub to a target protein through 
substrate's N-terminus has been reported [83], as well as though the thiol group 
of cysteine (formation of thioester bond) [84] and the hydroxyl group of serine or 
threonine residues [85]. Repetition of the ubiquitination cycle leads to the 
formation of poly-Ub chains by utilizing anyone of the seven Lys residues of the 
Ub monomer, as well as Ub's N-terminus. Clear evidence is emerging that 
proteins labelled with poly-Ub chains of a specific topology and length are driven 
to a specific process. For example, Lys48-linked chains classically signal the 
target protein degradation by the proteasome [86], whereas Lys63-linked chains 
act as a trigger in a variety of pathways including DNA damage tolerance [87], the 
inflammatory response [88], protein trafficking [89] and regulation of protein 
synthesis [90]. Furthermore, it has been reported that Lysll-linked chains serve 
as potent proteasomal degradation signals [91]. Studies on the BRCA1-BARDt 
complex, have shown that Lys6-linked poly-Ub chains are likely to be involved in 
DNA repair [92, 93]. 
1.4.2.1 THE UBIQUITINATION CYCLE 
The ubiquitination cycle starts with the activation of the C-terminus of Ub by El 
activating enzyme. This ATP dependent step forms a Ub-adenylate intermediate 
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i.e. a Ub-AMP adduct is bound to the E1 enzyme, which finally results in the 
formation of a thioester between a side chain of a cysteine (Cys) residue of E1 
enzyme and the C-terminus of Ub. The activated Ub moiety is then attached to a 
Cys residue of an E2 conjugating enzyme, and finally transferred to an amino 
group (usually E-amino group of a Lys residue) of the substrate through the E3 
Ub protein ligase enzyme. Furthermore, the ligation of Ub to the target protein 
can be catalysed via two pathways, dependent on the type of the E3 enzyme that 
participates. There are two types of E3 Jigases: The HECT -domain E3s form a 
thioester bond with Ub before substrate attachment. In contrast, the RING-
domain E3s, instead of a straight interaction with Ub, they function as a bridge 
between an activated E2 and the substrate [94] (Figure 1.4.2) . 
o . ~ ~
o 
SH 
~ ~ C , , ~ ~
K 
I 
I 
Figure 1.4.2 Major enzymatic pathways of protein ubiquitination 
To date, only two E1 Ub activating enzymes have been discovered in the human 
proteome, in contrast to 50 E2 activating enzymes and 600 E3 ligase enzymes 
[95]. This hierarchical distribution of the Ubiquitination enzymes leads to the 
existence of a large number of possible enzyme combinations (E1jE2jE3) that 
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are able to carry out the ubiquitination mechanism, which results in high 
substrate specificity. 
1.4.3 UBIQUITIN BINDING DOMAINS 
UBDs are modular protein domains that associate with Ub through non-covalent 
interactions. These motifs are found in proteins-Ub receptor proteins-which 
execute disparate biological functions, for example UBDs are present in the 
degradation machinery proteasome 26S and in the endocytic machinery EPS15. 
In addition, UBDs are present in ubiquitination enzymes, for example, in the E2 
or Ub-conjugating enzyme (Ubc) [82, 96]. Therefore, this non-covalent 
interaction may promote covalent Ub attachment (ubiquitination) and thus the 
formation of poly-Ub chains of specific length and topology, as well as direct the 
fate of ubiquitinated proteins leading to regulation of cellular processes. 
Several UBDs have been identified and categorized. UBDs within the same family 
show structural similarities and it is believed that they interact with the same 
region of Ub to form a non-covalent Ub.UBD complex. For example, a-helical 
domains non-covalently bind to Ub via a hydrophobic patch located in the ~ ~
sheet region of Ub, known as the Ile44 hydrophobic patch (Figure 1.4.1b). In 
contrast, ZnF (Zinc finger) domains bind to Ub via three different regions (Asp58, 
Ile44 and Gly76) located in the surface of Ub. 
The binding affinities between Ub and UBDs are moderate to weak (Table 1.4.1). 
There is a range of binding affinities against mono-Ub and poly-Ub chains (in 
terms of length and topology) within the same family of UBDs (Table 1.4.1). 
However, the binding affinity and as a consequence the Ub-type preferred by an 
isolated UBD, might differ from that preferred by the UBD-containing protein due 
to steric interactions, for example. 
42 
Introduction cnapter 1 
Table 1.4.1 Binding affinities of monoUb.UBD complexes 
Source Binding affinity Function Ref. UBD Protein Kd (PM) Method* 
a-Helix 
MlU Rabex-S 29±4.8 SPR [97] 
28.7 ITC 
Endocytocis [98] 
DUIM Hrs 190 SPR MVB biogenesis [99] 
Proteasome targeting, [100, 
UBA HHR23A 400±100 NMR kinase regulation and 101] 
autophagy 
UQl Ubiquilin-l 20±S NMR [102]] 
Ub-conjugating (Ubc) domains 
DNA repair. MVB 
UEV TsgI01 S10±3S SPR biogenesis and kinase [103]] 
regulation 
UBC UBCHSC 300 NMR Ub transfer [104]] 
Zinc finger (ZnF) 
NZF Npl4 126±26 SPR ERAD, MVB biogenesis [105] 
and kinase regulation 
A20 Rabex-S 22±0.4 SPR Endocytocis and kinase [97] ZnF 
12 ITC regulation [98] 
ZnF Proteasome function, Isopeptidase T 2.8 ITC aggresome function and [106) UBP 
autophagy 
... NMR: Nuclear Magnetic Resonance 
SPR: Surface Plasmon Resonance 
CD: Circular Dichroism 
ITC: Isothermal Titration Calorimetry 
1.4.3.1 HELICAL DOMAINS 
Most of the identified UBDs are members of the a-helical UBD family which 
interact with Ub via the Ile44 hydrophobic patch located on the surface of Ub. 
These domains can be further grouped into two subcategories, a) the single a-
helix domains which bind Ub through a single a-helix and b) the three-helix 
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bundles which bind Ub through two of the three a-helices. For example, the UBA 
(Ub associated) domain of the human homologue Rad23A (hHR23A) is a three-
helix bundle and binds to Ub through a conserved hydrophobic patch formed by 
a1 and a2 helices [107]. To date, only three single a-helix domains have been 
reported: UlM (Ub Interacting Motif), DUlM (Double-sided Ub Interacting Motif) 
and MIU (Motif Interacting Ub). In contrast, several three-helix bundles have 
been identified and some of the most common UBDs are listed in Table 1.4.1. 
Single a-helix domains: UIM and its variants MIU and DUIM 
UlM was the first single a-helix domain described[108]. It is found in many 
trafficking proteins such as the SSa subunit of the proteasome, the vacuolar 
protein sorting proteins including Hrs (yeast Vps27p) and the Stam1 (yeast 
Hse1), as well as the endocytic proteins Eps1S and Eps1SR which are essential 
for endocytosis of receptors like the ligand complex of the epidermal growth 
factor (EGF) with its receptor (EGFR) [109]. 
MIU, a variant of UIM, it is presented only in the endosomal trafficking regulator 
RabS exchange factor Rabex-S, which contains another UBD, the A20 ZnF domain. 
Like UIM, MIU bind Ub via the IIe44 hydrophobic patch but with the single helix 
in inverted orientation against Ub's surface i.e. the C-terminus of UIM domain 
corresponds to the N-terminus of MIU domain. This inversion, however, allows 
MIU to interact with Ub more extensively compared to UlM, creating extra 
hydrogen bonds with the Lys63 region of Ub [97]. 
The last member of the single a-helix subfamily is DUIM which is found in the 
hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) protein that 
is essential for the endosomal sorting of ubiquitinated membrane proteins. For 
example, Hrs is needed for the sorting of the amino-terminal cytoplasmic domain 
of human transferin receptor (TfR) from endosomes to lysosomes for 
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degradation [99]. The DUIM domain is an alternative to a double repeat of UIM 
domain (Ub Interacting Motif) that is able to bind two Ub moieties 
simultaneously (one moiety in each side). It has been reported that this double-
sided binding capability is essential for the degradation of the epidermal growth 
factor (EGF) receptor [81,99]. 
Three-helix bundles 
The Ub associated (UBA) domain was the first Ub binding domain described. It 
was discovered in a bioinformatic analysis of the enzymes involve in the 
ubiquitination pathway. It was found that a small motif about -55 residues long, 
with a conserved number of nonpolar residues (which is stabilizing its structure) 
was present in E2 and E3 and UBPs (Ub carboxyl-terminal hydrolases) families 
as well as in Ub-like (UBL) domains[110]. The UBA-containing proteins as well as 
the UBA-UBL proteins are involved in the transfer of polyubiquitinated 
substrates (Lys48-linked) to proteasome[78, 111], in DNA excision-repair [107] 
and cell signalling via protein kinases. 
An example of a UBA-containing protein is the human homologue of yeast 
Rad23A (hHR23A) which is involved in DNA-repair [107] and in proteasome 
proteolytic pathway [112], and contains two UBA domains, one internal (UBA1) 
and one at the C-terminus (UBA2). Both domains fold into similar three-helix 
bundles that are stabilised by hydrophobic interactions. In addition, both 
domains have a hydrophobic surface patch which is believed to mediate binding 
to Ub by interacting with Ub's hydrophobic surface patch Ile44 [113]. Studies 
reveal that the UBA2 domain shows strong binding preference for Lys48-linked 
poly-Ub chains [100]. 
The presenilin-interacting protein [114, 11S], human ubiquillin-l (UQ1 or 
hPLIC1), is an example of a UBL-UBA protein which is consisted of an N-terminal 
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UBL and a C-terminal UBA domain. The UBA domain of UQl (UQ1-UBA) forms a 
three-helix bundle and bind mono-Ub via the hydrophobic surface of Ub Ile44 
with a relatively high affinity (Kd-20IlM) compared to other UBA domains [102]. 
In addition, the same study showed that in contrast to the UBA2 domain of 
hHR23A, the UQ1-UBA domain has no selectivity against Lys48 and Lys63 chains, 
but in general it binds more strongly to poly-Ub chains than mono-Ub [102]. 
1.4.3.2 ZINC FINGER DOMAINS 
Zinc finger (ZnF) domains represent the second largest family of UBDs. ZnFs are 
categorised in three classes; the NZF, the A20 ZnF and the ZnF UBP domains. In 
contrast to helical domains, ZnF bind to Ub via three different regions located on 
Ub's surface. For example, while the A20-type ZnF domain of RABS guanine 
nucleotide exchange factor (RABEXS) bind to Ub via the polar surface of Ub 
around Asp58, two other members of the ZnF family, the nuclear protein 
localization 4 ZnF (NZF) domain and the Ub-binding ZnF (UBZ) domain, bind to 
Ub via its hydrophobic surface around Ile44. The ZnF domain of IsoT, in contrast, 
interacts with Ub via the latter's C-terminal residue (Gly76) [82,116]. 
1.4.3.3 OTHER UBDS 
Ub-conjugating (Ubc) domains, also known as E2 conjugating enzymes, contain a 
common 150-amino-acid catalytic core with an all3 fold [94]. The role of E2 
enzymes in protein ubiquitination has been previously discussed in this chapter. 
The UEV (Ubc E2 variant) domain, in contrast to Ubc domains, does not contain a 
catalytic cysteine residue. It has been shown that a UEV domain, Mms2, 
heterodimerizes with Ubc13 domain to facilitate the assembly of Lys63-linked 
poly-Ub chains [117]. 
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1.5 AIMS AND OBJECTIVES 
The intrinsic importance of the Ub-UBD interactions has been extensively 
discussed previously in this Chapter, and therefore their study accumulates high 
scientific interest. A number of biophysical methods, including NMR, SPR and ITC 
are currently employed to study Ub-UBD non-covalent complexes. These 
techniques have contributed significantly to our understanding of the often weak, 
non-covalent interactions of Ub. However, each technique has its limitations and 
drawbacks, which are discussed later in Chapter 4. The aim of Chapter 4 is to 
develop and apply a rapid and highly sensitive ESI-MS method to determine 
affinity and linkage-selectivity of Ub-UBD interactions. 
The investigation of weak hydrophobic interactions seen in many Ub-UBD 
complexes, is expected to be very challenging for a gas-phase method such as 
ESI-MS. Indeed, as it will be shown in Chapter 4, a number of Ub-UBD complexes 
that are studied in this thesis, are readily dissociated and therefore their binding 
affinity cannot be determined. The aim of Chapter 3 is to develop a simple, clean 
and effective method for reducing charge state distributions and consequently 
prevent facile dissociation of the Ub-UBD complexes. 
The role of unanchored poly-Ub chains has only recently begun to be understood 
and linked to Ub-mediated processes. In a similar manner to conjugated Ub 
chains, unanchored chains also exhibit linkage specificity and, therefore, their 
study is equally important. Chapter 5 aims to examine the development and 
employment of a top-down proteomics approach to reveal the topology of 
unanchored poly-Ub chains. Additionally, the presence of cyclic Ub2 component 
in commercial samples of Lys48-Ub2 and in samples of endogenous purified Ubz 
material is also investigated in Chapter S. 
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In Chapter 6, the unusual effects of ammonium and alkali metal ion adducts upon 
the conformation of the three-helix bundle proteins UQ1-UBA and hHR23A-
UBA2 are investigated. In the final Chapter 7, the synthesis of small peptides and 
the employment of ESI-MS to investigate their potential inhibitory activity 
against the Ub-lsoT-ZnF interaction, are examined. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 MATERIALS 
2.1.1 SAMPLES PURCHASED /PROVIDED 
Ultrapure water (18.2 Mil·cm), obtained from a Millipore water purification 
system (Epsom, UK), was used in the preparation of all sample solutions. 
2.1.1.1 UBIQUITIN AND UBIQUITIN MUTANTS 
. ~ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Ammonium acetate was purchased from Thermo Fisher Scientific (Loughborough, 
UK). Lyophilized bovine red blood cell ubiquitin was obtained from Sigma-Aldrich 
(Poole, UK) and prepared as a 116 11M sample in 25 mM ammonium acetate solution. 
Lyophilized diubiquitins (Lys11-Ub2, Lot# 32141210; Lys27-Ub2, Lot# 34144710; 
Lys48-Ub2, Lot# 3291529 and Lot# 11515211; Lys63-Ub2, Lot# 1691689) and 
tetraubiquitins were obtained from Boston Biochem (Cambridge, USA) and 
prepared as a 58 11M and 29 J..lM samples, respectively, in 25 mM ammonium acetate 
solution. The uhiquitin mutants (double mutant Leu8/Ala, Ile44/Ala and 
~ - G l y 7 5 / G l y 7 6 6 deletion mutant) were designed and expressed by Dr. Jed Long 
(University of Nottingham). These samples were supplied as purified lyophilized 
stocks and were prepared as 116 J..lM samples in 25 mM ammonium acetate solution. 
2.1.1.2 UBIQUITIN BINDING DOMAINS 
.----------------------------------
The UBDs were expressed as GST fusion proteins in E. coli strain XL10-Gold, purified 
and thrombin cleaved. GST-fusion UBD plasmids were constructed and transformed 
into E. coli glycerol stocks by Dr. Debora Channing (University of Nottingham). More 
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details about the expression and purification of UBDs are given below (see Methods 
section). 
Preparation of solutions for protein overexpression and purification 
Luria Broth (LB) was obtained from Sigma-Alrich (Poole, UK). LB is consisted of 
40% tryptone, 40% sodium chloride and 20% yeast extract The solution was 
prepared by adding 25 g LB to 1 L deionised water and autoclaved at 121°C, 
overnight. 
Ampicillin stock: 100 mg/mL stock prepared by dissolving 1 mg in 10 mL of 
deionised water and was filter sterilised. 
IsopropyI1-thio-JJ-n-galactopyranoside (lPTG) obtained from Roche Diagnostics 
Ltd (Burgess Hill, UK) and prepared as a solution to a final concentration of 200 mM. 
Tri-buffered Saline with 0.1 % Triton (TBS-T): Solution consisted of 10 mM tris-
HCI, 150 mM NaCl and 0.1% Triton X-I00 at pH 7.5. 
Throbin cleavage buffer (TCB): Solution consisted of 20 mM tris-HCI, 150 mM 
NaCI and 2.5 mM CaCh [what do you mean dehydrated? Surely it was a solution] at 
pH 8.4. 
Thrombin was obtained from Sigma-Aldrich (Poole, UK). 
2.1.1.3 CHARGE REDUCTION BY SOLVENT EXPOSURE EXPERIMENTS 
Acetonitrile, methanol, isopropanol and dicloromethane were purchased from 
Thermo Fisher (Loughborough, UK). Bovine pancreas trypsin (TPCK treated), 
benzamidine hydrochloride, ubiquitin and horse heart myoglobin were obtained 
from Sigma-Aldrich (Poole, UK). Human transthyterin (TTR) was obtained from 
AppliChem GmbH (Darmstadt, Germany). TTR was desalted using Vivaspin columns 
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(MWCO 10 kDa), (Sartorius, Goettingen, Germany), prior to use. Myoglobin and 
ubiquitin were prepared in 25 mM CH3COONH4 to a final protein concentration of 
2J..lM and 1 J..lM, respectively. TTR (2.5 llM) and a mixture of trypsin (12 IlM) and 
benzamidine hydrochloride (53llM), were prepared in 10 mM CH3COONH4. 
2.1.1.4 MOBILITY CALIBRATION STANDARDS 
.-----------------------------
Lyophilised myoglobin, human heart cytochrome c, bovine red blood cell 
ubiquitin and bradykinin were purchased from Sigma-Aldrich (Poole, UK) and 
were prepared as a 1 IlM samples in CH30H/H20/CH3COOH (50:50:1 (vol/vol)) 
solution. Acetic acid was obtained from Thermo Fisher Scientific (Loughborough, 
UK). 
2.1.1.5 PEPTIDE SYNTHESIS 
The N-a-Fmoc protected amino acids, Fmoc-Gly-OH, Fmoc-Arg(Pbt)-OH, Fmoc-
Leu-OH, Fmoc-Lys(Boc)-OH, Fmoc-His(Trt)-OH and Fmoc-Phe-OH, and the 
preloaded Fmoc-amino acid resins, Fmoc-Gly-Wang resin and Fmoc-Val-Wang 
resin, as well as the phosphonium-based activating reagent HCTU (0-(lH-6-
Chlorobenzotriazole-1-yl)-l,l,3,3-tetramethyluronium hexafluorophosphate) 
were obtained from Merck Bioscience Ltd (Nottingham, UK). Dimethylformamide 
(DMF), dicholomethane (DCM) and diethyl ether were purchased from Thermo 
Fisher Scientific (Lough borough, UK). N,N-diisopropylethylamine/N-
methylpyrrolidone (DIPEA/NMP) solution (2M), piperidine (99.5 %), 
trifluoroacetic acid (TFA, 99.5%) and triisoprolysilane (TIPS) were purchased from 
Sigma-Aldrich (Poole, UK). 
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2.1.2 INSTRUMENTS 
.... - .... _ .... _-.. _ .... _ ...... _. __ ......... __ .... _ ....__ . __ ...... - ............. __ .. _-----
2.1.2.1 MASS SPECTROMETERS 
_ ....... _ ...................... _ ............ _ •.. _ ................ _ ..... _ ..._ ........ _ ........................... - .. __ ... _--
Synapt HDMS, Waters 
Mass spectrometry (MS) and ion mobility-mass spectrometry (IM-MS) experiments 
were performed on a SYNAPTTM HDMS (Waters, Altrincham, UK), a hybrid 
quadrupole-ion mobility spectrometry-orthogonal acceleration time-of-flight (oa-
TOF) MS instrument, with travelling-wave ion mobility spectrometry (TWIMS) 
capability, equipped with the standard z-spray source and a nanoESI source. A 
schematic representation of the instrument is shown below in Figure 2.1.1. 
lOClCSPtAy l()(XM.U5 
wru lHEHNCE SI'aAI' 
Figure 2.1.1 A schematic of the Waters Synapt HDMS (adapted from reference [63]) 
Instrument control as well as data processing was performed using the Waters 
MassLynxTM 4.1 data system. All spectra were acquired in ion positive mode and the 
TOF analyzer operated on V-mode. Minimum smoothing and background 
subtraction was applied to the obtained spectra prior to analysis. More details about 
the major instrument components and their operation are given in a separate 
section in this chapter. 
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LTQ FT-ULTRA, Thermo Scientific 
Experiments of top-down proteomics to characterize in vivo polyubiquitin chains 
were performed of an L TQ FT -Ultra (Thermo Fisher, UK), a hybrid Linear Ion Trap-
Fourier Transform Ion Cyclotron Resonance MS instrument, with CID, IRMPD 
(infrared multiphoton dissociation) and ECD capabilities. The instrument was 
equipped with the standard nanospray ion source (Thermo Scientific, UK) . For 
continuous flow nanospray LC-MS operation, the fused-silica SilicaTipTM nanospray 
emitters (Cat.No FS360-75-30-CE5C10.5, NewObjective (Presearch Ltd, UK)) were 
used. A schematic representation of the instrument is shown in Figure 2.1.2. 
Differentially Pumped by Triple Ported Turbo Pump 
FTMS Data \<J 
7 T Actively Shielded 
Superconducting Magnet 
IRMPD laser Assembly 
Figure 2.1.2 A schematic diagram of the LTQ FT-ULTRA. Reproduced (modified) 
from http://thomson.iqm.unicamp.br!instruments details .php?cod instrument- 3 
Instrument control as well as data processing was performed using the Xcalibur 2.0 
SR2 data system. All spectra were acquired in ion positive mode . 
... -_ ........ - .... __ ...... - .............. __ .. _.. . .... _ ... _ .._ ...... _ .......... "_ ....... -----"---"-------
2.1.2.2 LIQUID CHROMATOGRAPHY SYSTEMS 
Ultimate 3000 Nano-Le, Dionex 
The eluted proteins that were subjected to top-down experiments were 
chromatographically separated and introduced to the L TQ FT Ultra MS system using 
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a Ultimate 3000 nano-LC system (Dionex, UK). Instrument control was performed 
either via the DCMSLink for Xcalibur 2.0, or via the Chromeleon 6.8 data system. The 
eluents from the column were directly driven to MS analysis. The sample manager 
compartment kept under the constant temperature of 8°C. The injected samples 
were initially loaded to a trap column and then they were loaded to the analytical 
column by back-flushing the from the trap column. The trap columns (PepMap C4 or 
C18) were purchased from Dionex, UK. The analytical columns were manufactured 
in house using a pressure cell (Brechbuhler, Germany) to pack 75 J..lm i.d. capillary 
columns (CatNo.IF360-75-50-N-5, NewObjective (Presearch Ltd, UK)) with either 
C4 or C18 reverse phase packing material. 
Agilent 1100 HPLC 
Peptides were purified by RP-HPLC using an Agilent 1100 system, consisting of a 
binary pump, a column compartment, a diode array detector and an autosampler. 
Purification was carried out on a semi-preparative column (Jupiter 300, 5 J..lm C18 
300 A, 250 x 10.0 mm, Phenomenex). The column was provided by Dr. David Tooth 
(University of Nottingham). Instrument control was performed using the 
MassLynxTM 4.1 data system. 
--------_._---------------
2.1.2.3 OTHER INSTRUMENTS 
Protein expression and sample preparation 
The centrifugations for cell collection were performed in an Avanti JA-25-50 
centrifuge while protein concentrations were performed in a CS-15R (Beckman) 
centrifuge. 
Protein samples were desalted and buffer exchanged for mass spectrometry analysis 
using ultracentrifugation spin filters with 3 kDa or 10 kDa molecular weight cut-off 
(Sartorius, Germany) and an Eppendorf 5417C centrifuge. 
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Peptide synthesis 
1. A rotary evaporator, Stuart RE300, connected to a water jet vacuum pump 
was used to remove the excess cleavage mixture (see Methods). 
2. A vacuum centrifuge, Jouan RCI022 (Thermo Scientific, UK) was used to re-
concentrate the purified peptides. 
3. The purified peptides were lyophilised using the Heto Powerdry® LL1500 
freeze dryer (Thermo Scientific, UK). 
2.2 METHODS 
Some of the ESI mass spectra presented in this thesis have been truncated in the x axis 
for clarity, i.e. only the area of interest is shown. 
2.2.1 CHARGE REDUCTION BY SOLVENT EXPOSURE 
Charge reduction was obtained by simple exposure of the electrospray plume into 
acetonitrile vapour. The experiments were performed on a Synapt HDMS 
instrument. Reduction of charge states on the observed spectrum occurs instantly, 
while recovering to usual charge states takes less than a minute by simple removal 
of the solvent container from the source housing. 
For solvent exposure experiments, a cap of a Falcon tube containing solvent was 
placed into the source housing and in the case of ESI the source was closed. The 
container was placed just inside the doorway to the source chamber (Figure 2.2.1). 
Typical settings for ESI experiments: positive ion mode with the ESI capillary held 
between 2.5 and 3 kV; nitrogen desolvation gas, 200 L h-1; source temperature, 50 
°C; desolvation gas temperature, 50°C; cone gas flow, 30 L h-1• 
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Figure 2.2.1 Photograph of the solvent container placed inside the doorway of the 
ESI source chamber. 
In order to use the nanoESI source in a sealed environment, the front of the source 
was enclosed in a sealed polythene bag (Figure 2.2.2). A nitrogen rich atmosphere 
was achieved by flushing with nitrogen for approximately 2 minutes. 
Figure 2.2.2 Photograph of the solvent container in a nanoESI source . 
For nanoESI experiments, Waters nanoflow probe tips (Manchester,UK) were used. 
NanoESI experiments typical settings: capillary voltage, 0.95-1.4 kV; source 
temperature, 50°C. 
Instrument parameters 
Four different protein complexes were used (Table 2.2.1). 
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Table 2.2.1 
Parameter Ub/UQl Myoglobin Human Trypsin/ 
complex TTR Benzamidin 
e 
Backing pressure (mbar) 4.0 2.1 5.0 4.0 
Trap pressure (mbar) 1.9x10-2 8.6x10-3 1.1xl0- 1.0x10-2 
2 
Trap collision voltage M 5 5 20-80 2 
Transfer collision voltage (V) 5 5 5 5 
Sampling cone voltage M 40 20 60 20 
Extraction cone voltage M 5 5 5 5 
IMS cell pressure (mbar) 4.5x10-1 - - -
Traveling wave height M 8 - - -
Traveling wave velocity 300 
- - -
(m/s) 
2.2.2 STUDIES OF UBIQUITIN-UBD INTERACTIONS 
2.2.2.1 EXPRESSION AND PURIFICATION OF UBDs 
The UBDs were expressed as glutathione S-Transferase (GST) fusion proteins in E. 
coli strain XL10-Gold. All constructs were verified by DNA sequencing. E. coli 
bacterial cultures were prepared by inoculating glycerol stock cells in 10 mL LB 
solution containing 10 J.lL ampicillin stock (100 J.lg/mL) and incubating overnight at 
37 DC with constant agitation (220 rpm). The solution was transferred to 1L of 
sterilised LB solution (25mg/mL) that contained 1 mL of ampicillin stock (100 
J.lg/mL). Bacteria were grown at 37°C for 4 h and then induced with 0.2 mM IPTG at 
OD600 - 0.6 and incubated overnight at 20°C with agitation (200 rpm). Cells were 
pelleted by centrifugation (20 min at 4000 rpm) and were frozen for at least 2 h. 
Then cells were re-suspended with 10 mL of TBS-T solution and lysed by sonication 
(three times for 30 sec at 6-7 microns with 1 min relaxation between sonication 
cycles). Lysate was clarified by centrifugation (20 min at 15000 rpm) and the 
supernatant was applied to a 5 mL gravity polypropylene column (Qiagen Ltd, UK) 
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containing 130 ilL glutathione beads (glutathione Sepharose™ 4B, GE Healthcare, 
UK) pre-equilibrated with TBS-T solution. The lysate-glutathione beads mixture was 
incubated for 1 h at 4 °e with continuous mixing by rotation. After the binding of 
GST-UBD fusion protein, the beads were washed with three column volumes ofTBS-
T solution followed by one washing cycle with TeB solution and finally incubation 
with 5 U of thrombin (diluted in 1 mL TeB) at 4 °e overnight Released UBDs were 
eluted and the beads were washed with TeB (3 mL). 
The amino acid sequence of each domain used in this study is shown in Table 2.2.2. 
The N-terminal Gly-Ser dipeptide is residual from thrombin cleavage. 
Table 2.2.2 Sequences of UBDs used in this thesis 
UBDs Sequence ofthrombin cleaved product 
Rabex5-MIU GSQKQIQEDW ELAERLQREE EEAFASSQS 
UQ1-UBA GSVRFQQQLE QLSAMGFLNR EANLQALIAT GGDINAAIER LLGS 
hHR23A-UBA2 GSQVTPQEKE AIERLKALGF PESLVIQAYF ACEKNENLAA 
NFLLSQNFDD E 
IsoT-ZnF 
GSKQEVQAWD GEVRQVSKHA FSLKQLDNPA RIPPCGWKCS 
KCDMRENLWL NLTDGSILCG RRYFDGSGGN NHAVEHYRET 
GYPLAVKLGT ITPDGADVYS YDEDDMVLDP SLAEHLSHFG 
IDMLKMQKTD K 
2.2.2.2 PROTEIN QUANTIFICATION BY LOWRY ASSAY 
.------------------------------------
The assay was carried out in a 96-well plate. BSA (bovine serum albumin) standard 
(1 mg/mL) was prepared in solution A (0.1 M NaOH / 0.3 KOH 9:1 (v/v)). A series of 
dilutions of BSA standard was performed to give eight BSA standards (200 ilL each) 
with concentrations in a range of 0-80 J.lg. Standards were prepared in triplicates. 
Similarly, 10 J.lL of each sample was diluted in solution A to a final volume of 200 J.lL. 
SO JlL of Lowry reagent (sodium carbonate solution / sodium potassium tartrate 
solution / copper sulphate solution, 10:1:1 (v/v) were added to all standards and 
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samples and incubated for 10 min. Then, 50 ~ L L of Folin reagent (10% (vjv) Folin 
and Ciocalteu's phenol reagent (Fisher Scientific, UK) in solution A) were added. The 
plate was incubated for 30 min at room temperature. Once colour had developed, 
the absorbance at 750 nm was measured using a plate reader (OYNEX technologies). 
2.2.2.3 SAMPLE PREPARATION FOR MS ANALYSIS 
.............. _ ............................................................................................ -.. _ ..... _ .......... _ ........ _ ..... _ .._ ....... _ .... _-- ----- -
UBOs were desalted and buffer exchanged into 25 mM NH40Ac buffer using Vivaspin 
500 ultrafiltration spin filters with 3kOa (in the case of IsoT -ZnF 10kOa) molecular 
weight cut-off (Sartorius, Goettingen, Germany). The IsoT -ZnF domain, subsequent 
to buffer exchange in 25 mM NH40Ac, was mixed with 0.5 mM dithiothreitol (OTT) 
at 4 °C, 24h prior the addition of Ub in order to reduce the disulfide-linked dimer to 
the monomeric domain. Samples were aliquoted (400 ~ L ) ) and stored in -20°C. 
Titration MS experiments 
Figure 2.2.3 illustrates the procedure flowchart of the method used in the titration 
MS experiments. 
UI .. UIO DesaHed i
Buffer exchange 
Purified and thrombin 
c leaved UBDs 
1 
GST· togged UBD. 
exp<essed In E.coH 
5050 
solu tion mtxtUfe 
1 
Solution mixtures 
uao Ub 
( ~ I I ) ) (flM ) 
A O.S 
S 2 O.S 
C 3 O.S 
0 O.S 
E 6 O.S 
8 O.S 
100 ESI-MS 
:: , "I" .' U", . t . I 
Figure 2.2.3 Procedure flowchart of the titration MS experiments 
Multiple replicates of six titration samples were prepared as 1:1 solution mixtures to 
final concentrations of Ub (0.5 11M (111M in the case of UQ1-tetra-Ub)) and UBD (1, 
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2, 3, 4, 6 and 811M). The samples were vortexed and subjected to MS analysis with 
no further preparation, using a syringe pump (Harvard syringe pump, model 55-
2222 Holliston, MA, USA) and a 100 ilL Hamilton syringe (Bonaduz, Switzerland), at 
a flow rate of 5 ilL min-1. Table 2.2.3 gives the instrument conditions. 
Table 2_2.3 Instrument (Synapt HDMS) parameters used in Ub-UBD interactions 
Pressures 
Region Value Comment (mbar) 
Backing 3.8-4.4 Optimum pressure for optimum transmission of the protein complexes 
Trap 2.1)(10-2 Argon collision gas 
IMS 4.4)(10-1 Nitrogen buffer gas 
TOF 1.5)(10-6 
Temperatures and gas flows 
Source temperature SO DC 
Cone gas flow 30 L h-1 Nitrogen gas 
Desolvation temp. SO DC 
Desolvation gas flow 200 L h-1 Nitrogen gas 
Voltages 
Region Value (V) Comment 
Capillary voltage 2600 
Cone voltage 60-80 
Extraction Cone 5.0 
Transfer voltage 5.0 
Trap collision energy 8.0 - 60.0 Adjusted to induce protein complex dissociation 
Transfer collision energy 5 
Ion Mobility parameters 
TWIMS Wave Velocity 280 m/s IMS Gas (N2) flow 26 mL/min 
TWIMS Wave Height 8.0 V Trap Gas (Ar) flow 2.5 mL/min 
The parameters were experimentally optimized to provide the highest relative 
signals for the Ub.UQl complex sprayed from 25 mM ammonium acetate in the 
presence of acetonitrile vapour. The instrument operated on positive Mobility-TOF 
mode (V-mode). The quadrupole ion transmission profile (Quad profile) 
parameters: Mass 1, 1000 m/z; Dwelll, 5%; Ramp 1, 0%; Mass 2,2000 m/z; Dwell2, 
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55%; Ramp 2, 40%; Mass 3, 4000 m/z. The instrument operated over the scanning 
range of 700-4000 m/z. 
2.2.2.4 DETERMINATION OF UB.UBD BINDING AFFINITY BY ESI-MS 
The equilibrium expression for the dissociation of a Ub-UBD complex is given by 
equation 2.2.1, where [Ub]eq, [UBD]eq, [Ub·UBD]eq are the equilibrium concentration 
of Ub, UBD and their complex, respectively. 
[Ub ]eq [UBD]eq 
Kd = [Ub - UBD]eq 
Equation 2.2.1 
The free and the bound Ub ions as measured by mass spectrometry in positive ion 
mode are Ubn+ and Ub.UBDn+, respectively. Providing that electrospray response 
factors for Ubn+ and Ub·UBDn+ are similar, it can be assumed that the ratio (R) of the 
ion intensity (I) of the bound and unbound protein ions represent solution equilibria 
(equation 2.2.2). 
Equation 2.2.2 
Assuming that Ub molecules can be either free or UBD-bound the mass conservation 
is given by equation 2.2.3, where [Ub]o is the initial concentration of Ub. 
[Ub]o = [Ub ]eq + [Ub • UBD]eq Equation 2.2.3 
Combining equations 2.2.2 and 2.2.3, the equilibrium concentration of Ub.UBD 
complex can be determined from the ratio R and the [Ub]o (equation 2.2.4). 
[Ub]o 
[Ub • UBD]eq = 1 + R Equation 2.2.4 
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Similarly, the mass conversion for UBD is given by equation 2.2.5, where [UBD]o is 
the initial concentration of UBD. 
[UBD]o = [UBD]eq + [Ub • UBD]eq Equation 2.2.5 
Combining equations 2.2.2, 2.2.4 and 2.2.5 and replacing to equation 2.2.1, the Kd 
will be determined from the ratio (R) and the initial concentrations ofUb and UBD. 
( [Ub]O) Kd = R [UBD]o ---l+R 
Equation 2.2.6 
2.2.3 TOP-DOWN PROTEOMICS TO CHARACTERIZE POLYUBIQUITIN 
CHAINS AND CYCLIZATION OF LYS-48 LINKED DIUBIQUITIN 
2.2.3.1 AFFINITY CHROMATOGRAPHY 
The assays for the purification of ubiquitin dimmers, using either the IsoT -ZnF or 
ZnF A20 domains, from skeletal muscle or from cultured cell proteins extracted 
from HEK293T cells, were performed by Dr. Joanna Strachan (University of 
Nottingham). Briefly, proteins were captured from an in vivo source by affinity 
chromatography using a sepharose-immobilised recombinant ubiquitin-binding 
domain (ZnF A20 domain or ZnF UBP). Polyubiquitinated proteins were removed by 
treatment with the catalytic core of the USP2 deubiquitinating catalytic core (ENZO 
Life Science) [118]. 
-----,------,---" 
2.2.3.2 SAMPLE PREPARATION FOR MS ANALYSIS 
Samples were eluted from the beads using 0.1 % formic acid, vortexed and incubated 
at room temperature (-20°C) for 30 min followed by centrifugation (8000 rpm for 
5 min). An aliquot of the supernatant was removed and diluted 5-fold with 0.1% 
formic acid in 95:5 water/acetonitrile (v/v) and transferred into polypropylene 
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vials (Dionex, UK). Monoubiquitin and diuiquitin (Ubz) standards, were prepared as 
a 1 JlM samples in 0.1 % formic acid in 95:5 water/acetonitrile (v Iv). 
2.2.3.3 NANOLe - MS AND MS/MS ANALYSES 
.------------------------------------
NanoLC separation and MS detection were performed using an Ultimate 3000 
nanoLC system (Dionex, UK) coupled to an LTQ FT -Ultra MS (Thermo Scientific). 
MS/MS spectra were obtained and compared with those acquired for Lysll-, 
Lys27-, Lys48- and Lys63-linked Ub2 standards (BostonBiochem, USA). 
Liquid Chromatography 
Reversed-phase liquid chromatography was performed using either on a C4 column 
(15 cm x 75 Jlm, 5 Jlm, 300 A, packed in house) or a C18 column (15 cm x 75 Jlm, 
3 Jlm, 100 A, packed in house). A C4 PepMap300 (Dionex, UK) trapping column (300 
Jlm x 5 mm) was used to concentrate the injected sample (1-3 JlL sample injection). 
The trapping column was switched in-line with the analytical column after a 3 min 
loading time. A linear gradient of mobile phase B (acetonitrile/water (95:5, v Iv) 
with 0.1% formic acid), in mobile phase A (water/acetonitrile (95:5, v/v) with 0.1% 
formic acid) was used to elute the samples from the hydrophobic stationary phase 
(C18 or C4). The gradient is given in Table 2.2.4 
Table 2.2.4 
Time (min) A% B% Flow 
fuLlmirli 
0.00 100 0 0.200 
30.00 30 70 0.200 
30.01 10 90 0.200 
35.00 10 90 0.200 
35.01 100 0 0.200 
50.00 100 0 0.200 
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Mass Spectrometry - LTQ FT-Ultra parameters 
The instrumental conditions were optimised using Ub2 standards. The heated 
capillary temperature was set at 200 °e; spray voltage, 1.6 kV; capillary voltage, 43 
V.A full scan mode (300-2000 m/z) was used. MS/MS experiments were carried out 
by performing cm in the linear ion trap and subsequent transfer of the resulted 
fragments to the ICR cell for further measurement An isolation widow width of 8 Da 
was used for selected protein charge states, which were subsequently activated for 
30 ms using 18% normalised collision energy and an activation q of 0.25. A mass 
resolving power of 200,000 at 400 m/z was used and AGC (Automatic gain Control) 
was applied in all data acquisition modes. 
2.2.4 ION MOBILITY - MASS SPECTROMETRY EXPERIMENTS 
As has been mentioned in Chapter I, the ces of gas phase ions is directly related to 
its mobility through a gas under the influence of electric field. However, when 
TWIMS device is used instead of a conventional drift tube, it is necessary to calibrate 
the instrument is order to determine cess. 
2.2.4.1 TWIMS CALIBRATION AND CCS CALCULATION 
A calibration approach that has been well described in previous studies [57, 64, 65] 
was used in this thesis. The measurements of the calibrants and the analyte proteins 
were performed under the same instrument conditions; ESI capillary voltage, 2.6 kV; 
sampling cone voltage, 20 V; extraction cone voltage, 1 V; transfer voltage, 5 V; 
source temperature, 40 °C: desolvation temperature, 50 °C; cone flow gas, 30 L.h-I; 
desolvation flow gas, 200 L·h-1• The ion mobility cell contained N2 gas and operated 
at a pressure of S.OxlO-l mbar; travelling wave height and velocity, 6.2 V and 200 
m·s- l , respectively; transfer wave height and velocity, 5.0 V and 300 m·s-I, 
respectively; trap and transfer collision voltage,S V and 4 V, respectively; trap DC 
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bias, 11 V; backing pressure, 3.8 mbar; trap pressure, 2xl0-Z mbar; TOF region 
pressure, 1.3xl0-6 mbar. Quad profile: Mass 1, 700 m/z; Dwel11, 5%; Ramp 1, 0%; 
Mass 2,1000 m/z; Dwell 2, 55%; Ramp 2,40%; Mass 3,3000 m/z. 
Calibration was performed using the native-like ions from the following proteins: 
bradykinin [119], melitin and ubiquitin [120]. The measured drift time (to) of each 
charge state of the three calibrant proteins was recorded and it then converted to a 
corrected drift time (to'), using equation 2.2.7 [64] 
, _ _ (freqUencY(PUSher)) (_1_) _ r::::J:(_1_) 
tD - tD 33 6 1000 1.3'0' m/z 1000 Equation 2.2.7 
where frequency (Pusher) = 90l1s (Experimental Mass Spectrometer Parameter). The 
CCS values (0) from the databases, they were converted to corrected CCS values (0') 
using equation 2.2.8 
Equation 2.2.8 
where, 0 is the CCS value as given in the databases and 11 is the reduced mass that is 
calculated by equation 2.2.9. 
Equation 2.2.9 
A plot of In 0' against In to' is constructed and its slope, m, was used to obtain to" 
(Equation 2.2.10) values that were further used to construct the linear plot n 
=f (to"). The latter was used to calculate the experimental CCS values of protein ions. 
Equation 2.2.10 
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Theoretical CCS values were obtained either by MOBCAL [74, 75] (TM) or by the CCS 
calculator (PA) as implemented in OriftScope 2.1 [121]. 
_._ ..... _ .... _ .... _ ...... _ .... - .. _. __ ..... __ ... _-_ .. _ .. ,--------------------
2.2.4.2 MOLECULAR DYNAMICS 
The +3 species of UQ1-UBA domain was modelled, by replacing the negatively 
charged residues, glutamic acid (Glu) and aspartic acid (Asp) with the neutral 
residues glutamine (GIn) and asparagine (Asn), respectively. The construction of the 
modelled mutant was based on the available NMR structure of UQ1-UBA domain 
(POB 10: 2JY5), which was modified using PyMOL (molecular visualization system) 
and MolProbity [122, 123]. The molecular dynamic (MO) simulations were carried 
out by Dr Neil Oldham using the AMPS-NMR (AMBER based Portal Server for NMR 
structures) suite of programs (bttp:/lwww.enmr.eu!webportall) [124]. Gas-phase 
MO simulations, for a total time period of 1 ns, were performed at 100 K, 300 K,400 
K, 600 K and 900 K, with a time step of 1 ps in each case, which resulted in 1000 
candidate structures at each temperature. The AMBER99SB force field was 
employed for all calculations. The following sander [125] parameters were utilised: 
gas phase conditions (1GB = 0) without periodic boundary (NTB = 0), a non-bonded 
cut-off of 12 A. constant temperature (as specified above for TEMPO and TEMPI), 
with temperature scaling (NTT) = 3 and a collision frequency of 1 pS .. l. Following a 
similar approach the +4 charge state of. hHR23A-UBA2 domain, was modelled, 
based on the available NMR structure (POB 10: lOQY). 
Determination of 1M-like CCS values 
The TM method is generally believed to be the most realistic model for the 
theoretical calculation of protein CCS values, although it is computationally 
demanding. In contrast, the PA approach can calculate CCS values much faster, 
however, not as reliably as TM. Given that MD simulations under the conditions used 
generated 1000 structures per distinct temperature, the TM approach was 
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unfeasible. Instead a "hybrid" approach was employed to calculate theoretical CCS 
values for the modelled structures. By calculating the TM values for ten structures 
over the size-range of outputs from MD simulations of UQ1- UBA from 300 K to 900 
K, a constant factor of 1.12 (± 0.01) for conversion between the rapidly-calculated 
PA CCS (using the Waters DriftScope PA CCS calculator) and the TM CCS for this 
protein was determined. Using this factor, TM-like CCS values for all 1000 output 
structures from each MD simulation were generated and plotted (Figure 2.2.4). 
Benesch and Ruotolo [126] have determined a similar ratio (1.14) for numerous 
proteins, over a wide range of cess, by comparison of theoretical PA eess with 
measured ecs values. 
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Figure 2.2.4 Ion mobility drift traces for UQ1-UBA showing modelled +3 charge 
state (consist of 1000 structures) at different temperatures 
2.2.5 PREPARATION AND PURIFICATION OF PEPTIDES 
The peptide synthesis was performed using the solid-phase peptide synthesis 
(SPPS) approach Figure 2.2.5. 
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Figure 2.2.5 The solid-phase peptide synthesis (SPPS) principle 
Chapter 2 
In contrast to the in vivo peptide synthesis, in SPPS method the peptide chain is 
assembled from C-terminus to N-terminus. Therefore, the C-terminus amino acid 
residue is immobilised to an insoluble support via its carboxyl group, while its (X-
amino group and any side chain E-amino group are masked by protecting agents that 
can be selectively and individually removed. Usually, the E-amino group protecting 
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agents and the cleavage of the peptide from the support are carried out under the 
same conditions. There are two approached that can be used to carry out SPPS; the 
Merrifield technique [127] and the Fmoc/tBu method. The latter approach was used 
for the synthesis of peptides present in this thesis. 
2.2.5.1 FMOC SOLID-PHASE PEPTIDE SYNTHESIS 
The principal features of the Fmoc SPPS method, as it was utilised in this thesis, are 
illustrated in Figure 2.2.6. 
Fmoc 
o 
H2N0oU Wang resin I ~ ~# o ~ ~ j 
Fmoc-Ar9(PbfrOH\ 
HCTU I DIPEA 
o 0 
o I # ~ ~~ - - H - N N- -H N N N
Y
\ ~ V V 0 .. J 
H ~ ~
\
1. Piperidine I DMF 
2. TFAlH20 
NH2 0 
H 2 N y ~ ~ ~ 0 o H H
NH 0 
Figure 2.2.6 The Fmoc SPPS. Synthesis of the dipeptide Arg-Gly. 
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In brief, the C-terminal residue of a target peptide is anchored to the TFA-Iabile, 
Wang resin (p-hydroxylbenzyl alcohol (PHB) on polystyrene) via its carboxyl group, 
and carries a base-sensitive a-amino Fmoc (fluorenylmethyloxycarbonyl) protecting 
group. In contrast, any side chain g-amino groups are masked by acid-labile 
protecting agents, which are not affected by the reactions conditions employed to 
deprotect a-amino group" and to assemble the peptide chain. Preloaded Fmoc-
amino acid-Wang resins and Fmoc protected residues were used in this thesis. 
Manual synthesis 
Peptide synthesis was performed in a custom-modified glass chromatography 
column (100 mm x 10 mm 1.0) with a sintered disk (porosity 3), fitted with a 3-way 
stopcock (SGL Ltd, Staffordshire, UK) that connects the vessel to either a nitrogen 
source (position 1) or vacuum (position 2) (Figure 2.2.7a). 
Figure 2.2.7 a) The apparatus that was used in manual peptide synthesis, b) the 
home-build 4-positions glass manifold. 
Basic operation of the device is as follows: resin and all solvents are added from the 
top of the vessel; the reaction mixture is agitated by nitrogen-bubbling (tap position 
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1) and the solvents/reagents are removed by the application of vacuum (tap 
position 2). A home-built 4-position (socket size 814) glass manifold was also used 
for high throughput peptide synthesis. The manifold was fitted with a three-way 
stopcock, for the nitrogen and the vacuum inlets (Figure 2.2.75b). Figure 2.2.8 is a 
graphical description of the Fmoc SPPS methodology. 
Fmoc removal 
Preloaded 
resin swelling - ~ ) ) Washing 
TFA-mediated 
Washing ~ ~ cleavage 
\ / 
Coupling 
Figure 2.2.8 Diagram showing the Fmoc SPPS process 
The quantity of the preloaded resins and Fmoc-amino acids that were used for the 
production of each hexapeptide, are given in Table 2.2.5. Ten hexapeptides were 
synthesised; LRLRGG, LRLRGV, LRLAGG, LALRGG, FRLRGG, LRFRGG, KRFRGG, 
KRLRGG, HRLRGG and FALRGG. 
Table 2.2 .5 
MW Weight Weight 
Amino acid Resin mmol/g (g/mol) (mg) * (mg) ** 
Fmoc-Gly-OH 297.3 149 Fmoc-Gly-Wang 0.79 126 
Fmoc-Arg(Pbt)-OH 648.78 324 Fmoc-Val-Wang 0.61 164 
Fmoc-Leu-OH 353.41 176 ** This equals to 100 ~ m o l e s s
Fmoc-Ala-OH 311.33 155 
Fmoc-Phe-OH 387.43 193 
Fmoc-Lys(Boc)- 468.54 235 
OH 
Fmoc-His(Trt)-OH 619.71 310 
* This equals to 500 J.Lmoles 
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PROCEDURE 
..... _._ .. _._ .. _ .......... _ ... _ .. _._ .......... __ ..... _._. __ .... _ ... _._ ........ -.. _ .... _ ........ __ .. _---------------_._----
Reagents 
Deprotection reagent: 20% Piperidine in DMF (v/v). 
Coupling reagent: HCTU was prepared as 0.45 M solution, typically by dissolving 
1.86 gin 10 mL DMF. 
Cleavage buffer: TFA/Water/TIPS (95:5:5 v/v) 
Step I: Resin Swelling 
Preloaded Fmoc-amino acid-Wang resin (100 f.lmoles) was added into the reaction 
vessel and washed with 1 mL ofDMF. Then, the tap was set to position 0 (close) and 
further 2 mL of DMF were added. The solution was initially mixed gently with a glass 
pipette and was the mixture was left for 20 min. Finally, the excess of DMF was 
removed by the application of vacuum (tap position 2). 
Step II: Fmoc removal 
Deprotection reagent (1 mL) was added into the reaction vessel and the mixture was 
agitated gently for 10 min (tap position 1). Solvent was drained off and fresh 
deprotection reagent (1 mL) was added. After 10 min, the reagent was drained off 
and the resin was washed with 1 mL DMF (2 times). Then, further DMF (1 mL) was 
added and the mixture was agitated gently for 2 min and then disposed to waste. 
Finally, the resin was further washed with DMF (2 mL). 
Step III: Coupling reaction 
Fmoc-amino acid (500 f.lmoles, i.e. 5 eq. relative to resin) was dissolved in 1 mL of 
coupling reagent (note: 1 mL of coupling reagent equals to 450 f.lmoles). Then, 2M 
DIPEA/NMP (O.S mL, i.e. 1000 Ilmoles) was added and the solution was mixed 
thoroughly. The solution was added to the N-deprotected resin and the mixture was 
agitated for 1 h by nitrogen bubbling (tap position 1). Reagents were drained off by 
applying vacuum (tap position 2) and the resin was washed with 1 mL DMF (2 
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times) followed by wash with 1 mL of OCM (2 times). After that, the resin was re-
swelled by agitating it gently with OMF (2 mL) for 5 min. Finally, the solvents were 
drained off and steps II and III were repeated in order to elongate the peptide chain. 
Alternatively, Fmoc group was removed (step II) and the unprotected peptide was 
cleaved from the resin as is described below (step IV). 
Step IV: TFA-mediated cleavage 
It is crucial to completely remove all traces of OMF, to prevent formation of TFA-
DMF complexes. Therefore, the resin was thoroughly washed with OCM (2 mL, 5 
repeats) and diethyl ether (2 mL) and then, it was air-dried for 20 min by utilizing 
the vacuum line. Then, the resin left to dry overnight. After that, cleavage buffer (2 
mL) was added into the reaction tube and the resin - cleavage buffer mixture was 
agitated very gently with nitrogen bubbling (tap position 1) for 1.5-2 h. The solution 
was collected into a small round-bottom flask (25 mL) and the resin was washed 
with 1 mL clean TFA (the wash was collected as well). 
Step V: Peptide isolation 
In order to remove the excess of the cleavage mixture, a rotary evaporator was 
utilized. The synthesised peptide was precipitated by the addition of cold diethyl 
ether (10 mL). Then, the ether solution was carefully rejected and the peptide was 
washed with further diethyl ether. After that, the peptide was left overnight to dry. 
The isolated peptides were re-solvated in a HzO:CH3CN (95:5) solution containing 
0.1 % TFA, and were further purified by RP-HPLC (see section 2.2.4.3). The purified 
peptides were concentrated by high speed vacuum centrifugation and freeze-dried. 
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CHAPTER 3 
CHARGE STATE AND ADDUCT 
REDUCTION USING SOLVENT 
VAPOUR EXPOSURE 
3.1 INTRODUCTION 
The successful use of MS in studying proteins and their non-covalent interactions is 
mainly attributed to the ESI process and its capacity of producing multiply charged 
ions. The development of charge state manipulation techniques has expanded its 
capabilities. Several methods have been reported to either increase [128-131] or 
decrease [132, 133] the level of charging of protein ions electrosprayed from 
aqueous solutions. Increased charge states usually result in wider CSDs, and are 
commonly preferable in accurate mass measurements, or in certain tandem MS 
experiments. For example, the efficiency of ECD [134] is highly dependent upon 
ion's charge state. In the context of non-covalent interactions, this allows top-down 
analysis of protein complexes to be carried out [135]. The use of solution additives, 
known as supercharging agents, has been widely employed to increase charge states 
while preventing the non-covalent interactions [130, 131]. However, recent studies 
on the effects of supercharging agents on protein structure, using IM-MS, suggest 
that structural unfolding may be the origin of increased charge [136]. An alternative 
method involves the introduction of acid vapour in the curtain gas of the ESI source 
has also been reported [137]. 
The disruption of protein's higher structure has been related to increased charge 
states [138]. This leads to the assumption that lower charge states minimize 
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structure unfolding, leading to the formation of more native-like and stable species. 
This is mainly attributed to reduced intra- and intermolecular Coulomb repulsion 
within a protein ion complex. In a structural sense however, lower charge states can 
show significant collapse in the gas-phase [51], driven by the collapse of external 
side chain residues throughout the polypeptide [139]. 
Several approaches have been reported to reduce the charge states of protein ions 
produced by ESI. For example, studies have shown that the use of basic buffer salts 
such as triethylammonium bicarbonate (TEAB) result in significant charge state 
reduction [140, 141]. This is attributed to the high gas-phase basicity of the 
triethyllamonium cation in comparison to the ammonium cation and involves a 
proton competition mechanism. The Robinson group has recently used 
triethylammonium acetate buffer (TEAA) in combination with aza-18-crown-6 
(A18C6) to investigate the dissociation pathways of the homtetrameric protein 
human transthyretin (hTTR) [142]. They have shown that at relatively high charge 
state, an unfolded monomer is released from the parent ion. In contrast, a compact 
monomer was produced at reduced charge states and a covalent peptide bond 
cleavage was preferred over dissociation of the non-covalent complex at the very 
lowest charge states. The use of very strong organic bases, including strained-
systems referred to as 'proton sponges', has also been suggested [143]. Proton 
sponges have the ability to retain high proton affinities in the gas phase. The study 
revealed a linear relationship between the average charge state and the gas-phase 
basicities of the additives used. The use of the heterocyclic base imidazole either as a 
solution additive or when introduced as a separate spray in the source region, has 
also been reported [133, 144, 145]. It has been suggested that imidazole promotes 
the formation of mUltiple non-specific adducts around the protein ion, which 
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provide a cooling effect as they evaporate during transmission of the ions into the 
intermediate vacuum region of the MS. 
Other methods involving the use of gas phase bases, include the addition of polar 
solvents to the nitrogen bath gas[30] and mixing ESI droplets and steam using a 
"Tee" interface [146]. Zen obi and co-workers have employed a charge state 
reduction technique to determine gas-phase basicities of proteins. In these studies, 
totally desolvated protein ions obtained by electrosonic spray ionization (ESSI) [147] 
were exposed to the vapour of various bases [148, 149]. Protein charge states can 
also be manipulated by gas-phase ion/ion reactions [150-153]. A very effective 
method of reducing charge states in a controllable way, was proposed by Scalf [132]. 
The method involves the use a 21OPO source, located immediately after the ESI 
source, to generate a-particles which interact with the gases originating from the 
ESI source. This leads to the production of a bipolar ionised gas that induces charge 
reduction in the droplets and ions produced by the electrospray process. 
This chapter describes a simple, clean and effective method for reducing charge 
states observed in ESI-MS without the use of any solution additives or instrumental 
modifications. This approach is applicable to both ESI and nanoESI spray setups and 
has the additional benefit of reducing common adducts. Its utility is demonstrated 
using four systems: the weak Ub-UQ1 non-covalent complex, the weak trypsin-
benzamidine protein-inhibitor complex [133, 154], holo-myoglobin, and the hTTR 
complex, which undergoes charge state-dependent dissociation pathways [142]. 
3.2 RESULTS AND DISCUSSION 
It has been noted previously that for a given protein the charge states obtained from 
ESI and nanoESI typically differ in their distribution. This is generally explained by 
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the significantly smaller droplet sizes obtained by nanoESI compared with 
conventional ESI [155, 156]. However, the design of the ESI and nanoESI chambers 
introduces another variable: the composition of the atmosphere under which the 
ionization process (either ESI or nanoESI) takes place. While in most commercial ESI 
sources the electrospray process is carried out under relatively dry nitrogen 
atmosphere, in nanoESI, it is performed in an open source design without a 
nebuliser gas. Figure 3.2.1 shows the mass spectrum of myoglobin, sprayed from 25 
mM ammonium acetate, acquired by ESI (a, b) or nanoESI (c, d) under nitrogen rich 
atmosphere (a, c) or normal laboratory atmosphere conditions (b, d). Compared the 
spectra obtained under the same conditions (a, c or b, d), it is clear that they bear a 
notable similarity to each other. 
Figure 3.2.1 ESI mass spectra of myoglobin (2j.lM) sprayed from 2SmM ammonium 
acetate solution. (a) and (c) were acquired using ESI and nanoESI respectively 
under an enclosed nitrogen atmosphere. ESI and nanoESI spectra obtained under 
atmospheric conditions (open source) are presented in (b) and (d). 
Therefore, a limited manipulation of charge states can be achieved by simple control 
over the conditions under which the electrospray process takes place. An apparent 
difference between nitrogen rich atmosphere and normal laboratory atmosphere is 
the amount of oxygen that is present in each case. To investigate the effects of 
oxygen upon CSD, oxygen was either introduced into the closed chamber of a 
commercial Waters ESI source or it was used as a nebuliser gas instead of nitrogen. 
No change in CSD was observed. 
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Another atmosphere-related parameter that varies significantly, is the water vapour 
content (relative humidity). To investigate this, a small reservoir (see Chapter 2) of 
water (- 5 mL) was introduced into the closed source housing. Figure 3.2.2b shows 
the CSO of myoglobin achieved when water was introduced to the closed 
environment of the ESI source compared to when no water was present (Figure 
3.2.2a). A shift to lower charge state was observed, similar to the shift observed in 
case of ESI operation under laboratory atmosphere conditions (Figures 3.2.1a and 
3.2.1b). An ion-molecule mechanism that involves a gas-phase charge transfer 
between protein ions present in the charged droplet and neutral water vapour in the 
atmosphere, can be used to explain this phenomenon. Such a charge state reduction 
mechanism should be highly dependent on the gas-phase basicity of the neutral 
solvent vapour. Figure 3.2.2 shows the ESI mass spectra of myoglobin sprayed from 
25 mM ammonium acetate in the presence of five common laboratory solvents 
(water, isopropanol, methanol acetonitrile and triethylammine) in comparison to a 
solvent free environment. With the exception of isopropanol, a strong relationship 
was observed between the gas-phase basicity of the solvents used and the amount 
of charge reduction. Although isopropanol possesses a gas-phase basicity (763 
kJ·mo}-1) greater than that of acetonitrile (748 kJ·mo}-1), it provokes less charge-shift 
compared to methanol (725 kJ mol-1). Isopropanol, however, exhibits roughly half 
the vapour pressure of acetonitrile (Figure 3.2.2) and approximately one third that 
of methanol, which will clearly affect gas-phase presence of this solvent. To 
investigate the effects of solvent volatility upon the reduction of charge states of 
protein ions, two experiments were performed. Firstly, the rate of solvent 
evaporation was increased by simply increasing the number of isopropanol 
containers (and thus solvent surface area) in the source. Figure 3.2.3 shows the ESI 
mass spectrum of myoglobin sprayed from 25 mM ammonium acetate in the 
presence of multi pie isopropanol reservoirs. 
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No Solvent 
N2 atmosphere Proton Gas-Phase Vapour Pressure Affinity Basicity @25°C (kJ/mol) (kJ/mol) mmHg 
3100 3500 mlz 
Water 691.0 660.0 23.7 
3100 3500 mlz 
Isopropanol 793.0 762.6 42.7 
6+ 
3100 
6+ 
3500 mlz 
Methanol 754.3 
3500 m/z 
Acetonitrile 779.2 
6+ 3100 3500 m/z 
Triethylamine 981.8 
5+ 
3100 3500 mlz 
724.5 126.9 
748.0 88.6 
951.0 57.1 
Figure 3.2.2 ESI spectra of myoglobin (2IJ.M) sprayed from 25mM ammonium 
acetate in a closed source. Each spectrum was recorded with a different solvent 
(approximately 5ml) present within the source in an open top container. The 
values were obtained from reference [157] 
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Figure 3.2.3 ESI mass spectra of 2 J.!M myoglobin sprayed from 25 mM ammonium 
acetate, under exposure to isopropanol vapour. Increasing degrees of charge 
reduction are observed upon introduction of each additional container to the 
source. 
Apparently, the vapour pressure of isopropanol would remain constant regardless 
to quantity of liquid solvent present. However, the condensed solvent and its vapour 
are not in equilibrium due to the influence of the nebuliser gas (nitrogen) flow 
which constantly flushes the source. In addition to this experiment, the effect of 
volatility was also investigated by reducing the evaporation rate of a high volatile 
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solvent (acetonitrile). This was achieved by placing inside the ESI source a reservoir 
containing frozen acetonitrile and continuously acquiring data as the acetonitrile 
was progressively melting (Figure 3.2.4). 
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Figure 3.2.4 ESI mass spectra of 2 11M myoglobin sprayed from 25 mM ammonium 
acetate, under exposure to acetonitrile vapour. 
It is notable that all solvents used in the above experiments, with the exception of 
triethylamine, exhibit lower gas-phase basicities than the desolvated myoglobin 
ions (- 822 kJ·mol-1) [148]. This suggests that proton transfer must occur at the 
level of charged droplets, where proton transfer from H30+ to neutral solvent would 
be energetically favourable. This is supported by the fact that the ions generated in a 
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typical ESI process are believed to be largely solvated therefore proton competition 
must utilise neutral solvent vapour and charged water droplets. 
The presence of alkali metal adducts in biomolecules has been proved problematic 
for ESI-MS. For example, it has been shown that alkali metal cations can destabilise 
the interaction between a protein and its ligand by lowering the activation barrier to 
dissociation [158]. In addition, there is a reduction in the signal-to-noise ratio for 
an adducted ion when compared with a purely protonated ion. Therefore, a method 
that reduces the adduction of alkali metal ions would be very useful. Figure 3.2.5 
shows the nanoESI mass spectra of a myoglobin sprayed from 25 mM ammonium 
acetate obtained under laboratory atmosphere conditions and under exposure to 
acetonitrile vapour. Both spectra were acquired from the same sample sprayed from 
the same nano-tip emitter. 
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Figure 3,2.5 nanoES} of 2 ~ M M myoglobin sprayed from 25 mM ammonium acetate 
solution under (a) open laboratory atmosphere and (b) exposure to acetonitrile 
vapour. 
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In both cases, it is clear that adduction is more pronounced for lower charge states. 
However, in case of charge reduction (Figure 3.2.5b), a reduction in adducts was 
also observed. By adding the intensities of all adducts across the charge states and 
expressed them as percentage of the summed protonated intensities, a decrease in 
total adduction, from 52 % to 34 % was determined. From the proposed a charge 
transfer mechanism at the droplet stage of the electrospray process, it seems 
plausible to suggest that acetonitrile favours the removal of alkali metal cations over 
protons, possibly via multiple coordination of the metal. 
In order to test the feasibility of this straightforward charge reduction approach, 
which requires only the exposure of electrospray plume into solvent vapour, a series 
of examples where charge state is crucial, was selected from the literature. A recent 
study has shown that different dissociation pathways are achieved when different 
charge states are subjected to cm [142]. The study showed that cm of specific 
charge states (15+, 11+ and 9+) of the homotetrameric TTR complex yielded 
different products, result in asymmetric charge partitioning in case of the 15+ 
charge state and symmetriC partitioning in case of 11 + charge state. The subunits 
derived from the dissociation of the former (15+) exhibited significant unfolding 
whereas those subunits generated by the latter (11 +) retain near 'native-like' 
geometries. The charge states were formed by conventional nanoESI (charge states 
12+ to 15+) and by the use of solution based additives. such as TEAA (in case of 11 +) 
and TEAA with A118C6 (in case of 9+) [142]. Given that the most important 
information in a structural biology sense were derived from intermediate charge 
states that were created by charge reduction, we tested the applicability of the 
solvent (acetonitrile) vapour exposure approach to this system. Figure 3.2.6a and b 
shows the mass spectra of hTTR sprayed from 25 mM ammonium acetate under 
conventional nanoESI and in the presence of acetonitrile vapour. 
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Figure 3.2.6 NanoESI spectra of hTTR (2.5 J.1M) sprayed from 25 mM ammonium 
acetate (a) under atmospheric conditions and (b) in the presence of acetonitrile 
vapour 
It is notable that the degree of charge reduction obtained by solvent (acetonitrile) 
vapour exposure was between the levels obtained by the solution based additives, 
TEAA and TEAA + A118C6, respectively. Moreover, this method allowed access to 
both 11+ and 9+ charge states, which were proven to be the most important ones. 
[142] 
A weak hydrophobic protein-protein system, the Ub-UQ1, was also used to further 
demonstrate useful biological applications of this method. The association between 
Ub and UQ1 is driven by hydrophobic interactions, which are significantly weaker in 
the absence of water. It has therefore been a notable challenge to maintain, within 
the desolvated environment of the mass spectrometer, complexes that are driven by 
these forces. Illustrated in Figure 3.2.7a, is the ESl mass spectrum of Ub and UQ1 
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sprayed from 25 mM ammonium acetate. The (Ub+UQ1+7H+)7+ ion is observed at 
1896 m/z. Quadrupole isolation of this ion (Figure 3.2.7b) shows that it is readily 
dissociated into its components (Ub 4+ and UQ1 3+) without the elevated collision 
energy. Ion mobility measurements were applied to this complex to determine its 
CCS. Figure 3.2.7c shows the drift trace ofthis species, which is presented on a CCS 
axis. The dashed line represents the theoretical CCS (1457 ..\2) as calculated by a 
"hybrid" PA-TM (projection approximation, trajectory method) method (see Chapter 
2) of the available NMR structure of the complex (POB: 2JY6). As illustrated in 
Figure 3.2.7c, the experimentally measured CCS for the 7+ complex ion was 1703..\2. 
When measured in the presence of acetonitrile vapour, charge states of the complex 
were effectively reduced to 6+ and 5+ (Figure 3.2.7d). Additionally, no complex 
dissociation was observed post quadrupole isolation of the (Ub+UQ1 +6H+)6+ as 
demonstrated in Figure 3.2.7e. Presumably, this is principally a result of lowering 
the kinetic energy transferred to the complex throughout the MS instrument and 
reducing perturbation of the complex by protonation. The compact nature of the 
complex was confirmed when analysing the resulting drift trace for this ion (Figure 
3.2.7f), which was highly Gaussian and in good agreement with the theoretically 
calculated CCS, indicative of an ion that has not undergone gas-phase collisional 
activation and where there is little Coulombic repulsion. 
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Figure 3.2.7 ESI mass spectra of Ub (4 ~ M ) ) and UQ1 (16 ~ M ) ) complex, sprayed from 
2SmM ammonium acetate solution under (a) atmosphere conditions and (d) 
exposure to acetonitrile vapour. Spectra of quadrupole isolated Ub-UQl complex 
charge states 7+ (b) and 6+ (e). Ion mobility drift time converted to a CCS axis, of 
the Ub.UQ1 complex charge states 7+ (c) and 6+ (f). 
To further investigate whether exposure of the electrospray plume to acetonitrile 
vapour induces any conformational changes to gas-phase protein ions of a specific 
charge state, we have performed IM-MS analysis of gas-phase myoglobin ions 
generated under standard ESI process (25 mM ammonium acetate) and under the 
exposure of ESI to acetonitrile vapour. Illustrated in Figure 3.2.8 are the 1M drift 
traces of the 8+ myoglobin ions obtained by conventional electrospray process (blue 
trace) and after exposure of the electro sprayed droplets to acetonitrile vapour (red 
trace). The latter shows a slightly narrower distribution of gas-phase conformers 
than the former. The difference is not significant though, and therefore, it can be 
concluded that solvent exposure has no effect on the mobility of the ions, indicating 
that the method does not adversely affect protein structure. 
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Figure 3.2 .8 1M drift traces for the 8+ myoglobin ions obtained by standard ESI 
(blue trace) and under exposure to acetonitrile va pour (red trace). 
Clearly, the aforementioned Ub.UQ1 protein-protein system demonstrates how 
lower charge states can be beneficial in reducing the perturbation of protein 
complexes during ionization in the mass spectrometer. Additional benefits of using a 
charge reduction method can be also seen in MS experiments designed to measure 
apparent solution based affinity constants (Ka) of protein-ligand interactions. As 
demonstrated by the example of Ub·UBD above, non-polar hydrophobic forces are 
greatly reduced in the absence of water. Therefore, preserving these interactions 
upon transition to the gas-phase is crucial for the measurement of a representative 
degree of binding. Several studies have successfully demonstrated the ability of ESI-
MS to preserve such interactions [17, 133, 159-162], however, the determination of 
affinity constants for a variety of non-covalent complexes has proved problematic 
[154, 163]. For example, the complex between trypsin (Tryp) and its inhibitor 
benzamidine (Bzn) is destabilised in the gas-phase and it was proved to be 
extremely challenging to be studied using ESI-MS [154]. Two studies by Klassen and 
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co-workers, have shown that the use of imidazole either as a solution additive, or as 
a separate spray in the source region, stabilise the Tryp-Bzn complex by promoting 
non-specific binding of the complex to imidazole [133, 144]. As an alternative 
method, we tested the applicability of solvent (acetonitrile) vapour exposure 
approach to this problem. Figure 3.2.9a and b shows the mass spectra of Tryp (12 
/lM) and Bzn (53 /lM), sprayed from 10 mM ammonium acetate solution, in an open 
laboratory atmosphere and under exposute to acetonitrile vapour, respectively. 
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(Tryp+Bnz)8+ 
Tryp8+ / 
--.. 
(Tryp+Bnz)6+ 
T r y p ~ ~ / 
3000 3800 m/z 
Figure 3.2.9 NanoESI spectra of 12 J.1M trypsin (Tryp) and 52 J.1M benzamidine 
(8zn) sprayed from 10 mM ammonium acetate in an open laboratory atmosphere 
conditions (a) and under exposure to acetonitrile vapour (b). 
In the case of conventional nanoESI (Figure 3.2.9a), the most abundant distribution 
corresponds to that of unbound trypsin [Tryp + nH]n+ ions ranging in charge state 
between n=7-10. A small distribution for the [Tryp-Bzn + nH] n+ complex at charge 
states n=7 and a is also detectable. The calculated Ka value (see Chapter 2) from this 
spectrum is 0.5 x 104 M-1, which is significantly lower than the previously reported 
Ka value of 2.6 x 104 M-1 (taken from kinetic (Ki) measurement) [164] and of values 
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between 1.9 )( 104 M-1-2.1 )( 104 M-1 determined by direct nanoESI-MS approach 
combined with imidazole [133, 144]. In contrast, the Ka determined from the 
spectrum illustrated in Figure 3.2.9b is 2.2 x 104 M-l, which is in a good agreement 
with the literature values reported previously. Thus, the simple exposure of the 
electrospray plume to acetonitrile vapour is effectively capable of stabilise weak 
gas-phase protein-ligand interactions. 
3.3 CONCLUSIONS 
This chapter has shown that exposure of the electrospray plume to solvent vapours, 
and particularly to acetonitrile vapour, is a simple and effective method that can be 
used to decrease protein ion charge states and reduce cation-adduct formation. The 
fidelity of the method has been successfully tested in a number of MS experiments, 
which include examples of an intact protein, a protein-protein association and a 
protein-ligand complex. Moreover, the results of the charge reduction method that 
is described in this chapter were also compared with results obtained by other 
techniques. In all the cases, solvent exposure method was proven to effectively 
reduce charge states to a similar or even higher degree. 
Lowering charge states reduces Coulombic repulsion-driven unfolding and 
dissociation events in the gas-phase, decreases amount of kinetic (hence internal) 
energy gained, and eventually assists the preservation of weak interactions upon 
their transfer to gas-phase. The applicability of solvent exposure methC?d in studies 
of weak non-covalent interactions has been successfully demonstrated in the cases 
of [Tryp-Bzn] complex and [Ub-UQ1] complex. 
As has been demonstrated, the degree of charge reduction is clearly dependant on, 
the gas-phase basicity (GB) and the volatility of the solvent The fact that charge 
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state reduction is obtained using solvents of substantially lower GB values than the 
desolvated protein ions, lead us to the conclusion that the effect must occur between 
the charged droplets and solvent vapour while the protein is still solvated. The 
proposed droplet-solvent vapour competition mechanism it is also supported by the 
generally accepted belief that total desolvation is not achieved in the source region 
of a standard ESI source. 
Furthermore, an earlier study by Fernadez de Mora [33] has provided a relationship 
between the mass of a spherical globular protein and the predicted maximum 
charge state, which is given by: 
in which, y is the surface tension ofthe water droplet, Eo the electrical permittivity of 
vacuum, e the elementary charge and R the radius of the droplet. By assuming that 
the density of a protein is similar to that of water and that the radius of a protein is 
correlated to its molecular weight, the above equation can be rewritten as: 
Z = 0.078 Ml/2 
in which M is the mass of the protein in Daltons [160]. 
From the above, it is clear that the highest value of charges that will be found on a 
spherical globular protein depend upon the solution parameters of the surface 
tension and the final droplet radius. Therefore, a droplet-solvent vapour process 
that would result in increased surface tension will consequently reduce the 
maximum charge state of a protein. 
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CHAPTER 4 
PROBING AFFINITY & UBIQUITIN 
LINKAGE SELECTIVITY OF 
UBIQUITIN-BINDING DOMAINS 
4.1 INTRODUCTION 
It is well established that Ub interacts with UBDs through non-covalent associations 
which are driven by hydrophobic interactions. These interactions may promote 
covalent Ub attachment (ubiquitination) and direct the fate of ubiquitinated 
proteins leading to regulation of cellular processes [82]. Examples of these include 
interactions with the UBA domain of UQ1, a protein which acts as a presenilin 
regulator [115], and the UBA domains of hHR23A protein which mediates the 
delivery of substrates to the 26S proteasome [112] and the regulation of p53 [165], 
as well as nucleotide excision repair [166]. Moreover, associations between the 
vesicular trafficking protein Rabex-S and Ub are mediated by a RUZ (Rabex-S 
ubiquitin binding ZnF) domain which interacts with an Asp58-centred region and a 
MIU domain that binds the I1e44-centred patch on Ub [98]. The deubiquitinating 
(DUB) enzyme isopeptidase-T (Iso-Tor USPS) carries out the dissociation of free 
poly-Ub chains into mono-Ub moieties. Since the interaction is mediated by a ZnF 
Ub-protease (UBP) domain, which recognizes the C-terminal Gly residue of Ub 
[106], it is believed that the ZnF UBP domain of IsoT (hereon refer to as IsoT-ZnF) 
has no preference for chain length or topology. The specific recognition of poly-Ub 
chain length and topology by UBDs is only now beginning to emerge. Recent studies 
have revealed that the UQ1-UBA domain does not possess any binding preference 
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for poly-Ub chain linkage [101, 102]. In contrast, the hHR23A-UBA domains are 
reported to show a clear selectivity for Lys48-linked over Lys63-linked poly-Ub 
chains [100, 101, 112, 167]. 
The intrinsic importance of UBDs has also been highlighted by their recent links to a 
variety of pathological conditions, including cancer and immunodeficiency [168]. In 
addition, mutations in UBDs are important in human diseases, including the skeletal 
disorder Paget's disease of the bone [169]. The importance of quantifying UBD 
binding affinities is exemplified by the Vps36 protein, which although it appears to 
bind Lys63-linked or linear Ub2 equally well when using pull-down assays, 
fluorescence studies have shown that it preferentially binds to the former [170]. 
Methods that are currently employed to study Ub.UBD non-covalent associations 
include; nuclear magnetic resonance (NMR) [100, 102, 171, 172], surface plasmon 
resonance (SPR) [97, 167], isothermal titration calorimetry (ITC) [106] and 
fluorescence anisotropy (FA) [173]. NMR and SPR experiments have been used to 
probe the specificity of a number of UBDs for mono-Ub and poly-Ub chains [97,100, 
102, 167, 171, 172] and have contributed significantly to our understanding of the 
often weak non-covalent interactions of Ub. However, NMR and ITC require 
substantial quantities of protein, often at non-physiological concentrations, and are 
relatively low-throughput Although SPR is a more sensitive and rapid method, it 
can suffer from artefacts associated with immobilization of one of the protein 
binding partners such as avidity effects. In addition, studies on complexes where the 
mass of poly-Ub.UBD non-covalent assembly exceeds the 40 kDa may be very 
challenging by NMR. Given these considerations, the development of a rapid and 
highly sensitive method for studying the affinity and specificity of UBDs would 
revolutionize the study ofthese crucial regulatory complexes. 
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Several studies have successfully demonstrated potential use of ESI-MS as a tool to 
probe non-covalent associations. These studies have also shown that the binding 
constants determined by ESI-MS experiments were found to be in a good agreement 
with those obtained by other biophysical methods, such as NMR, SPR and ITC [17, 
133, 159-162]. Other studies, however, have concluded that the affinity constants 
for a variety of non-covalent complexes could not be determined by ESI-MS, or the 
values where significantly different from solution measurements [154, 163]. These 
effects have often been attributed to the instability of the complex in the gas phase 
due to the absence of stabilizing hydrophobic effects. Liu and Konermann [174], 
have suggested that the determination of the binding affinity for a protein-protein 
assembly by ESI-MS can be challenging due to potential differences in the behaviour 
of individual and complexed proteins in the vacuum of the MS. However, under 
carefully optimised instrumental conditions it is feasible to study protein-protein 
interactions quantitatively by ESI-MS [174]. The association between Ub and UBOs 
is driven by hydrophobic interactions, which are significantly weaker in the absence 
of water. It is therefore a considerable challenge to maintain, within the desolvated 
environment of the MS, complexes that are driven by these forces. This chapter 
describes the successful development of an ESI-MS approach for the quantitative 
study of the weak hydrophobic interactions seen in many Ub.UBO complexes. 
Principally, it shows that the ESI-MS method can report binding constants in good 
agreement with solution data obtained by other biophysical techniques and that the 
complexes observed arise due to specific interactions between binding surfaces. In 
addition, UBn preference for poly-Ub length and topology can be revealed. The 
applicability of ESI-MS in studies of Ub ternary complexes involving multi-site uan 
interactions is also demonstrated. 
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4.2 RESULTS AND DISCUSSION 
Key to the success of this method is the ability of ESI-MS to preserve the Ub-UBD 
interactions upon transition to the gas-phase, hence allowing an accurate 
representation to the degree of binding to be measured. A series of previously 
studied Ub-UBDs complexes was selected in order to evaluate the potential use of 
MS as a tool for studying Ub-UBD interactions. Particularly, representative UBDs 
from two categories were chosen; helical domains including the single a-helix 
domain MIU and the three-helix bundles, UQ1-UBA domain and hHR23A-UBA2 
domain; ZnF domains including the IsoT-ZnF, commonly referred as ZnF-UBP 
domain. Comparison of values measured by ESI-MS (Table 4.2.1) with those taken 
from the literature (Table 4.2.1, values in parenthesis) shows an excellent 
agreement, indicating that the ESI-MS method reported in this Chapter is suitable 
for quantifying these biologically important interactions. 
Table 4.2.1 Apparent dissociation constants (Kd) values for UBO-(poly-)Ub interactions 
Kd (IlM)a 
uaD Ub Lys4B-Ubz Lys 63-Ubz Lys 11-Ubz Lys 27-Ubz Lys 4B-Ub4 Lys 63-Ub4 
UQ1- 22±2 15±2 24± 2 2HZ 35±3 13±2 lS±2 UBA (20±5)[102] ( 4±5)[10Z] (lB±18)[102] (1.2)[101] (0.5)[101] 
200±l4 1B±2 126±1B 
72±10 BH10 
B±l >70b 
UBA2 (400±100)[100: (18±7)[100) (210±100)[171: (7.7)[101] (2B)[101] 
MIU 
36±4 
(29±1)[97] 11±2 16±2 12±Z ND NO NO 
IsoT-ZnF 
2.3±0.Z 
(2.B±O.1)[106] 3.6±0.B 2.B±0.3 1.7±0.2 ND ND NO 
a The Kd values reported here (mean ± SO) were averaged from values measured at 
different concentrations. Given in parenthesis the previously reported values obtained 
by NMR or SPR. 
b Complex signal below the limit of detection, which equates to a Kd of 70 IlM for this 
system using the available concentration of 0.5 IlM. 
NO, not determined 
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The apparent Kd values shown in Table 4.2.1 were determined from titration 
experiments where the concentration of Ub component was kept constant while the 
concentration of UBDs was varied. The resulting solutions were then subjected to 
ESI-MS analysis and the ratios (R) of the total signal intensities attributed to free 
and UBD-bound Ub ions, were recorded (see Chapter 2, equation 2.2.2) . The 
apparent K dS were then calculated using the equation 2.2.6 (see Chapter 2). An 
example of the calculation process is shown below (Table 4.2.2). 
Table 4.2 .2 Determination of the apparent Kd value of the Ub eUQ1-UBA complex. 
[Ub] o and [UBD] o are the initial concentrations of Ub and UBD components, 
respectively. I(Ub n+) and 1((UbeUBD)n+) are the signal intensity attributed to free 
and bound Ub ions, respectively. n+ is the observed charge state. 
[Ublo = 0.5 11M [UBDlo = 1 11M [Ublo = 0.5 11M [UBDle = 2 11M 
n+ J(Ubn+) n+ J((UbeUBD)"+) n+ I(Ubn+) n+ I((UbeUBD)"+) 
4 471 5 13 4 459 5 27 
5 488 6 31 5 533 6 74 
6 38 6 49 
Ln = 997 Ln =44 Ln = 1041 Ln = 101 
Ratio (R) = 22.7 Ratio (R) = 10.3 
Kt = 22.2 J.LM 1 I Kt = 20.2 J.LM 
rUble = 0.5 11M [UBD]e = 311M rUble = 0.5 11M [UBD]e = 4 11M 
n+ J(Ubn+) n+ J((UbeUBD)n+) n+ J(Ubn+) n+ J((UbeUBD)n+) 
4 477 5 46 4 453 5 48 
5 528 6 115 5 515 6 132 
6 47 6 41 
Ln = 1052 Ln = 161 Ln = 1009 Ln = 180 
Ratio (R) = 6.5 Ratio (R) = 5.6 
K K = 1 1 . 2 ~ ~ 1 I Kt =22.0 JJM 
[Uble = 0.5 11M [UBDle =6 11M rUble = 0.5 11M [UBD]e = 811M 
n+ J(Ubn+) n+ J((UbeUBD)n+) n+ J(Ubn+) n+ 1((UbeUBD)n+) 
4 456 5 75 4 445 5 85 
5 521 6 195 5 502 6 219 
6 48 6 47 
Ln = 1052 Ln = 161 Ln = 994 Ln = 304 
Ratio (R) = 22.3 Ratio (R) = 3.3 
~ ~ ~ i = ~ . . ; J A M M "'," " J I "=25.8 JJM 
averaged Kd = 22 ± 2 b!:M 
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It is worth noting that multiple replicates (at least 3) of each titration sample were 
performed. For convenience, the example (Table 4.2.2) shows the results obtained 
from only one titration series. In addition, to minimize the time of calculations and 
calculation errors, a Kd calculator software has been developed (see Appendix). 
4.2.1 OPTIMISATION OF ESI-MS CONDITIONS 
It has been mentioned previously that the study of protein-protein interactions 
would be feasible under carefully optimised instrumental conditions. To do so, the 
relatively "strong" (see Table 1.2) Ub-UQI-UBA complex (Kd = 20 ± 5 J.lM) [102] was 
chosen as a reference to optimise the instrumental parameters (see Chapter 2). 
Illustrated in Figure 4.2.1a is the ESI mass spectrum of the (Ub-UQI-UBA) complex 
sprayed from 25 mM ammonium acetate. The 8+ and 7+ complex ions are observed 
at m/z 1659 and 1896, respectively. Quadrupole isolation of the [Ub-UQ1-
UBA+8H+]8+ ion shows that it is readily dissociated into its components (Ub, 5+; 
UQ1-UBA, 3+) without elevated collision energy (Figure 4.2.2a). Presumably, this is 
principally a result of the relatively high kinetic (and hence internal) energy gained 
by the 8+ complex ion, and Coulombic repulSion between the binding partners. As a 
consequence the binding affinity determined from this spectrum (Figure 4.2.1a) was 
found to be 47 J.lM, which was more than two-fold lower compared to the previously 
reported literature values (Kd-20 J.lM). It has been previously discussed in Chapter 
3, that lowering charge states reduces the amount of kinetic energy gained as well as 
decreases the Coulomb repulsion-driven unfolding and dissociation events in gas-
phase; exposure of electrospray plume into acetonitrile vapour lead to charge 
reduction. Figure 4.2.1b shows the ESI spectrum of (Ub-UQ1-UBA) complex 
obtained in the presence of acetonitrile vapour. The charge states of the complex 
were effectively reduced to 6+ and 5+ at m/z 2612 and 2654, respectively. 
Additionally, no complex dissociation was observed post quadrupole isolation of the 
6+ complex ion (Figure 4.2.2b). Under these conditions, Ub charge states are 
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distributed between 3+ (2856 m/z) and 6+ (1428 m/z), with the 4+ (2142 m/z) and 
5+ (1714 m/z) ions the dominant peaks. Unbound domain is observed at 2351 m/z 
(2+) at 1568 m/z (3+) and at 1176 m/z (4+). 
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Figure 4.2.1 a) ESI mass spectra of Ub (0.5 ~ M ) ) and UQ1-UBA (4 11M) complex, 
sprayed from 2SmM ammonium acetate solution, b) ESI mass spectra of Ub (0.5 
11M) and UQ1-UBA (4 ~ M ) ) complex, sprayed from 2SmM ammonium acetate 
solution in the presence of acetonitrile vapour. 
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Figure 4.2.2 ESI mass spectra of quadrupole isolated Ub.UQ1-UBA complex charge 
states (a) 8+ and (b) 6+ of Ub (0.5 IlM) and UQ1-UBA (4 ~ M ) ) complex 
It was observed that increasing the concentration of domain resulted in its 
dimerisation, which affects the determination of Kd and it must be considered in the 
Kd calculations. Therefore, to simplify calculations, we kept the concentration of the 
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domain below 6 IlM, where negligible amount of dimer was formed. The mean 
apparent Kd value determined from these measurements was 22 ± 211M, which is in 
good agreement with 20 ± 5 11M from NMR [102] and 27 11M from SPR [101] 
experiments. 
4.2.2 CONFIRMING UB-UBD INTERACTION SPECIFICITY 
The specificity of the interaction and the formation of the Ub-UBD complex, which 
has been observed in this MS study was examined and confirmed by comparing 
wild-type Ub (wt-Ub) with two Ub mutants; a Leu8AlajIle44Ala double mutant 
(Figure 4.2.3a) and the deletion mutant ~ - G l y 7 5 j G l y 7 6 - U b b (Figure 4.2.3b). 
a. b. 
-Gly75/Gly76 
Figure 4.2 .3 Cartoon representation of (a) the L8A/144A Ub double mutant and (b) 
the deletion mutant il- G75/G76- Ub (PDB ID : lUBQ) 
....... _ .......... _ .. _ .... _ .. _.. _ ... _._ ........ _--_ .. __ ........ _-._._ ... _-_._ .. _ .. _ ... __ ..... _--_._._------_._--- - --------
4.2.2.1 CONFIRMING SPECIFICITY OF HELICAL DOMAINS 
The Leu8AlajIie44Ala double mutant of Ub was used to test the specificity of the 
single a-helix domain MIU and the three-helix bundle UQ1-UBA, which are known 
to bind Ub via its Ile44-centred hydrophobic patch (Figure 4.2.4). 
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Figure 4.2.4 Cartoon representation of UQ1-UBA (red) complex with wt-Ub (left 
panel) and L8A/I44A Ub double mutant (right panel) (POS ID : 2JY6) 
Illustrated in Figure 4.2.5 is the ESI mass spectra obtained for the complex between 
UQ1 and either the wt-Ub or the LeuSAlajlle44Ala-Ub double mutant, 
electrosprayed from 25 mM ammonium acetate in the presence of acetonitrile 
vapour. The formation of complex is clearly depleted for the mutant variant 
highlighting the specificity of the observed gas-phase complex ion. 
4+ 
100 • • Ubiquitin (wild type) 
V Ubiquillin-1 (UQ1 ) 
a . ~ ~ 6+ 2+ $ V 5+ $ 3+ 
• 
4+ 
100 ® ® Ublquitin mutant (I44A . L8A) 
2+ 
b. ~ ~ V 
3+ 
2000 2100 2200 2300 2400 2500 2600 2700 2800 2900 mlz 
Figure 4.2.5 ESI mass spectrum of UQ1-UBA (2 ~ M ) ) complex with a) wt-Ub (1 ~ M M ) 
and b) Leu8Ala/lle44Ala (1 ~ M ) ) double mutant, sprayed from 25mM ammonium 
acetate solution under acetonitrile vapour. 
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In addition to the above experiment, a competition analysis was also performed. 
Illustrated in Figure 4.2.6 is the ESI mass spectrum of UQ1-UBA with wt-Ub and 
Leu8Ala/lle44Ala-Ub double mutant, electrosprayed from 25 mM ammonium 
acetate in the presence of acetonitrile vapour. Formation of the wt-Ub.UQ1-UBA 
complex was clearly detectable as 5+ and 6+ ions, whilst the Leu8Ala/Ile44Ala-Ub 
mutant complex with UQ1-UBA was barely detectable demonstrating the specificity 
of the interaction observed by ESI-MS method. 
4+ • rUb] 
100 4+ • ® ® [Ub(L8A,I44A)] 
V [UQ1] 
e [Ub e UQ1] 
2+ 
V 
~ ~0 
6+ 
~ ~ 5+ ~ ~
O F T ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
2000 2200 2400 2600 m/z 
Figure 4,2.6 ESI mass spectrum of 4 J..lM UQ1-UBA, O.S J..lM LeuSAlajlle44Ala-Ub 
and O.S JlM wt-Ub, sprayed from 25 mM ammonium acetate solution, in the 
presence of acetonitrile vapour, showing specific binding. 
These results demonstrate the importance of Leu8 and Ile44 in the interaction of Ub 
with UQ1-UBA, and confirm the specificity of the complex detected by ESI-MS. 
4.2.2.2 CONFIRMING SPECIFICITY OF ZINC FINGER DOMAINS 
In contrast to the helical domains, the IsoT -ZnF domain interacts with Ub via the 
latter's C-terminal residues [106] (Figure 4.2.7). The ~ - G l y 7 5 / G l y 7 6 - U b b deletion 
mutant was used to test the specificity of this ZnF domain. 
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Figure 4.2.7 Cartoon representation of IsoT-ZnF (bright orange) complex with wt-
Ub (left panel) and Ll-G75/G76-Ub mutant (right panel) (POS 10: 2G45) 
Figure 4.2.8 shows the ESI mass spectra of the IsoT -ZnF complex with a) wt-Ub and 
b) ~ - G l y 7 5 / G l y 7 6 - U b b deletion mutant, electrosprayed from 25 mM ammonium 
acetate. Note that in this experiment, the domain was observed and treated as a 
disulfide-linked dimer, which has been previously reported [106]. 
12+ 11+ 
100 ]I ]I [lsoT-lsoTj 
13+ tUb • IsoT-lsoTj 
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a . ;I. 12+ 
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1 )1 
b. ;I. 
10+ 
2500 2700 2900 3100 
Figure 4.2.8 ESI mass spectrum of IsoT-ZnF (211M) complex with a) wt-Ub (111M) 
and b) Ll-Gly75/Gly76-Ub (I 11M) deletion mutant sprayed from 25mM ammonium 
acetate solution. 
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In addition to the above experiment, a competition analysis was also performed. In 
this case the reduced IsoT monomer (see Chapter 2) was used. Comparison of data 
obtained for IsoT-ZnF domain binding to wt-Ub and a ~ - G l y 7 5 / G l y 7 6 - U b b deletion 
mutant showed the formation of a wt-UbelsoT-ZnF complex. No association 
between ~ - G l y 7 5 / G l y 7 6 - U b b and the domain was observed (Figure 4.2.9) . 
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,.. [Ub(11-G75,G76)] 
~ ~ [lsoT] 
7+ ; [Ub-lsoT] ,.. 
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11+ ; ; 
~ ~0 5+ 
5+ 
• 6+ 9+ ,.. ,.. 
0 
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Figure 4.2.9 ESI mass spectrum of IsoT-ZnF (2 ~ M ) , , ~ - G l y 7 5 / G l y 7 6 - U b b (0.5 11M) 
and wt-Ub (0.5 11M) and sprayed from 25 mM ammonium aceta te solution, in the 
presence of acetonitrile vapour, showing specific binding. 
These results demonstrate the requirement of the C-terminal residues Gly75 and 
Gly76, for the interaction of Ub with IsoT -ZnF, and confirm the specificity of the 
interaction observed by MS. 
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4.2.3 SPECIFICITY FOR POLy-UB CHAIN TOPOLOGY 
4.2.3.1 THE CASE OFTHE hHR23A-UBA2 DOMAIN 
_. __ ._._ ... _-_._ .. __ ._ ........ _ .. _ .... _ ..... __ ._--_._ .. __ ._----_._ .. __ ._-- ----------- -----
The UBA2 domain of hHR23A is known to demonstrate preferential binding to 
Lys48-linked poly-Ub over mono-Ub and Lys63-linked poly-Ub [100, 101, 112, 
167] . Comparison of ESI-MS spectra obtained in this study for UBA2 complexes with 
mono-Ub (Figure 4.2.10) and poly-Ub (Figure 4.2.11 and Figure 4.2.12), showed that 
complex formation is preferred for Lys48-linked poly-Ub chains, and that this 
selectivity was most pronounced for Ub4 (Figure 4.2.12). Illustrated in Figure 4.2.10 
is the ESI mass spectrum obtained for the Ub.UBA2 complex, electrosprayed from 
2SmM ammonium acetate in the presence of acetonitrile vapour. The 
(Ub+UBA2+6H+)6+ ion is observed at 2382 m/z. Ub's charge states are distributed 
between 4+ (2142 m/z) and 5+ (1714 m/z). Unbound domain is observed at 1430 
m/z (4+) and at 1907 m/z (3+). The Kd value was determined from a titration 
experiment in which the Ub concentration was fixed at 0.5 11M and the concentration 
of UBA2 domain of hHR23A was varied from 2 to 811M. The average value of Kd 
determined from these measurements is 200 ± 14 11M, which is somewhat smaller 
than the previously reported value 400 ± 100 11M [100]. 
4+ 
100 5+ • • 
3+ 
III 
*' 
4+ 6+ 
lit J ~ L l l l ~ ~ • 0 1 1 " 1400 1800 m/z 2200 2600 
Figure 4.2.10 ESI mass spectrum of 0.5 11M Ub (blue) and 2 11M hHR23A- UBA2 
(red), sprayed from 25mM ammonium acetate solution under acetonitrile vapour. 
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The ESI mass spectra obtained for UBA2 complex with Lys48- and Lys63-linked 
Ub 2, electrosprayed from 25mM ammonium acetate are shown in Figure 4.2.11. 
Likewise, Figure 4.2.12 shows the ESI mass spectra of UBA2 complex with Lys48-
and Lys63-linked Ub4• It is clear that formation of complex is preferred for Lys48-
linked poly-Ub. ESI-MS apparent Kd values for UBA2 (Table 4.2.1) were found to be 
in good agreement with previously reported values obtained by NMR [100, 101, 
171]. 
It is notable that charge reduction was not absolutely required to stabilize 
complexes between the UBA2 with Ub2 and Ub4 chains, as similar apparent K dS were 
obtained with and without exposure to acetonitrile vapour. Charge reduction does, 
however, have the advantage of simplifying the spectrum of UBA2 and Ub4 by 
preventing signal overlap. 
100 ~ + + Kd = 18 ~ M M
.. [K48-Ub2] 
a. ~ ~
,,+ '- [K48-Ub2· UBA2] 
-.+ 
~ + +
O ~ - - ~ ~ - - ~ ~ ~ - - ~ - L ~ ~ ~ - - ~ ~ ~ ~ - - ~ - - -
100 ... 
Kd = 126 ~ M M
2100 2200 2300 
.. [K63-Ub2] 
te [K63-Ub2 ·UBA2] 
2400 2500 m/z 
Figure 4.2 .11 ESI mass spectra of UBA2 (4 11M) with: a) Lys48-linked Ub2 (0.5 11M), 
b) Lys63 -linked Ub 2 (0.5 11M), sprayed from 25 mM ammonium acetate solution. 
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Figure 4 .2.12 ESI mass spectra of UBA2 (4 ~ M ) ) with: a) Lys48-linked Ub 4 (O .S ~ M ) , ,
b) Lys63-linked Ub 4 (0.5 ~ M ) , , sprayed from 25 mM ammonium acetate solution 
under acetonitrile vapour 
-------_ .. __ ._-------_._-----_._---- ---------------
4.2.3.2 THE CASE OFTHE UQI-UBA DOMAIN 
.. - .. _--_ .. _-_ ..__ .. _._ .... _----_._-_._._. __ .. _ .._.---_. __ ._---_._-_._--------------
In contrast to the linkage specificity evident for the UBA2 domain, it has been 
reported that the UQ1-UBA domain shows no selectivity towards Lys48- and 
Lys63-linked Ub2 chains [102]. ESI-MS of UQ1-UBA complexes with mono-Ub 
(Figure 4.2.1b, see 0) and poly-Ub chains (Figure 4.2.13 and Figure 4.2.14) 
confirmed the aforementioned behaviour of UQ1-UBA domain. Figure 4.2.13 
illustrates the mass spectra obtained for UQ1-UBA complex with Lys48- and Lys63-
linked Ub2, electrosprayed from 25 mM ammonium acetate in the presence of 
acetonitrile vapour. Formation of complex is observed for both chain linkages. 
Measured apparent KdS for Lys48-linked Ub2 (Kd = 15 ± 2 ~ M ) ) and Lys63-linked Ub2 
(Kd = 24 ± 2 ~ M ) ) were found to be similar in value and in good agreement with 
previously reported data (Table 4.2.1). 
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Figure 4.2.13 ESI mass spectra of 4 11M UQ1 with : a ) Lys48- linked Ub z (O .S 11M) and 
b) Lys63-linked Ub z (0 .5 11M) , sprayed from 25 mM ammonium acetate solution 
under acetonitrile vapour. 
Furthermore, the binding between UQ1-UBA with either Lys48- or Lys63-linked 
forms of Ub4 was also determined to be in the 15 \-lM range (Figure 4.2.14). These 
data are consistent with the conclusions of a NMR study that suggested that 
intermolecular contacts between the UQ1-UBA and the individual Ubs in Lys48-
and Lys63-linked Ubz chains, are essentially the same as with mono-Ub [102]. In 
contrast, a SPR study [101], showed that the UQ1-UBA interaction with Ub4 
moieties, is somewhat stronger than the values reported by the ESI-MS method 
(Table 4.2.1). The SPR experiments, however, were conducted on dimeric GST-
(UQ1-UBA) fusions, and hence, artifactual chelate effects leading to apparently 
higher affinity with longer poly-Ub chains are a possible explanation. Indeed, this 
effect has previously been observed with GST -UBD fusion proteins [175] . 
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Figure 4.2.14 ESI mass spectra of 4 11M UQ1 with: a) Lys4B-linked Ub 4 (0.5 11M) and 
b) Lys63-linked Ub 4 (0 .5 11M), sprayed from 25 mM ammonium acetate solution 
under acetonitrile vapour . 
4.2.4 QUANTIFYING UB-UBD BINDING AFFINITY 
.... _ .... _ ....... __ .•........... _ .......... _ ..... _--_._ .. _ ... _--... _.-...... _ .. _ ....... _-_ .. _ ....... _ ..... _--_._----_.-_. __ .-_._----_._--
4.2.4.1 USIQUITIN COMPLEXES WITH UQ1-UBA DOMAIN 
---_._._._. __ .. _ ... _ ..... _ .. _._-_ .. _-----_._-----_._._- ---- -----------
The UQ1-UBA forms complexes with mono-Ub, Lys48- and Lys63-linked Ub2 as 
well as Lys48- and Lys63-linked Ub4 and have been examined in sections 0 and 
4.2.3.2. with Apparent KdS are shown in Table 4.2.1 and are compared with the 
previously reported values determined by other methods. Additionally to these 
measurements, the apparent KdS of UQ1-UBA complexes with Lysll- and Lys27-
linked Ub2 were also determined (Table 4.2.1). Figure 4.2.15 illustrates the mass 
spectra obtained for UQ1-UBA complex with Lys11- and Lys27-linked Ub2, 
electrosprayed from 25 mM ammonium acetate in the presence of acetonitrile 
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vapour. Formation of complex is observed for both chain linkages. Similarly to the 
other Lys-linked Ub2 chains, little binding preference was exhibited. 
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Figure 4.2 .15 ESI mass spectra of 4 ~ M M UQ1 with: a) Lys11-linked Ub 2 (0 .5 ~ M ) ) and 
b) Lys27- linked Ub 2 (0.5 ~ M ) , , sprayed from 25 mM ammonium acetate solution 
under acetonitrile vapour. 
4.2.4.2 USIQUITIN COMPLEXES WITH hHR23A-UBA2 DOMAIN 
---------------------------------
The UBA2 complexes with mono-Ub, Lys4S- and Lys63-linked Ub2 as well as Lys4S-
and Lys63-linked Ub4 have been examined in section 4.2.3.1. The apparent KdS are 
shown in Table 4.2.1 and are compared with the previously reported values 
determined by other methods. In addition to these values, new data for Lysll- and 
Lys27-Ub2·UBA2 interactions were also determined (Table 4.2.1). Figure 4.2.16 
illustrates the mass spectra obtained of UBA2 complex with Lysll- and Lys27-
linked Ub2, electrosprayed from 25 mM ammonium acetate. The measured apparent 
KdS for these two linkage topologies are also significantly weaker than for the 
Lys4S-Ub2 linkage (Table 4.2.1), which confirms the preference of UBA2 domain 
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towards Lys48-linked poly-Ub chains and demonstrates the ability of ESI-MS 
method to probe selectivity of Ub·UBD interactions. 
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Figure 4.2.16 ESI mass spectra of UBA2 (4 11M) with: a) Lys11-linked Ub 2 (0.5 11M), 
b) Lys27-linked Ub 2 (0 .5 11M), sprayed from 2SmM ammonium acetate solution. 
4.2.4.3 UBIQUITIN COMPLEXES WITH MIU DOMAIN 
--------------------------------
MIU binds to the hydrophobic patch Ile44 on the ~ - s h e e t t region of ubiquitin, with a 
Kd _30 11M. Illustrated in Figure 4.2.17 is the mass spectrum obtained for the Ub.MIU 
complex, electrosprayed from 25 mM ammonium acetate in the presence of 
acetonitrile vapour. The (Ub+MIU+6H+)6+ and the (Ub+MIU+5H+)5+ ions are 
observed at 1996 m/z and 2395 m/z, respectively. Ub's charge states are distributed 
between 4+ (2142 mjz) 5+ (1714 m/z) and 6+ (1428 mjz). Unbound domain is 
observed at 1704 mjz (2+) and at 1136 mjz (3+). The apparent Kd value determined 
from these measurements was 36 ± 4 11M, which is in good agreement with 
previously reported values determined by SPR (Table 4.2.1). 
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Figure 4.2 .17 ESI mass spectrum of 0 .5 ~ M M Ub and 2 ~ M M MIU complex. sprayed from 
25mM ammonium acetate solution under acetonitrile vapour. 
Further studies of MIU domain interactions with Ub2 moieties, particularly Lys48-, 
Lys63- and Lys11-linked chains, have shown that the MIU domain possesses no 
selectivity towards any of the Ub 2 linkages examined here (Table 4.2.1) . A study that 
has been published after the completion of the experiments described in this 
Chapter, has used bio-Iayer interferometry (BLI) to probe Ub4 linkage selectivity of 
the tandem UBDs (MIU and A20-ZnF domains) of Rabex-5 [176]. The study has 
shown that MIU domain exhibits some selectivity for linear and Lys63-linked Ub4 
over Lys48-linked Ub4. In addition, the binding affinities of MIU domain for Ub4 
chains (linear Ub4. 0.28 ± 0.14 11M; Lys63-Ub4, 1.0 ± 0.65 11M; Lys48-Ub4, 3.1 ± 1.1 
11M) were found to be somewhat higher than the determined values for the Ub2 
linkages (Table 4.2.1)' Further to the different experimental setup between the two 
studies (BLI and ESI-MS), another difference that might be contributed to these 
discrepancies is the use of a longer domain in the case of the BLI study; in the BLI 
study, the Tyr25AlaJTyr26Ala GST -Rabex-S9_73 double mutant was used to study 
interactions of MIU with Ub4, in contrast to the thrombin cleaved Gly-Ser-Rabex-
548-75 that used in the case of ESI-MS method. It has been shown that Ub bind MIU 
domain via the latter's hydrophobic patch centred around AlaS8 residue (involving 
lIe51, Trp5S, LeuS7, Ala58, Leu61 and Phe69 residues) [97]. 
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Although the form used in the ESI-MS study includes all the residues involved in 
MIU's hydrophobic patch, the contribution of the other residues (towards the N-
terminal) in the stabilization of poly-Ub chains is unknown. Indeed, the apparent K dS 
determined by ESI-MS for MIU domain complexes with Ub2 linkages were smaller 
than the mono-Ub-MIU complex (Table 4.2.1). Figure 4.2.18a shows the structure of 
mono-Ub-Rabex-517-74 complex as determined by crystallography [98]. The 
structure of the Rabex-517-74 (light blue) shown here, is a very good approximation 
of the Rabex-5 form used in the BLI study. In contrast, the Rabex-5 form used in the 
ESI-MS study is shown in Figure 4.2.18b. Comparison of the two Rabex-5 forms 
highlights the potential role of the additional residues, in the stabilisation of poly-
Ub-MIU domain interactions. 
Figure 4.2 .18 Cartoon representation of Ub (dark grey) complex with (a) Rabex-
517-74 and (b) MIU domain used in this study; Rabex-5 4B-74, (PDS 10: 2C7M) . 
--_ .. _----_ .. _-----------_._--_ .. _---_._-----------------
4.2.4.4 UBIQUITIN COMPLEXES WITH IsoT -ZnF DOMAIN 
The IsoT-ZnF domain demonstrates a very high Ub binding affinity with a Kd-3 ~ M M
[106]. Illustrated in Figure 4.2.19 is the mass spectrum obtained for the Ub-IsoT-
ZnF complex, electrosprayed from 25 mM ammonium acetate. Note that in this 
experiment, the domain was observed and treated as a disulfide-linked dimer 
(2xIsoT), which has been previously reported [106] . The (Ub+IsoT-ZnF+nH+)n+ 
complex ions ranged in charge state between n=12-15. Additionally, a smaller 
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distribution of unbound dimer domain ions (lsoT -ZnF+nH+t+ at charge states 
n=10-12 were observed. Ub's charge states are distributed between 5+ (1714 m/z), 
6+ (1428 m/z) and 7+ (1224 m/z). The apparent Kd determined from these 
measurements is 2.5 ± 0.5 ~ M , , which is in excellent agreement with 2.8 ± 0.1 ~ M M
determined from ITC measurements [106]. It has to be noted that the calculation of 
Kd was based on the assumption that both sides of the dimer can equally bind Ub 
and that only one form of complex is formed (only one Ub moiety bind to the dimer). 
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Figure 4.2 .19 ESI mass spectrum of 0.5 ~ M M ubiquitin (blue) and 2 11M IsoT-ZnF (red 
and orange) complex, sprayed from 25 mM ammonium acetate solution. 
To test of the validity of this assumption, the IsoT -ZnF dimer, which is formed by a 
disulfide bond between the Cys195 residues of the monomeric species [106], was 
reduced to its monomer form by dithiothreitol (OTT) (see Chapter 2). Illustrated in 
Figure 4.2.20 is the ESI mass spectrum of the IsoT -ZnF domain complex with Ub, 
sprayed from 25 mM ammonium acetate. The (Ub+lsoT-ZnF+nH+t+ complex ions 
are ranging in charge state between n=9-11. Additionally, a distribution of unbound 
(lsoT -ZnF+nH+t+ ions at charge states n=5-9 is presented. Ub's charge states are 
distributed between 5+ (1714 m/z), 6+ (1428 m/z) and 7+ (1224 m/z). 
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Figure 4.2.20 ESI mass spectrum of IsoT-ZnF (211M) and Ub (0.5 11M) sprayed from 
25 mM ammonium acetate. 
The binding affinity determined from these data (2.3 ± 0.5 ~ M ) , , was found, again, to 
be in good agreement with the literature value (2.8 ± 0.5 ~ M ) ) [106]. Furthermore, it 
supports the assumption been made before in the case where the dimer form of the 
IsoT -ZnF domain was used. 
Further studies of IsoT -ZnF domain interactions with Ub2 mOieties, particularly 
Lys48-, Lys63- and Lysll-linked chains, have shown that the IsoT -ZnF possesses 
no selectivity towards any of the Ub2 linkages and bind them with affinities very 
similar to that observed for mono-Ub (Table 4.2.1). Given that the IsoT -ZnF domain 
binds Ub via IsoT-ZnF's C-terminal residues (Gly7S and Gly76) and that unanchored 
poly-Ub chains have a free C-terminus, these results were expected. Interestingly, it 
was observed that the use of charge reduction on complexes of IsoT -ZnF resulted in 
almost identical Kd values compared to those obtained from conventional ESI 
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process. This suggests that these species are more stable in the gas-phase at higher 
charge state compared to complexes formed with the other UBDs examined here. 
Moreover, the formation of the Iso-ZnF complex with Lys48-Ub2 led to an 
interesting observation that has further demonstrates the capability of ESI-MS 
methodology to probe specificity of Ub.UBD interaction, and is extensively 
discussed in Chapter 5. Briefly, it was found that commercially obtained Lys48-Ub2 
contained a significant amount of cyclic Lys48-Ub2, which in contrast to the acyclic 
form, was not able to bind IsoT -ZnF domain, due to the lack of a free C-terminus. 
4.2.5 MULTISITE BINDING OF UB TO UBDs 
The crosstalk between different Ub-dependent pathways is very difficult to study 
using currently available biophysical techniques. Therefore, a rapid and sensitive 
method that could probe such interactions is essential. Having established that ESI-
MS methodology is able to detect specific interactions between Ub and a range of 
UBDs, it was postulated that it could be also employed to examine multiple domain 
interactions with different Ub site specificities. A recent study has assessed the 
probability of Ub-mediated ternary complex formation [177]. As it has been 
mentioned above, the UQ1-UBA and the IsoT -ZnF domains bind Ub via latter's Ile44 
hydrophobic patch and Gly75/Gly76 C-terminus, respectively. Therefore, these 
domains should be able to form a ternary Ub.UQ1-UBA.lsoT-ZnF complex. ESI-MS 
of a mixture of the three components did, indeed, lead to a clearly detectable ternary 
complex (Figure 4.2.21), confirming that multiple domains can bind mono-Ub or 
poly-Ub simultaneously. 
114 
Probing affinity and Ub linkage selectivity of UBDs 
100 
~ ~o 
4+ 
• 
7+ ~ ~ 6+ $ 
2200 
2+ 
V 
6+ 
~ ~
9+ ;; 
2600 
8+ ; 
5+ 
~ ~
3000 
• [Ub] 
V [UQ1] 
$ [Ub-UQ1] 
~ ~ [\soT] 
Chapter 4 
;; [Ub-\soT] 
~ ~
• [Ub-UQ1-\soT] 
..., 
7+ 
; 
3400 
Figure 4 .2.21 ESI mass spectrum of O.S ~ M M mono-Ub with 4 ~ M M UQ1-UBA and 2 ~ M M
IsoT-ZnF. in the presence of acetonitrile vapour. showing the presence of a 
Ub-UQ1-UBA-lsoT-ZnF ternary complex. 
Additionally to the formation of the ternary complex. the binary complexes Ub-UQl 
and Ub-lsoT -ZnF were also observed. There was no evidence for the formation of 
any non specific complex between the two UBDs, UQ1-UBA and IsoT-ZnF. This, 
again, demonstrates the ability of ESI-MS methodology to detect specific 
interactions. 
4.2.6 FIDELITY OF THE MS METHOD 
A series of experiments has been conducted in order to test the fidelity of results 
derived from the ESI-MS methodology. Particularly, it has been demonstrated that 
the use of a charge reduction approach was essential, at least for some complexes, to 
minimize disruption of non-covalent complexes in the MS region (section 0). Lower 
charge states were obtained by exposure of the electrospray plume to acetonitrile 
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vapour (see Chapter 3). Although it has been shown that charge reduction it was not 
always essential, its use is recommended in cases where there are concerns over 
complex stability. The specificity of the observed non-covalent complex was tested 
and confirmed by competitive and non-competitive assays using wt-Ub and mutant 
Ubs. Furthermore, the use of ESI-MS methodology as a tool to probe Ub-linkage 
selectivity was evaluated by the cases of UQ1-UBA and UBA2 domains. 
The ESI-MS methodology requires only the measurement of the ratio of the total 
intensity of the bound (complexed) and unbound (free) Ub ions generated by the 
electrospray process and the knowledge of the initial concentration of Ub and UBD 
(see Chapter 2). It has to be noted here, that determination of binding affinity is 
based on measurements of the solution equilibrium concentrations of the binding 
partners. ESI-MS, in contrast, measures the ion abundance, which is the result of the 
conversion of analyte species in solution into measurable ESI-MS signal. The 
relationship between signal intensity and solution-phase concentration is given by 
IA=YA[A], where IA and [A] are the signal intensity and the solution concentration of 
analyte A, and 'YA is the response factor, which reflects the extent of conversion as 
defined above. Therefore, the use of ESI-MS as a tool for binding affinity 
measurements requires the knowledge of the analytes response factors, particularly 
their ratio. Methods for determining ESI-MS response factors have been reported 
[178, 179], however, due to the complexity of these approaches, it is usually 
postulated that the ratio of the response factor is equal to 1 [180]. In cases of 
protein-ligand associations where the ligand is relatively small compared to the size 
of the protein, the assumption that free and bound protein ions have similar 
response factors is valid. However, formation of protein-protein complexes in 
solution can be associated with conformational changes that, may affect the 
response factors. It is also known that the effective hydrophobicity of a protein in 
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solution is linked to its ESI ionization efficiency which, in turn, is related to the 
response factor of the protein [181]. Therefore, if the free state of a protein is 
partially unfolded compared to the complex form, its effective hydrophobicity will 
be enhanced and as a consequence the ionization efficiency of the free protein will 
be increased, leading to discrepancies in the response factors of unbound and bound 
protein ions [174]. Interactions between Ub and UBDs will bury a small number of 
hydrophobic residues on both proteins, and therefore the ionization efficiency of the 
complex and the unbound Ub species it might be affected. Such a scenario would 
influence the response factors and possibly would drive off the response factors 
ratio from the ideal value of 1. To examine whether or not this case applies to the 
Ub.UBD complexes studied in this project, we applied a simple test. A study by 
Kaltashov and Mohimen, has shown that for natively folded proteins there is a linear 
relationship between In (average ESI charge state) and In(surface area, A2) with a 
slope of 0.69 ± 0.02 [182]. Using the logic developed by Liu and Konermann [174], 
significant departure from this relationship may indicate changes in ionization 
efficiency and hence response factors. These changes might be driven by the 
formation of protein-protein association that result in the exposure or burial of 
hydrophobic residues. 
Plotting In(average ESI charge state) versus In (surface area, A2) for mono-Ub and 
the four complexes investigated in this study, resulted a straight line with a slope of 
0.68 ± 0.01 (Figure 4.2.22), which is in excellent agreement with the value reported 
by Kaltashov and Mohimen [182]. Thus, we conclude that formation of Ub.UBD 
complexes is not linked with major conformational changes in the subunits, 
consistent with previously reported data from solution studies [102], and that burial 
of a relatively small number of hydrophobic residues does not appear to impact 
upon ionization properties of the complex compared to the unbound Ub. 
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Figure 4.2.22 Plot of In(average ESI charge state) versus In(surface area, A2). 
Solvent accessible surface areas were calculated for Ub, Ub.MIU and Ub.UQ1-UBA 
complexes from modified PDB files lD3Z, 2C7M and 2JY6, respectively, using the 
program GetArea ( h t t p ; l / c u r j e . u t m b . e d u / ~ e t a r e a , h t m l ) . . The modified PDB 
structures were built by adding or subtracting amino acids, to/from the published 
structures, using PyMOL. Model structures for the Ub.UBA2 and Ub.lsoT-ZnF 
complexes were build from PDB files 1Z06 and 2G45, respectively. 
4.3 CONCLUSIONS 
The ESI-MS approach described in this Chapter provides a new, rapid and highly 
sensitive tool for studying the affinity and specificity of Ub.UBD complexes. The key 
advantages of this method are the speed of analysis (in an optimized instrument the 
analysis can be completed within minutes), the low sample consumption (less than 
50 ilL of sample at micromolar concentration are required for a single 
measurement), sensitivity (weak and low abundance complexes can be detected 
without the need of saturation, as demonstrated in case of the UBA2 complex with 
Ub) and selectivity. 
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The method is based on titration experiments, where the concentration of the Ub 
component is fixed to 0.5 IlM and the concentration of UBD varies from 1 to 8 IlM. 
Although, the concentration of UBD could be increased, we have shown that the 
sensitivity of the method allows a very weak interaction between mono-Ub and 
UBA2 (Kd = 200 IlM) by the addition of only 4 IlM of the UBD. Moreover, in the cases 
of the UQ1-UBA and UBA2 domains we have also observed that increasing the 
domain concentration above 6 J.1M resulted in the formation of a significant amount 
of UBD homodimer, which may affect precise determination of Kd. Indeed, the ability 
to work at low micromolar range better reflects the physiological situation as the 
cellular concentration of Ub is estimated to be approximately 85 11M [183]. 
The experiments were performed on a commercially available IM-MS instrument 
(SYNAPTTM HDMS, Waters, UK). Although the determination of binding affinities by 
ESI-MS, does not require the ion mobility function, its use in our experiments has 
demonstrated some clear benefits. For example, in the case of Ub.UBA2, the 
unbound mono-Ub ion 3+, the unbound domain ion 2+ and the complex ion 5+, 
show m/z values of 2856 m/z, 2858 m/z and 2857m/z, respectively, which are 
almost impossible to discriminate in the mass spectrometer. The problem was 
overcome by the use of IM-MS, which has the additional ability to separate ions 
based on their mobility through a buffer gas, providing a second dimension for 
resolution of isobaric or near-isobaric species. 
Perhaps the most compelling evidence for the applicability of this approach for 
studying Ub.UBD complexes is the excellent agreement achieved between ESI-MS 
affinity data and that of other biophysical methods. When tested against a series of 
previously studied Ub.UBD complexes the MS results were found to be in an 
excellent agreement with the Kd values that have been previously determined. In 
addition, we have provided new insights into binding affinities of previously 
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unstudied complexes. The methodology described shows great promises in probing 
biologically-relevant multivalent interactions with poly-Ub, for example to gain 
insights in to how UBDs of proteasome subunits, Rpn13-Pru and Rpnl0-UIM, 
cooperate to function as a 'molecular ruler' effectively sensing the length of poly-Ub 
chains delivered to the proteasome [184, 185]. 
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CHAPTER 5 
TOP-DOWN PROTEOMICS TO 
CHARACTERIZE PO LY -UB CHAI N S 
AND CYCLIZATION OF LYS48-UB2 
IN VITRO AND IN VIVO 
5.1 INTRODUCTION 
The role of unanchored poly-Ub chains has only recently begun to be understood 
and linked to Ub-mediated processes. Piotrowski et al. have demonstrated that in 
vitro synthesised Lys48-poly-Ub chains could inhibit the proteasomal degradation 
of polyubiquitinated substrates [186]. In addition, it has been shown that 
degradation of the polyubiquitinated p53 by the 26S proteasome is affected by the 
accumulation of free chains in cells that is caused by IsoT knockdown [187]. The 
potential roles of unanchored Lys63-linked chains in activating kinases [188] and in 
signalling during innate immunity [189, 190], as well as the inhibition of the DUB 
enzyme, Ub carboxyl-terminal hydrolase isozyme L3 (UCH-L3) by Lys48-Ub2 [191], 
have also been reported. Similarly to conjugated Ub chains, unanchored chains also 
exhibit linkage specificity and therefore, their study is equally important. 
In addition to unanchored poly-Ub chains, in vitro-generated cyclic forms of Lys4B-
Ub2,-Ub3 and -Ub4 have also been reported [192-194]. In each of these species, the 
normally free C-terminal Gly76 residue of the proximal Ub forms an additional 
isopeptide bond with the Lys48 of the distal Ub, which probably occurs due to the 
close spatial proximity of these residues in the compact conformations of Lys48-
poly-Ub. Notably however, to date cyclic poly-Ub has not been identified in vivo. 
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The potential of MS-based, bottom-up proteomics to study ubiquitin modification 
has been previously demonstrated [195, 196]. This method has managed to detect 
all seven Lys-linkages in yeast [197] and HeLa cells [198], however, some important 
structure information is lost due to trypsin digestion. For instance, the bottom-up 
approach cannot discriminate homogeneous Lys-linked poly-Ub chains from forked 
chains [195]. Contrary, middle-down approaches have utilized partial digestion of 
poly-Ub chains under native conditions, allowing this way, mapping of the absolute 
topology of poly-Ub chains [199]. Moreover, absolute quantification (AQUA) 
approach for the analysis of linkage types has been employed to determine the 
percentage composition of poly-Ub linkages attached to individual proteins or 
mixtures [200, 201]. In contrast to bottom-up and middle-down methods which 
rely on tryptic digestion, top-down approach does not require the use of proteases. 
Although the potential of top-down proteomics to study ubiquitin modification has 
been demonstrated using poly-Ub chains generated in vitro [199], characterization 
of endogenous unanchored poly-Ub chains using such an approach has not yet been 
achieved. 
This chapter describes the successful employment oftop-down proteomics to reveal 
the topology of an unanchored poly-Ub chain (Lys48-Ub2) that has been purified 
from tissue extracts using affinity chromatography methodologies based on the use 
of the ZnF domains, IsoT-ZnF and A20 ZnF (from the ZNF216 protein), which bind 
Ub by utilizing latter's free C-terminal or Asp58 residue, respectively. Furthermore, 
the presence of cyclic Ub2 as the major component in a sample of commercial Lys48-
Ub2 (Boston Biochem, Cambridge, USA) as well as the isolation and characterization 
of endogenous cyclic Lys48-Ub2 from rat skeletal muscle and cultured mammalian 
cells, are also reported in this chapter. 
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5.2 RESULTS AND DISCUSSION 
5.2.1 MS ANALYSIS OF UNANCHORED POLY-US CHAINS 
The strategy used for A20 ZnF and IsoT -ZnF domain affinity chromatography is 
described elsewhere [118]. This section deals with the development of a MS top-
down approach for the characterization of endogenous unanchored poly-Ub chains. 
The immobilised A20 ZnF domain captures a complex mixture of polyubiquitinated 
proteins from rat skeletal muscle extracts (Figure 5.2.1A) including a prominent Ub-
immunoreactive band (Figure S.2.1A, red arrow), which co-migrates with species of 
commercial unanchored Lys48- and Lys63-linked Ub2 standards. 
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Figure S.2 .1 A) Anti-Ub Western blotting of purified polyubiquitinated proteins (P) 
from rat skeletal muscle captured by A20 ZnF domain . The high molecular weight 
smear is mainly attributed to ubiquitinated proteins. The arrow indicates a band 
that co-migrates with the Ub 2 standards . 8) Incubation of beads with (+) or without 
(-) USP2 followed by anti-Ub Western blotting of the beads (P) or elution (E) . 
Western blot assays were carried out by Dr. Joa nna Strachan . 
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Further analysis showed that deubitination of the A20 ZnF domain-immobilised 
polyubiquitinated proteins by USP2 DUB, spared the Ub2 (Figure 5.2.1B) . 
................................. _ .................. - ........ _ ....__ ._-----------------------
5.2.1.1 MS CHARACTERIZATION OF THE PURIFIED DI-UBIQUITIN 
............................... _ ........... _._ .......... _ ... _ .._ .................... -.. _.--_._--_ ... _--------_.:..-_-----_._--
The purified proteins that remained attached to the beads after USP2 treatment, 
were eluted using formic acid (see Chapter 2) and were subjected to nanoLC-MS 
analysis for accurate mass determination. Figure 5.2.2 shows the mass spectrum 
obtained for the purified protein under denaturing conditions. The deconvoluted 
mass obtained from this spectrum (m/z 17102) was consistent with the mass of 
unmodified and unanchored intact Ub2. Charge states from 10+ to 21+ are attributed 
to Ub2 species whereas the presence of a small amount of mono-Ub is also observed 
at charge states 11+ (m/z 779.61) and 12+ (m/z 714.64). 
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Figure 5.2.2 LC-ESI-MS spectrum of Ub2 purified from rat skeletal muscle. 
To investigate the topology of the purified Ub2 species, we performed LC-MS/MS 
analysis of an in-gel tryptic digest (of the purified Ub2 species) using both, cm and 
ECD fragmentation (Figure 5.2.3). This bottom-up approach is based on the 
generation of poly-Ub linkage specific GG-modified tryptic peptides, which contain a 
missed tryptiC cleavage at the modified Lys site. For example, the ubiquitin tryptic 
peptide LIFAGKQLEDGR has an average mass of 1346.55 Da and contains only the 
Lys48 residue. In the case of a Lys48-linked poly-Ub chain, the di-Gly peptide will 
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remain attached to the Lys48 residue therefore it will increase the mass of the 
related ubiquitin tryptic peptide by 114.04 Da. The sequence of the GG-modified 
peptide, LlFAGK(GG)QLEDGR, can be revealed and hence verified by cm and ECD 
fragmentation, as demonstrated in the case of Lys48-Ub2 (Figure 5.2.3). 
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Figure 5.2.3 LC-ESI-MS/MS spectra of tryptic peptide 43-54 from Ub2 purified 
from rat skeletal muscle resulting from (A) CID of the [M+2H]2+ at m/z 731.0 and 
(8) ECD ofthe [M+3H]3+ at m/z 487.7, clearly locating the linkage site to Lys48. 
The bottom-up experiments suggested that the purified Ub2 species observed in rat 
skeletal muscle sample was Lys48-linked. 
To further investigate the presence of endogenous unanchored poly-Ub chains in the 
rat skeletal muscle samples, we also performed pull-down assays using the IsoT-
ZnF domain. This UBD utilizes Ub's free C-terminal to bind, therefore exhibits 
specificity for unanchored poly-Ub chains whereas due to the binding mechanism it 
is unlikely to show any poly-Ub linkage specificity. Indeed, in chapter 4, it has been 
well demonstrated that IsoT -ZnF, binds mono-Ub and different linked Ub2 chains 
125 
Top-down proteomics and Cyc1ization of Lys4B-Ub2 ChapterS 
with similar affinity. Figure 5.2.4 illustrates the LC-MSjMS spectra obtained for the 
tryptic peptides derived from the gel-purified Ubz, using ECD fragmentation. 
Signature peptides from both, Lys48-linked (1460.65 Da) and Lysll-linked 
(2402.68 Da) were detected (Figure 5.2.4). 
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Figure 5.2.4 ECD MS/MS spectra of the tryptic peptides (A) 43-54 and (B) 7-27 
derived from purified Ub2 that was captured from rat skeletal muscle by IsoT-ZnF 
domain. These spectra suggest the presence of Lys48 (A) and Lysll (8) linkages. 
-----_._._--
5.2.1.2 TOP-DOWN MS CHARACTERIZATION OFTHE LYS48-UBz 
------------- ._----------------
Top-down MS was performed to probe the structure of the sample and to ascertain 
linkage information. Illustrated in Figure 5.2.5 is the cm MSjMS spectrum of mono-
Ub, resulting from low energy em ofthe [M+11H]11+ ion (mlz 779.2). Both, band y 
ions were generated; b18 = mlz 2032.13, b39 = mlz 4307.30, b52 = mlz 5834.12 
y24 = mlz 2725.50, y58 = mjz 6527.50 and y74 = mlz 8300.52 (Figure 5.2.5). 
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Figure 5.2 .5 C!D MS/MS deconvoluted spectrum obtained for the 11 + precursor ion 
(m/z 779.2) of mono-Ub demonstrating the major fragmentation patterns in the 
polypeptide chain. The top schematic shows the fragmentation sites of mono-Ub, 
resulting from low energy C!D. 
Based on the em MSjMS results obtained for mono-Ub, a top-down approach 
should theoretically be able to distinguish between Lys6/11-, Lys27/29/33-, 
Lys48-, and Lys63-linked poly-Ub chains. In the particular case of Ub2 species the 
differentiation could be based on the presence or absence of diagnostic ions 
produced by single fragmentation events (Table 5.2.1). 
Table 5.2.1 Predicted m/z values of diagnostic b ' and y series ions produced by a 
single C!D fragmentation of Ub 2 with the indicated Lys linkages. 
b' m/z K6 Kll K27 K29 K33 K48 K63 Y m/z K6 Kll K27 K29 K33 K48 K63 
52 14377 + + + 24 2725 + + + 
39 12850 + 37 4252 + + 
36 12541 40 4561 + 
18 10575 + 58 65 27 + 
13 10004 63 7098 + 
Blue highlighted boxes indicate the predicted ions to be produced by fragmentation of a 
given Ub2. Red highlighted boxes indicate the Ub2 standards analysed in this study and 
the relevant detected diagnostic ions are indicated '+'. b' ions represent the b ions derive 
from the fragmentation of the proximal Ub only i.e. the distal Ub remains intact. 
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cm MSjMS of the 15+ precursor ion (m/z 1141) for both, Lys48-Ub2 and Lys63-Ub2 
standards resulted in the formation of diagnostic fragment ions (Figure 5.2.6). The 
b52' (m/z 14375.7) and y24 (m/z 2726.5) ions are only produced from Lys48-Ub2 
species. Figure 5.2.6C shows the deconvoluted em MS/MS spectrum for the 15+ 
precursor ion of the A20 ZnF-purified rat muscle Ub2. The presence of the diagnostic 
ions, b52' and y24 confirms that the Ub2 is not Lys63-linked. Given that no specific 
ions associated with other non-Lys48 linkages were observed, is concluded that the 
purified Ub2 species was Lys48-linked, which is consistent with the results obtained 
from the bottom-up experiments. 
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Figure 5.2.6 LC-MS/MS deconvoluted spectra obtained for the 15+ precursor ion 
(m/z 1141.8) for (A) commercial Lys63-Ub 2, (8) commercial Lys48 - Ub 2 and (C) 
Ub 2 purified from rat skeletal muscle . 
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5.2.2 CYCLIZATION OF LYS48-UB2 
Illustrated in Figure 5.2.7 are the ESI-MS spectra obtained for commercial samples 
of in vitro generated native Lysl1-, Lys63- and Lys48-Ub2 (only the [M+19H)19+ 
charge state is shown for clarity). In the cases of Lysll and Lys63 linkages, a single 
charge distribution was obtained at m/z 901.60 (19+), corresponding to a molecular 
mass (Mr) of 17,111 Da. In contrast, for Lys48-Ub2 species, two series were detected. 
Signals for 19+ ions occurred at m/z 901.60 (Mr 17,111 Da) and at m/z 900.65, 
which corresponds to Mr = 17,093 Da that is 18 Da lower than the mass of the full 
length polypeptide chain. The latter indicated dehydration, which is consistent with 
a cyclic form of Lys48-Ub2 that results from cyclisation of the C-terminus Gly76 of 
the proximal Ub with the Lys48 residue of the distal Ub. The close spatial proximity 
of these residues in the compact conformation of Lys48-Ub2 (Figure 5.2.8) 
presumably results their coupling in the E2 active site. 
~ r . . .. " .. ,,, .. , , , F , P 
19+ 
901.60 [Lys11-Ub2] 
".A" ........... , 'f",'.' t", 
~ ~ 19+ 
"0 901.60 [Lys63-Ub2] 
I r .." .. " .. " " " ,&11' "'" .... " " " 
~ ~ [Lys48-Ub2] 19+ [Lys48-Ub2] 
C (cyclic) --.. 900.65 19+.---- (non-cyclic) I .. , , . , , , , . , , , , , , , .A.".A,.,., , , ,"'''' .. , " , , , """'''', 
898.5 899.5 900.5 901.5 902.5 903.5 
m/z 
Figure 5.2.7 ESI-MS spectra of intact (A) commercial Lysll-Ub2, (8) commercial 
Lys63-Ub2 and (C) Lys4B-Ub2' showing the presence of cyclic Ub2 in the Lys48-
linked sample. Spectra were acquired under denaturing cond itions. Only the 
[M+19H)19+ ion is shown for clarity. 
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proximal Ub 
Figure 5.2.8 NMR structure of compact Lys48-Ub 2 (POB ID : 2BGF) showing the 
close spatial proximity of Gly76 (proximal Ub) and Lys48 (distal Ub) residues. 
Cyclic Lys48-Ub3 has previously been reported as a product of in vitro ligation of Ub 
using E2-25K [193], which is the E2 enzyme used in the production of the 
commercial Lys48-Ub2 analysed in this study. Cyclic Lys48-Ub2 was found to be the 
major form (ca. 70 %) in the original batch of commercial native Lys48-Ub2 (Lot # 
3291529). It is worth to be noted that new batches of commercial Lys48-Ub2 (Lot # 
11515211) contain much less cyclic material (Figure 5.2.9) as a result of improved 
production procedures implemented after our initial observations (halting E2 
catalysed polymerisation as soon cyclic Lys48-Ub4 is observed). Additionally, the 
possibility of product (commercial Lys48-Ub2) instability due to storage conditions 
(temperature and solution pH) was investigated. This was performed using the later 
batch of commercial Lys48-Ubz (Lot # 11515211) which was found to contain much 
less cyclic material than the older batch (Lot # 3291529). Two aliquots of the 
Lys48-Ub2 material in a nearly native solution (25 mM ammonium acetate) and in a 
highly organic solution (50% acetonitrile, 0.1% formic acid), respectively, were 
stored in a fridge (-- 4°C). Examination of these samples after a period of one week 
did not show any differences in the ratio of acyclic/cyclic form when compared with 
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the results obtained from "fresh" material. The same experiment repeated after two 
weeks and once again the ratio of acyclic/cyclic form remained unchangeable. This 
is consisted with production of cyclic material during Ub conjugation stage that is 
catalysed by the E2-2SK enzyme. 
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Figure 5.2.9 ESI-MS spectra of commercial native Lys48-Ub2 from two different 
batches (A) Lot#3291529 and (8) Lot#11515211, showing the reduction of cyclic 
Lys48-Ub2 in the new batches. Spectra were acquired under denaturing conditions. 
Only the 19+ ion is shown for clarity. 
Given that cyclic Lys48-Ub2 will not possess a free C-terminal Gly76 residue which 
is required for recognition by the IsoT-ZnF [106] it was postulated that the cyclic 
form would not bind to this UBD. Figure 5.2.10 shows the interacting regions of 
IsoT-ZnF (bright orange) and bound Ub (green) as determined by X-ray 
crystallography (pnB 10: 2G45) [106]. The C-terminus of Ub can clearly be seen to 
occupy the binding pocket of the IsoT -ZnF domain. When the NMR-derived com pact 
structure of Lys48-Ub2 (Figure 5.2.10, cyan, PDB ID: 2BGF) [202] is aligned it 
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demonstrates that the close intra-molecular association of Gly76 and Lys48 between 
the two Ubs should prevent interaction between cyclic Lys48-Ubz and the IsoT -ZnF. 
Figure 5 .2.10 Overlaid structures of mono-Ub (green) complexed to the IsoT-ZnF 
domain (bright orange surface) (POB 10 : 2G45) and compact Lys48-Ub 2 (cyan) 
(POB 10: 2BGF). The C-terminal Gly76 of mono-Ub binds deep pocket within IsoT-
ZnF. This is prevented by a second isopeptide bond between Gly76 (proximal Ub) 
and Lys48 (distal Ub) in cyclic Lys48-Ub 2. The figure prepared using PyMOL . 
To investigate this hypothesis, purified IsoT -ZnF was mixed with commercial 
Lys48-Ub2 (Lot # 3291529) and the resulting non-covalent complex analysed by 
ESI-MS under carefully optimised conditions (see Chapters 2 and 4). Examination of 
the resulting spectrum showed that only the acyclic form of Lys48-Ub2 was able to 
associate with IsoT -ZnF domain as expected. Contrary, the more abundant cyclic 
Lys48-Ub2 did not interact with the IsoT -ZnF domain, which confirmed the initial 
prediction (Figure 5.2.11). 
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Figure 5.2 .11 ESI-MS of 1 IlM Lys48-Ub2 (Lot#3291529) and 2 IlM IsoT-ZnF 
sprayed from 25 mM ammonium acetate, showing that only the acyclic population 
of Lys48-Ub2 is capable of forming complex. 
In chapter 4 I demonstrated the capability of ESI-MS in probing interactions of Ub 
with UBDs that target both, the Ile44-centred hydrophobic patch (including the UBA 
domains, UBA2-hHR23A, UQ1-UBA and MIU) and the free C-terminus of Ub (lsoT-
ZnF). In this chapter we have shown that cyclic Lys48-Ubz cannot bind IsoT-ZnF 
due to the absence of a free C-terminal Gly76 residue from the former. Considering 
these observations it was reasonable to question the behaviour of the 
aforementioned UBA domains against cyclic Lys48-Ub2. Interestingly, calculations of 
the apparent KdS based on either cyclic or acyclic Lys48-Ub2 made no significant 
difference to the values (Table 5.2.2), which is consistent with the utilisation of Ub's 
Ile44-centred hydrophobic patch rather than its free C-terminal. 
Table 5.2.2 Apparent Kd values for domains binding to cyclic and acyclic Lys48-Ub2 
UBD 
Kd (IlM) 
acyclic Lys48-Ub2 cyclic Lys48-Ub2 
UQ1-UBA 15 ± 2 15 ± 2 
UBA2 15 ± 2 21 ± 2 
MIU 9±1 14 ± 2 
IsoT-ZnF 3.6 ± 0.8 Not observed 
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The observation of cyclic Lys48-Ub2 in a commercial sample produced by enzymatic 
ligation in vitro, using the E2-2SK ubiquitin conjugating enzyme, led us to consider 
whether the cyclic material was also produced in vivo. Analysis of endogenous Ub2 
purified from rat skeletal muscle using the A20 ZnF UBn from the ZNF216 protein, 
showed the presence of both, acyclic and cyclic Lys48-Ubz (Figure 5.2.12), with the 
latter representing approximately 30% of the Lys48-Ub2 pool. 
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Figure 5.2.12 ESI-MS of intact CA) commercial Lys4B-Ubz and (8) Ubz purified from 
rat skeletal muscle using A20 ZnF, showing the presence of cyclic Lys48-Ub2. 
Spectra were acquired under denaturing conditions. Only the 19+ is shown for 
clarity. 
It has been shown in section 5.2.1 that the purified endogenous rat muscle Ub2 
pulled-down by A20 ZnF domain, was predominately Lys48-linked. In addition, the 
use of a top-down approach for Lys linkage characterization of Ub2 species was also 
demonstrated. MS/MS analysis of the isolated 17+ precursor ion (m/z 1006.5-
1007.5) of each Ub2 commercial standard resulted to the formation of band y ions. 
Figure S.2.13A-B shows the y58 14+ (m/z 1078.02; y ions in this case derived from 
the fragmentation of the distal Ub while proximal Ub remains intact) ion derived 
from Lysll- and Lys63-Ub2' respectively, whereas Figure S.2.13C shows the 
relevant spectra obtained in the case of Lys48-Ub2. The latter contains an additional 
peak at m/z 1076.73, which corresponded to the y58 14+ cyclic structure found only 
in the Lys48-Ub2 standard. 
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Figure 5.2.13 ESI-MS/MS spectra if the 17+ precursor ions of (A) commercial 
Lysll-Ubl, (8) commercial Lys63-Ubl and (C) commercial Lys48-Ubl, showing the 
fragment ion y58 14+. A cyclic Lys48-Ubl is observed at m/z 1076.73 
Using ESI-MS, we have shown that IsoT -ZnF domain cannot bind in vitro generated 
cyclic Lys48-Ub2 (Figure 5.2.11). Given that we have identified cyclic Lys48-Ub2 in 
samples of rat skeletal muscle (Figure 5.2.12) we postulated that IsoT -ZnF domain 
will be incapable of pulling-down endogenous cyclic material. Figure 5.2.14 shows 
the y58 14+ fragment ion generated from 17+ precursor ion of, commercial Lys48-
Ub2, A20 ZnF captured Ub2 and IsoT-ZnF captured Ub2, respectively. 
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Figure 5.2.14 ESI-MS/MS spectra if the 17+ precursor ions of (A) commercial 
Lys48-Ub2 and (8-C) Ub2 isolated from rat skeletal muscle using the A20 ZnF and 
the IsoT-ZnF, respectively. The y58' 14+ fragment ion exhibits a cyclic (orm in (A) 
and (8). The IsoT-ZnF domain Is unable to capture cyclic Lys48-Ubl effectively. 
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Further investigation using A20 ZnF domain pull-downs from cultured HEK293T 
cells also showed the presence of cyclic Lys48-Ub2 (Figure 5.2.15). 
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Figure 5.2.15 ESI-MS of Ubz pulled-down from HEK293T cells using the A20 ZnF 
domain, showing the presence of cyclic Lys48-Ub 2• Spectrum was acquired under 
denaturing conditions. Only the 18+ ion is shown for clarity. 
From the above experiments it is clear that endogenous cyclic Lys48-Ubz is formed 
in vivo and it is not an artefact of in vitro production. In addition, given the relative 
abundance of Ubz that we have noted in vivo and the care taken to avoid 
adventitious proteolysis or Ub conjugation during the purification protocol, the 
scenario of artificial cyclisation seems unlikely. It has to be noted here, that bottom-
up MS approach would fail to discriminate cyclic from acyclic Lys48-Ub2' since both 
forms will generate the same tryptic peptide, LlFAGK(GG)QLEDGR (even thought 
the cyclic material will appear as two equivalents of this peptide) which serves as 
the fingerprint of Lys48-linked poly-Ub chains. 
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5.3 CONCLUSIONS 
This chapter has demonstrated the potential use of top-down protein MS to study 
and characterize poly-Ub species derived from an in vivo source. Such a method, 
which avoids the use of proteases that destroy poly-Ub connectivity, could probe 
absolute poly-Ub chain topology. Using top-down proteomics and combining both, 
cm and ECD fragmentation techniques, we have managed to reveal the linkage type 
of Ubz purified from rat skeletal muscle using either A20 ZnF domain or IsoT-ZnF 
domain; linkage identified to be Lys48. The results were confirmed by bottom-up 
approaches; the sequence ofthe characteristic tryptic peptide, LIFAGK(GG)QLEDGR, 
was verified by ECD MS/MS. Although analysis of longer poly-Ub chains by this 
method is far more challenging, here we have provided the first proof of concept 
that top-down MS in combination with other techniques can be used to probe the 
connectivity of poly-Ub chains. 
The presence of cyclic Lys48-Ubz as the major component of a commercial native 
Lys48-Ubz, generated using E2-2SK, was also reported. Contrary, ESI-MS analyses 
of other linkage types (Lysll-, Lys27- and Lys63-) showed that these linkages were 
consisted exclusively from acyclic Ubz. It is noteworthy to mention that cyclic 
Lys48-Ub2 is absent in material available from Enzo, a supplier that uses modified 
[186] (as opposed to wild type sequence) Ub to generate poly-Ub in vitro. We have 
also demonstrated the incapability of IsoT -ZnF domain to bind cyclic Lys48-Ub2 due 
to the lack of a free C-terminus from the latter. 
Furthermore, and possibly more importantly, a cyclic Lys4B-Ub2 species has been 
identified in A20 ZnF pull-downs from muscle tissue and cultured mammalian cells. 
Contrary, cyclic form was absent from endogenous material pulled-down using the 
IsoT-ZnF domain, which is consistent with the need of a free C-terminus. Combined 
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these results with the results obtained from the analyses of in vitro generated poly-
Ubs, it is clear that cyclization occurs only in cases of Lys48-linked poly-Ub chains. 
This suggests that E2-25K may playa major role in the cyclization of Lys48-linked 
poly-Ub chains. Treatment of the A20 ZnF purified poly-Ubs with USP2 DUB, in 
order to remove longer unanchored poly-Ub chains, did not show any effect upon 
recovery levels of cyclic Lys48-Ub2• Indeed, cyclization of poly-Ub chains and hence 
lack of a free C-terminus, it is likely to induce to some extent at least, resistance to 
DUB activity. Indeed, in vitro generated cyclic poly-Ub is known to be resistant to 
many DUBs, however, it has been reported that red blood cell extract contains an 
activity able to open and disassemble the cyclic chain [193]. Therefore, cyclic poly-
Ub is unlikely to represent a dead-end product in vivo. 
In summary, cyclic poly-Ub could represent a structurally unique form of 
unanchored poly-Ub, with perhaps related functional properties, but with the ability 
to be protected from disassembly by free chain disassembling DUBs such as IsoT. 
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CHAPTER 6 
PROBING CONFORMATIONAL 
CHANGES ON THE STRUCTURE OF 
THREE-HELIX BUNDLE PROTEINS 
BY TWIMS 
6.1 INTRODUCTION 
TWIMS-MS has been successfully utilised to study the conformation and 
stoichiometry of proteins and protein assemblies [64, 66-70]. This success relies 
upon the ability of ESI to generate gas-phase ions, with low internal energies, 
directly from native aqueous solutions. Further to 1M approaches, charge state 
analysis has also been utilised to study mixed populations of gas-phase protein 
conformers. A study by Kaltashov and Abzalimov has shown that the mean charge of 
each discrete distribution of ions, produced by ESI, correlates with the exposed 
protein surface area of that population [203]. Positively charged protein ions are 
usually generated by adduction of H+, a phenomenon known as protonation. 
However, charged ions can also form with other adducting species, particularly with 
the alkali metal cations Na+ and K+, and the ammonium ion (NH4+). Typically, the 
extent of metal or ammonium adduction is highest on lower charge states. This can 
be attributed to their lower kinetic energy, and hence internal energy, leading to less 
efficient collisional cleaning [204]. Contrary to dissociation of alkali metal cations, 
which is often accompanied with a loss of charge, ammonium adducts are removed 
as neutral ammonia molecules. The presence of alkali metal adducts in biomolecules 
has been associated with a series of effects. For example, it has been shown that the 
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presence of alkali metal cations in a protein-ligand system can lower the activation 
barrier to dissociation leading to the destabilization of the complex [158]. In 
contrast, it has been demonstrated that metal adducts can stabilize gas-phase 
protein structure via formation of additional interactions [205, 206]. It was shown 
that the alkali metal adducted gas-phase ions exhibited lower CCS and hence more 
compact conformations, compared to their protonated counterparts. 
This chapter reports the unusual effects of ammonium and alkali metal ion adducts 
upon the conformation of the three-helix bundle proteins UQI-UBA and hHR23A-
UBA2. We demonstrate that the presence of cations, particularly Na+ and NH4+, in 
these proteins, provokes dramatic conformational changes to their gas-phase 
structures, whereas the purely protonated species exhibit compact structures. We 
also show that the CCS values of the latter are in good agreement with results 
obtained from molecular dynamics simulations. Moreover, we demonstrate that the 
adduction of multiple sodium cations can stabilize compact gas-phase 
conformations. 
6.2 RESULTS AND DISCUSSION 
Ammonium acetate solutions are often used at millimolar concentrations for 
"native-like" ESI-MS studies. This can mainly be attributed to its useful property of 
generating very clean mass spectra of protonated proteins in the gas-phase. It can 
prevent alkali metal adduction by promoting ion pair reaction between the 
ammonium ion and acidic functional groups of the protein. Removal of the ion 
paired acetate and ammonium ions, is entropically favourable and their facile 
dissociation (15 kcal mol-I for acetic acid and 11 kcal motl for ammonia), which is 
accompanied by a proton transfer reaction, makes ammonium acetate an ideal 
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buffer for 'native-like' ESI [207]. Figure 6.2.1A shows the ESI mass spectrum of 
UQ1-UBA domain sprayed from 25 mM ammonium acetate solution. Contrary to a 
typical positive ESI mass spectra, where protonated peaks are commonly 
accompanied by trace amounts of adducts (usually Na+, K+ and NH4+) here we 
observed very high levels of ammonium adduction. A graphical representation of the 
extent of adduction by charge state (Figure 6.2.1B) revealed an interesting trend. 
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Figure 6.2.1 The charge state distribution of protonated and ammonium adducted 
ions (A) ESI mass spectrum of UQ1-UBA domain sprayed form 25 mM ammonium 
acetate and (B) graphical representation of the relative intensity of protonated and 
ammonium adducted ions at each charge state 
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The purely protonated ions and their mono- and di-ammonium adducted 
equivalents formed three distinct CSDs. In contrast to our experience of all other 
proteins sprayed from similar neutral solutions, where adduction (usually Na+, K+ 
and NH/) is more prominent on the ions of lowest charge state, here the highest 
charge states were found to be more adducted. It is worth noting that the degree of 
ammonium adduction rarely reaches the levels observed here. Indeed, the ESl mass 
spectra of bradykinin, melittin and Ub, acquired under identical conditions, for the 
purpose of TWlMS calibration (see Chapter 2), showed almost no NH4+ adduction « 
10%). 
As previously mentioned the CSD of gas-phase protein ions is related to protein's 
exposed surface area in solution [203]. Considering that relationship, it can be 
postulated that ammonium adducted species derive by preferential adduction of 
ammonium ions on a distinct population of UQ1-UBA species that adopt extended 
conformations (and hence increased exposed surface area). Alternatively, it could be 
proposed that the process of adduct formation induces limited protein unfolding 
during the ESI process. A potential source of a UQI-UBA species with increased 
surface area is a permanently misfolded/partially denatured protein population in 
solution. Hypothetically, such putative forms could be resolved by gel filtration. 
Therefore, a sample of UQI-UBA protein was subjected to gel filtration on a POlO 
column (see Chapter 2). Fractions collected through the elution profile of the protein 
from the column were subjected to analysis by ESl-MS. No significant differences in 
CSOs of the protonated or adducted ions were observed, suggesting that no 
permanently unfolded population of UQI-UBA existed in solution. However, these 
results cannot exclude the possibility of rapidly interconverting conformers of UQ1-
UBA, which would immediately re-equilibrate upon separation. NMR studies, 
however, do not support the presence of such equilibrium in solution [102]. 
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To further investigate these interesting observations, we sought to examine the 
UQ1-UBA protein by ESl-TWlMS-MS. Figure 6.2.2 illustrates the ion mobility drift 
traces of the +3 (blue trace) and +4 (red trace) charge states obtained from the 
UQ1-UBA sprayed from 25 mM ammonium acetate. Traces represent the combined 
signal for protonated and mono-adducted ions for each charge state. In contrast to 
the +3 charge state which maintained a relatively narrow Gaussian distribution of 
conformers (the additional distribution on the left is due to background noise), the 
+4 charge state showed both, compact and unfolded distributions around 706 A2 
and 980 A2, respectively. 
100 
(M+3H)3+ (M+4H)4+ 
o ~ - - ~ - - - - - - ~ ~ - - - - ~ - - - - ~ ~ - - - - - - - - ~ - - - - - - - - - -
400 500 600 700 800 900 1000 1100 1200 
Figure 6.2.2 Ion mobility drift traces obtained for the +3 and +4 charge states of 
the UQ1 - UBA protein sprayed from 25 mM ammonium acetate solutions. 
When we examined the ESI spectra that resulted from the two distinct populations 
of the +4 charge state, an interesting phenomenon was revealed; the population of 
compact conformers was largely consisted of purely protonated species ([M+4Ht+) 
while the more open structures where a mixture of adducted species, mainly 
[M+3H+NH4]4+ and a lower amount of protonated ions. 
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The experimentally determined CCS value of the compact conformers (706 ;\2) was 
compared with theoretical CCS values calculated from the NMR solution structure of 
UQ1-UBA protein (PDB ID: 2JYS) and from modelled structures generated by MD 
simulations performed at 300 K (Figure 6.2.3). 
NMR solution 
structure 
MD simulations 
at 300 K 
720 A.2 
685 A.2 
Figure 6.2.3 A comparison of the theoretical CCS values of the NMR solution 
structure of UQ1-UBA domain (PDB ID: 2JYS) and of structures derived by MD 
simulations at 300 K. Only the most compact (635 A2), the most open (782 A2) and 
the most frequently occurred (720 A2) MD structures are shown 
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To further investigate the intriguing behaviour of the UQ1-UBA gas-phase ions 
(both, protonated and adducted) as discussed above (Figure 6.2.2), experimentally 
derived 1M drift traces of purely protonated (black, solid trace), singly ammonium 
ion adducted (red, dashed trace) and doubly ammonium ion adducted (blue, dotted 
trace) species were compared with the theoretical distribution of the conformers 
resulted from the modelled +3 charge state at 300 K (Figure 6.2.4). 
The experimental CCS (corresponding to the peak maximum in the mobility drift 
trace) for the +3 charge state (Figure 6.2.4b) was determined to be 706 A,2 which 
was in good agreement with the TM theoretical value (720 A,2) of the modelled +3 
charge state at 300 K (Figure 6.2.4a). This suggests that the [M+3H+P+ ions may 
adopt conformations of similar size to the folded structure. Unlike the [M+3H)3+ 
charge state, which maintained a relatively narrow Gaussian distribution of 
conformers, the [M+4H]4+ charge state showed a broad signal and an additional 
small distribution of unfolded conformers around 9801\2 (Figure 6.2.4c). In contrast, 
the [M+3H+NH4]4+ species (Figure 6.2.4c) adopted a distribution of mainly open 
conformations, around 985 A,2, with only a small population adopting compact 
structures. Figure 6.2.4d shows +5 charged ions that contain either one or two 
ammonium ion adducts. The [M+4H+NH4]S+ charge state, rather like the 
[M+3H+NH4]4+ ion, demonstrated two distributions of conformers, while the 
doubly-adducted species [M+3H+2NH4]S+ (Figure 6.2.4d) did not show any compact 
forms. 
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Figure 6.2.4 Ion mobility drift traces obtained for UQ1-UBA showing (a) modelled 
+3 charge state at 300 K, (b) +3 protonated charge state, (c) +4 charge state, 
protonated (black, solid trace) and slightly ammonium ion adducted (red, dashed 
trace) and (d) +S charge state, singly ammonium ion adducted (red, dashed trace) 
and double ammonium ion adducted (blue, dotted trace) 
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As mentioned above, a small population of purely protonated [M+4H]4+ ions exhibit 
extended conformations around 980 A 2 • These appear to be of similar size (in terms 
of CCS) to that of the structures adopted by the [M+3H+NH4]4+ ions (Figure 6.2.4c). 
We suspected that the unfolded conformers of the [M+4H]4+ ions may have derived 
from the fragile ammoniated complex [M+3H+NHd4+, via facile loss of ammonia in 
the mass spectrometer. To examine this hypothesis, the UQ1-UBA domain solution 
was desalted and buffer exchanged into 2 mM triethylammonium acetate (TEAA) 
solution. Due to the higher basicity of triethylamine compared to ammonia [208], 
only the +2 and +3 charge states of the protein were obtained. To counterbalance 
the charge reducing properties of TEAA and generate [M+4H]4+ ions, the 
superchargingg agent sulfolane (tetramethylene sulfone) [131] was added to the 
solution. Figure 6.2.5 shows the ion mobility drift traces of the [M+4H]4+ charge 
state obtained from the protein sprayed from 25 mM ammonium acetate (Figure 
6.2.5a) and from a solution consisted of 2 mM TEAA and 200 mM sulfolane (Figure 
6.2.5b). In the former, a small, but detectable peak for the more extended 
conformation was present (as seen previously) but in the latter trace this peak was 
essentially absent. 
This supports the hypothesis that the extended structures obtained for the 
[M+4H]4+ ions, in the original experiments, were due to dissociation of ammonia 
from the [M+3H+NH4]4+ complex. We conclude that the [M+4H]4+ ions (formed 
during the ESI process) did not exhibit a highly extended form, but that these 
extended conformations were only produced from the ammonium adduct. The fact 
that open conformers were observed even after quadrupole isolation of the 
[M+4H]4+ charge state (1176 m/z), suggests that the loss of ammonia possibly occur 
as early as the transfer region of the mass spectrometer; between the source and the 
quadrupole. Interestingly, the [M+3H+NH4]4+ complex showed both open and 
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compact forms, in contrast to the [M+4H]4+ ion (formed directly during ESI) which 
adapted relatively compact conformations. This mixed population suggests that the 
site of ammonium adduction might be important for determining protein 
conformation. 
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Figure 6.2 .5 1M drift traces obtained for the [M+4H]4+ ions of the UQ1 - UBA protein , 
sprayed from (a) 25 mM ammonium acetate and (b) solution consist of 2 mM TEAA 
and 200 mM sulfolane, showing the absence of extended conformers in the absence 
of ammonium ions 
The hHR23A-UBA2 domain has been chosen as a second example of a triple-helix 
bundle protein due to the fact that it exhibit solution structures that are similar to 
UQ1-UBA domain (Figure 6.2.6). 
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Figure 6.2.6 Superimposed structures of the hHR23A-UBA2 (blue) and UQI-UBA 
(red), showing the similar folding of these two three-helix bundle proteins 
Illustrated in Figure 6.2.7 is the ESI-MS spectra of the hHR23A-UBA2 protein, 
sprayed from 25 mM ammonium acetate solution. Similar to the UQ1-UBA domain, 
the CSD of adducted ions was found to be highest at higher charge states. 
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Figure 6 .2.7 ESI mass spectrum of hHR23A-UBA2 (2 mM) sprayed from 25 mM 
ammonium acetate, showing highest ammonium adduction at higher charge states 
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Figure 6.2.8 shows a comparison of theoretically and experimentally derived 1M 
drift traces obtained for the hHR23A-UBA protein. 1M drift traces of purely 
protonated (solid trace) and singly ammonium ion adducted (dashed trace) species 
obtained for hHR23A-UBA2 domain sprayed from 25 mM ammonium acetate, while 
theoretical distribution of the conformers resulted from the modelled +4 charge 
state at 300 K. The [M+4H+NH4]5+ ions adopted more extended conformations than 
their solely protonated counterparts, which showed two distributions of 
conformers, both close and open, around 827 }..2 and 965 }..2, respectively (Figure 
6.2.8c). The appearance of the two populations of protonated conformers can be 
explained by analogy with the case of UQI-UBA i.e. the extended structures of 
purely protonated ions are the product of facile dissociation of ammonia from the 
related ammonium adducted species. The comparable CCS values of the 
[M+4H+NH4P+ (940 }..2) and open form of [M+5H]s+ (965 }..2) support this 
assumption. Furthermore, MD simulations on the +4 charged modelled structure at 
300 K generated structures which demonstrated a narrow CCS distribution 
concentrated around 825 }..2 (Figure 6.2.8a). The compact structures obtained for 
the [M+5H]5+ ions (Figure 6.2.8c, solid trace) were found to exhibit conformations of 
similar size to the +4 modelled structures. In contrast, the [M+4H]4+ ions showed 
CCS around 782 }..2 that was slightly smaller (-5 %) compared to the compact 
conformers (825 }..2). This may be attributed to side chains collapse in gas-phase 
which is a phenomenon that has been described previously [59]. 
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Figure 6.2.8 1M drift traces obtained for hHR23A-UBA2 showing (a) modelled +4 
charge state at 300 K, (b) +4 protonated charge state and (c) +5 charge state, 
protonated (solid trace) and singly ammonium Ion adducted (dashed trace) 
In both cases investigated above, it has been shown that the presence of ammonium 
adducts was accompanied by conformational changes. But, how can the adduction of 
ammonium ion (or of another cation) induce structural rearrangements? 
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Protein gas-phase ions are stabilised by salt bridges and hydrogen bonds, which are 
the main forces that can preserve compact, folded protein conformations shortly 
after desolvation [209]. However, with increasing charge in combination with the 
absence of solvent, Coulomb repulsion becomes significant and overcomes the 
stabilizing intramolecular interactions. The result is the adoption of extended 
conformation by the protein in the gas-phase in order to counterbalance the 
repulsion forces [53]. An interesting study by Breuker and McLafferty [59] has 
shown that a protein in the gas-phase may re-fold to a structure where the charge 
sites are coordinated by other residues within the protein structure. According to 
the authors, such structure rearrangements depend on the charge state of the 
protein ion, and timescale of measurement. Therefore, both the number and site of 
the charges in the gas-phase ion influence the conformation. Another factor that 
may play an important role is the nature of the attached charge carrier, which could 
be a proton or another cation (e.g. Na+ or NH4+). Generally, H+ is attached to a basic 
site by forming one or two bonds. In contrast, alkali metal cation attachment, often 
requires the availability of several (generally up to six) coordinating electron pairs 
in its surroundings (known as charge solvation) [210]. The ammonium ion, on the 
other hand, has the ability to form multiple hydrogen bonds (N .. ·H· .. O) [211]. 
Moreover, the large size of the ammonium cation possibly will also influence the 
gas-phase structure of proteins. 
It is clear that disruption of salt bridges will induce a degree of unfolding and that 
the severity of this effect will depend on the site of adduction. The dramatic change 
in the conformation of, in particular, the UQ1-UBA protein can be attributed to 
disruption of salt bridges. The Arg546-Glu563 salt bridge has been identified as a 
potential candidate for this effect The two residues are located on the opposing 
faced helices a1 and a2, respectively (Figure 6.2.9) and are likely to stabilize the 
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global protein fold in gas-phase. Ammonium cation attachment at this site may 
break the salt bridge by cation displacement of the Glu563 side chain, leading to 
perturbation of the protein native fold . Moreover, the presence of a small compact 
population of the [M+3H+NH4]4+ can be related to the attachment of NH 4 + to other 
residues, an event which does not induce unfolding. In the case of the 
[M+3H+2NH4]s+ it is postulated that at least one of the two ammonium ions is 
adducted to Arg546 and thus only unfolded structures were obtained for this ion. 
C-terminus 
N-terminus 
Figure 6.2.9 A cartoon representation of th e 3D structure of the UQ1 - UBA domain 
as determined by NMR (PDB ID : 2JYS) 
The effects of multisodium adduction upon the conformation of UQ1- UBA domain 
were also investigated. Figure 6.2.10b-d illustrates the obtained 1M drift traces for 
the quadruply charged ions of M+nNa species, where n = 4-6, sprayed from 2 mM 
sodium acetate. Figure 6.2.10a shows the 1M drift traces of the [M+4Ht+ and 
[M+3H+Na]4+ charge states sprayed from 2 mM TEM solution. Comparison of the 
monosodiated with the multisodiated species reveals that, whilst a single Na+ ion is 
destabilising to UQ1-UBA structure, the attachment of additional sodium cations 
stabilizes the protein's compact gas-phase structure. 
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Figure 6.2.10 1M drift traces obtained for the +4 charge state of the UQ1-UBA 
. domain showing (a) Purely protonated and monosodiated species, (b) 
tetrasodiated. (c) pentasodiated and (d) hexasodiated species. The dashed lines are 
included to guide to the eye, 
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Indeed, the stabilization of the protein structure in gas-phase, which here is 
monitored by the depletion of the signal related to open conformations, scales with 
the number of sodium cations. 
The formation of multisodiated adducts can be rationalised by: a) replacement of H+ 
by Na+ and b) ion pairing of Na+ with the negatively charged acidic residues [207]. 
Stabilization of the gas-phase structure of the doubly charged bradykinin ion, has 
been attributed to the ability of Na+ to establish interactions with functional groups 
on the peptide backbone [205]. In the case ofUQ1-UBA protein, whilst monosodium 
adduction destabilises the compact structure, multisodiation lead to more compact 
forms. This may be attributed to formation of additional salt bridges (between Na+ 
and polypeptide functionality) that stabilize the gas-phase structure. 
6.3 CONCLUSIONS 
The effects of cation adduction upon the conformation of the three-helix bundle 
proteins, UQ1-UBA and hHR23A-UBA, have been demonstrated in this chapter. 
Unusually high levels of ammonium adduction have been observed when these 
proteins sprayed from 25 mM ammonium acetate solution. Intriguingly, these levels 
became highest for higher charge states. It has to be pointed out that ammonium or 
metal ion adduction is not always associated with increased (SD of protein ions. 
Indeed, such adducts are normally most abundant on lower charge states. 
Furthermore, the possibility of a permanent misfolded/partially denatured protein 
population in solution was investigated, but our results did not support this 
hypothesis. 
We have also employed ESI-TWIMS-MS approaches to study the aforementioned 
proteins. It has been demonstrated that ammonium cation adduction is associated 
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with extended conformations of the examined proteins, especially in the case of 
UQ1-UBA domain. It has also been shown that even within the same protein charge 
state, ammonium complexes give rise to more extended species than their purely 
protonated counterparts. It has been suggested that destabilization of the gas-phase 
structure of UQ1-UBA may be attributed to the disruption of a salt bridge formed 
between the Arg546 and Glu563, by ammonium cation attachment at the latter's 
side chain. 
The effects of sodium adduction upon the structure of UQ1-UBA have also been 
examined. Monosodium adduction led to similar to those caused by ammonium 
adduction. In contrast, it has been shown that the attachment of multiple sodium 
cations, stabilized the gas-phase conformation. Indeed, it has been demonstrated 
that the stabilization effect, scales with the number of sodium cations. 
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CHAPTER 7 
THE INHIBITION OF Ub-lsoT-ZnF 
I NTERACTION BY SYNTH ETI C 
PEPTIDES 
7.1 INTRODUCTION 
The majority of intracellular proteins are degraded by the Ub-proteasome pathway. 
Such regulatory mechanisms are crucial to maintain normal cellular homeostasis. 
The Ub-proteasome pathway is mediated by proteasome holoenzyme, Ub ligases 
and DUB enzymes [76]. Non-lysosomal proteolysis relies on the ability of Ub to label 
substrates for protein degradation by proteasome. Previous studies have linked the 
pathogenesis of various human diseases with deregulation of the Ub-proteasome 
pathway [212, 213]. Inhibition of this regulation mechanism, either at the level of 
proteasome, ubiquitination or DUB enzymes, provides new targets for the 
development of novel therapeutic strategies. Indeed, bortezomib, a boronic acid 
dipeptide [214], is the first proteasome inhibitor that has been approved for the 
treatment of mUltiple myeloma patients. A crystal structure of the yeast 20S 
proteasome in complex with bortezomib has shown that the latter blocks the 
activity of the proteolytically active threonine (Thr21) residue; the boron atom of 
bortezomib is covalently attached to the nucleophilic oxygen lone pair of Thr21 
[215]. 
Further to proteasome inhibitors, more recent studies have been focused on the 
discovery and development of inhibitors ofthe ubiquitination cycle (via inhibition of 
E1 and E3 enzymes) and of DUB enzymes, which have recently been linked to 
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several human diseases [216]. A recent study has reported the inhibition of the DUB 
enzyme USP7 (ubiquitin-specific protease 7) by the small molecule PS091 (2-
acetyl-4-nitro-S-(2,3-dicloro-phenylsulfanyl)-thiophene) [217]. USP7 stabilizes 
MDM2 (murine double minute oncogene) levels, which consequently mediates p53 
ubiquitination and thus its proteasomal degradation. The study also has suggested 
that PS091 inhibits USP7 activity without blocking proteasome function directly. 
This inhibition approach, according to the authors, is less likely to trigger off-target 
activities and associated toxicities. 
IsoT, also known as USPS, belongs to the group of DUB enzymes that disassemble 
unanchored poly-Ub chains and thereby recycling free Ub [218, 219]. More 
importantly, the deubiquitination procedure prevents accumulation of unanchored 
poly-Ub chains which can inhibit the proteasome [218,220]. The recognition of free 
poly-Ub chains by IsoT is mediated by a ZnF UBP domain which requires the C-
terminus of Ub for binding [106]. It has also been reported that modification or 
deletion of Ub's C-terminal residue, Gly76, reduces the rate of deubiquitination 
[221]. It can be assumed that a decrease in deubiquitination rate will result in 
accumulation of Ub moieties, which in turn may inhibit the proteasome. Therefore, 
disruption of the IsoT-poly-Ub complex may result in indirect inhibition of the 
proteasome by accumulated free poly-Ub chains. The crystal structure of the IsoT-
ZnF-mono-Ub interaction showed that the C-terminal residues ofUb (from Leu71 to 
Gly76) form a rigid tail that penetrates deeply into the hydrophobic pocket of the 
IsoT -ZnF domain [106]. Blockage of that pocket, therefore, will disrupt the complex 
and consequently deubiquitination rate. The tail formed by Ub's C-terminus 
residues adopts the ideal stereochemistry to fit into the hydrophobic pocket of IsoT-
ZnF domain. Therefore, a potential inhibitor has to exhibit a structure of similar 
stereochemistry. 
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The ability of ESI-MS to probe binding affinities of Ub.UBD interactions has been 
demonstrated in chapter 4. This chapter describes the synthesis of small peptides 
(based on Ub's C-terminal peptide, LRLRGG) and the use of ESI-MS to investigate 
their potential inhibitory activity against the Ub·IsoT-ZnF interaction. 
7.2 RESULTS AND DISCUSSION 
7.2.1 PEPTIDE SYNTHESIS AND PURIFICATION 
The peptides were synthesised using the Fmoc SPPS protocol described in chapter 2, 
and purified by preparative LC chromatography. Table 7.2.1 gives the peptides 
synthesised here, as well as the obtained quantity of each purified material. 
Table 7.2.1 Hexapeptides synthesised using Fmoc SPPS approach, showing their 
primary structure and the final purified quantity obtained for each peptide. 
Peptide MW Weight 
(Da) (mg) 
LRLRGG 670.8 1.1 
KRFRGG 719.8 1.4 
LRLAGG 585.7 9.1 
LALRGG 585.7 5.4 
FRLRGG 704.8 2.1 
LRFRGG 704.8 2.9 
KLRRGG 685.8 5.1 
HRLRGG 694.8 0.7 
FALRGG 619.7 2.9 
LRLRGV 712.9 1.2 
Figure 7.2.1 illustrates the ESI-MS spectra of LRLRGG peptide, obtained before and 
after purification, sprayed from denaturing solution (50% methanol, 1% acetic 
acid). 
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Figure 7.2.1 ESI mass spectra of LRLRGG (4 J.lM) peptide a) prior HPLC purification 
and b) after HPLC purification, sprayed from 50:50 MeCN:H zO, 0.1% Acetic acid. 
Illustrated in Figure 7.2.2 is the HPLC separation chromatograph obtained for the 
LRLRGG peptide, 
AU 
2.8e+1 
2.4e+1 
2.0e+1 
1.6e+1 
1.2e+1 
8.0 
4.0 
~ L R L R G G G
O . O ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ - - ~ ~ - -
2.00 4.00 6.00 8.00 10.00 12.00 14.00 nme 
Figure 7.2.2 HPLC separation chromatograph for LRLRGG peptide. Red highlighted 
is the collected HPLC fraction. 
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Similar purification profiles were obtained for all the peptides synthesised in this 
study, and the purity of each peptide was confirmed by ESI-MS. 
7.2.2 INHIBITION OF Ub- IsoT-ZnF COMPLEX 
The ability of ESI-MS to probe the specificity and selectivity of Vb -VBD complexes, 
has been demonstrated in chapter 4. The specificity of the IsoT -ZnF complex with 
Ub was also examined and confirmed using the deletion mutant ~ - G l y 7 5 / G l y 7 6 - U b . .
As previously discussed, Vb's C-terminal amino acids, Leu71 to Gly76, form a rigid 
tail that binds to the hydrophobic pocked of the IsoT -ZnF domain (Figure 7.2.3). 
Figure 7.2.3 Crystal structure of mono-Ub (grey surface) complexed to the IsoT-
ZnF domain (bright orange surface) (PDB ID: 2G45), showing the rigid tail formed 
of Ub penetrating into hydrophobic pocket of the domain. 
We postulated that the chemically synthesised peptide, LRLRGG which mimics Vb's 
C-terminal, should bind the IsoT -ZnF domain with relatively high affinity. Figure 
7.2.4a show the ESI mass spectrum of LRLRGG and IsoT -ZnF domain obtained in the 
presence of acetonitrile vapour. The 7+, 6+ and 5+ complex ions are observed at m/z 
2208,2576 and 3091, respectively. The Kd value determined from this spectrum was 
found to be 5.8 f.!M, which was somewhat higher than the value determined for the 
161 
The inhibition of Ub·/soT -ZnF complex Chapter 7 
Ub-!soT-ZnF complex (Kd-2.3 JlM). This can potentially be attributed to additional 
interactions that may be present in the Ub·IsoT -ZnF complex, which could stabilize 
the complex more effectively in solution and in the gas-phase. To examine the 
specificity of the (LRLRGG-!soT -ZnF) complex, we used the LRLRGV peptide as a 
negative control. In contrast to the LRLRGG peptide, the increased steric bulk of the 
(-terminal Val residue was predicted to prevent access of the LRLRGV peptide to the 
hydrophobic pocket of the ZnF domain. Indeed, LRLRGV peptide did not form 
detectable complex with the IsoT-ZnF domain (Figure 7.2.4b). This result is 
consistent with the crucial role of Ub's (-terminal Gly76 residue. 
Kd = 5.8 IJM 
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Figure 7.2.4 ESI-MS spectra of IsoT-ZnF (4 11M) complex with a) LRLRGG peptide 
(7.5 11M) and b) LRLRGV peptide (7.5 11M), sprayed from 2S mM ammonium acetate 
solution in the presence of acetonitrile vapour 
Having confirmed the specificity of the complex formed between IsoT-ZnF domain 
and the LRLRGG peptide, and given the importance of the Gly residue in this peptide, 
we went on to synthesise eight peptides in which the (-terminal dipeptide -GG was 
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kept unmodifi ed. The apparent binding affinity (Kd) values of each (peptide-lsoT-
ZnF) are given in Table 7.2.2. 
Tabl e 7.2.2 Apparent binding constant (Kd) values for (peptid e.\soT-ZnF) co mpl ex 
Peptide Kd ( ~ M ) )
LRLRGG 5.8 
LRFRGG 7.6 
FRLRGG 7.7 
KRLRGG 9.5 
HRLRGG 12 
KRFRGG 17 
FALRGG 34 
LALRGG 42 
LRLAGG 43 
LRLRGV Not Detected 
The determined binding affinities (Table 7.2.2) suggest an important role for the Arg 
residues in the (peptide-lsoT -ZnF) interaction. For example, when the distal and 
proximal Arg residues were systematically replaced by Ala (LALRGG and LRLAGG), 
the Kd values were found to be 42 IJ.M and 43 IJ.M, respectively, which w ere than 
seven-fold lower compared to the value determined for the LRLRGG peptide (5.8 
IJ.M). The simultaneous substitution of Arg for Ala and of Leu for Phe (FALRGG) 
resulted in higher binding affinity value (34 IlM) than the case of a single 
substitution of Arg for Ala. However, this was significantly lower than the value 
obtained for the wt-like peptide. In addition, the KRFRGG peptide bound to the 
IsoT -ZnF domain with a Kd value of 17 IJ.M. In contrast, the single exchange of Leu 
with Phe (LRFRGG and FRLRGG) did not appear to have significant influence on the 
binding interaction (KdS = 7.6 IlM and 7.7 IlM, respectively). Finally, replacement of 
N-terminus Leu with either Lys or His, produced peptides that bind domain with 
apparent Kd values of9.5 IlM and 12 IlM, respectively. 
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The inhibitory activity of the synthesised peptides upon the Ub-lsoT-ZnF complex 
was also investigated. Illustrated in Figure 7.2.5aFigure 4.2.6 is the ESI mass 
spectrum of IsoT-ZnF with Ub sprayed from 25 mM ammonium acetate. Formation 
of the Ub-IsoT-ZnF complex was observed at m/z 2335 (10+) and 2123 (11+) . 
Figure 7.2.5b shows the ESI mass spectra of IsoT -ZnF with Ub and LRLRGG peptide, 
sprayed from 25 mM ammonium acetate solution. Additionally to the Ub-IsoT-ZnF 
complex, the LRLRGG-lsoT-ZnF complex was also observed at m/z 2208 (7+),1932 
(8+) and 1717 (9+) . In the presence of the LRLRGG peptide the determined apparent 
binding affinity of the Ub-IsoT-ZnF complex was found to be lower (Kd = 3.4 11M) 
compared to 2.4 11M obtained previously, both in chapter 4 and in the literature 
[106]. 
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Figure 7.2.5 ESI-MS spectra of 2 11M IsoT -ZnF with a) 0.5 11M Ub and b) 0.5 11M Ub 
and 5 11M LRLRGG peptide, sprayed from 25 mM ammonium acetate solution 
The effects of peptide (LRLRGG) concentration upon the Ub- lsoT -ZnF interaction, 
were also investigated. To do this, the concentration of the complex's components 
(Ub and Iso-ZnF) was kept constant whilst the concentration of the peptide was 
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varied from 2 to 10 J...lM. Similarly, the effects of the following synthesised 
hexapeptides were also examined: LRFRGG, FRLRGG and KRLRGG. The results 
obtained for each peptide are given in Table 7.2.3. Figure 7.2.6, illustrates the effects 
of peptide concentration upon the binding affinity of the complex. 
Table 7.2 .3 Apparent binding constant (Kd) values for (Ub-IsoT-ZnF) complex in 
the presence of peptide inhibitors. 
Kd (J...lM) 
Peptide 
Peptide concentration (J...lM) 
0 2 4 6 8 10 
LRLRGG 2.4 3.4 3.5 3.5 3.7 4.3 
FRLRGG 2.4 3.6 3.6 3.8 4.0 4.2 
LRFRGG 2.4 3.5 3.7 4.0 4.4 4.8 
KRLRGG 2.4 3.8 3.9 4.4 3.7 4.0 
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Figure 7.2 .6 Diagram showing the inhibitory activity of synthetic peptides against 
the Ub-IsoT-ZnF complex; at 0 ~ M M peptide concentration the relative amount of 
complex is 1.0 
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All the four peptides used here (Table 7.2.3) have demonstrated inhibitory activity 
against the Ub-IsoT-ZnF complex, albeit not very effectively (ECso > 10 JlM in all 
cases). Substitution of Leu residue with Phe had a somewhat improved effect on the 
inhibitory activity of the peptides, FRLRGG and LRFRGG (especially the latter's) 
compared to that achieved by the wt-peptide, LRLRGG. 
7.3 CONCLUSIONS 
This chapter has described the chemical synthesis of hexapeptides by Fmoc SPPS 
approach. The peptides have been designed as alternatives to Ub's C-terminal 
hexapeptide, LRLRGG. The employment of ESI-MS to study the inhibitory activity of 
each peptide against the Ub-IsoT-ZnF complex, has been also demonstrated. The 
obtained data have confirmed again the crucial role of the C-terminal Gly residue, as 
the LRLRGV peptide was the only peptide of the total ten synthesised here that did 
not bind IsoT-ZnF. It has also been demonstrated that substitution of Arg by either 
Ala or Phe residues significantly decreased the binding affinity of the relevant 
peptide to the IsoT-ZnF domain. Although the peptides reported in this chapter, did 
not inhibit Ub-IsoT-ZnF complex very effectively (ECso > 10 J..lM), the data obtained 
here, is a proof of principle that ESI-MS can be used to screen, very efficiently, 
potential inhibitors of protein-protein interactions. 
166 
References 
REFERENCES 
1. Thomson, J.J., Rays of Positive Electricity and Their Application to Chemical 
Analysis. Longmans Green, London, 1913. 
2. Squires, G., Francis Aston and the mass spectrograph. J. Chern. Soc., Dalton 
Trans., 1998(23): p. 3893-3900. 
3. Edmond, d.H. and S. Vincent, in Mass Spectrometry: Principles and 
Applications2007, John Wiley & Sons, Ltd: England. 
4. Beckey, H.D., Principles of Field Ionization and Field Desorption in Mass 
Spectrometry1977, Oxford: Pargamon Press. 
5. Barber, M., RS. Bordoli, RD. Sedgwick, and A.N. Tyler, Fast atom 
bombardment of solids (FAB) - A new ion source for mass spectrometry. J. 
Chern. Soc., Chern. Commun., 1981(7): p. 325-327. 
6. Aberth, W., KM. Straub, and A.L. Burlingame, Secondary ion mass 
spectrometry with cesium ion primary beam and liquid target matrix for 
analysis of biorganic compounds. Anal. Chern., 1982. 54(12): p. 2029-2034. 
7. Tanaka, K., H. Waki, Y. Ido, S. Akita, Y. Yoshida, T. Yoshida, and T. Matsuo, 
Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-
flight mass spectrometry. Rapid Commun. Mass Spectrom., 1988. 2(8): p. 
151-153. 
8. Karas, M. and F. Hillenkamp, Laser desorption ionization of proteins with 
molecular masses exceeding 10000 Daltons. Anal. Chern., 1988. 60(20): p. 
2299-2301. 
9. Posthumus, M.A., P.G. Kistemaker, H.L.C. Meuzelaar, and M.e. 
Tennoeverdebrauw, Laser desorption mass spectrometry of polar non-volatile 
bio-organic molecules. Anal. Chern., 1978. 50(7): p. 985-991. 
10. Knochenmuss, R, A quantitative model of ultraviolet matrix-assisted laser 
desorption/ionization. J. Mass Spectrom., 2002. 37(8): p. 867-877. 
167 
References 
11. Karas, M. and R Kruger, Ion formation in MALDI: The cluster ionization 
mechanism. Chern. Rev., 2003. 103(2): p. 427-439. 
12. Zenobi, Rand R Knochenmuss, Ion formation in MALDl mass spectrometry. 
Mass Spectrom. Rev., 1998. 17(5): p. 337-366. 
13. Knochenmuss, Rand R Zenobi, MALDI ionization: The role of in-plume 
processes. Chern. Rev., 2003.103(2): p. 441-452. 
14. Dreisewerd, K., The desorption process in MALDI. Chern. Rev., 2003. 103(2): 
p.395-425. 
15. McKay, AR, B.T. Ruotolo, L.L. Ilag, and C.V. Robinson, Mass measurements of 
increased accuracy resolve heterogeneous populations of intact ribosomes. J. 
Am. Chern. Soc., 2006.128(35): p. 11433-11442. 
16. Robinson, V.C. and F. Sobott, Understanding protein interactions and their 
representation in the gas phase of the mass spectrometer, in Principles of Mass 
Spectrometry Applied to Biomolecules, J. Laskin and C. Lifshitz, Editors. 2006, 
Wiley: New Jersey. p. 147-237. 
17. Loo, J.A, B. Berhane, C.S. Kaddis, K.M. Wooding, Y.M. Xie, S.L. Kaufman, and 
l.V. Chernushevich, Electrospray ionization mass spectrometry and ion 
mobility analysis of the 20S proteasome complex. J. Am. Soc. Mass Spectrom., 
2005.16(7): p. 998-1008. 
18. Rayleigh, On the equilibrium of liquid conducting masses charged with 
electricity. Philos. Mag., 1882. 14(87): p.184-186. 
19. Zeleny, J., On the conditions of instability of electrified drops, with applications 
to the electrical discharge from liquid points. Proc. Cambridge Philos. Soc., 
1916.18: p. 71-83. 
20. Zeleny, J., Instability of Electrified Liquid Surfaces. Phys. Rev., 1917. 10(1): p. 
1-6. 
21. Dole, M., L.L. Mack, RL. Hines, RC. Mobley, L.n. Ferguson, and M.B. Alice, 
Molecular Beams of Macroions. ). Chem. Phys., 1968.49(5): p. 2240-2249. 
168 
References 
22. Fenn, ).B., M. Mann, C.K. Meng, S.F. Wong, and C.M. Whitehouse, Electrospray 
Ionization for Mass-Spectrometry of Large Biomolecules. Science, 1989. 
246(4926): p. 64-71. 
23. Fenn, ).B., Electrospray wings for molecular elephants (Nobel lecture). Angew. 
Chern., Int. Ed., 2003.42(33): p. 3871-3894. 
24. Taylor, G., Disintegration of Water Drops in an Electric Field. Proc. R. Soc. 
London, A, 1964. 280(1382): p. 383-397. 
25. Kebarle, P., A brief overview of the present status of the mechanisms involved 
in electrospray mass spectrometry. J. Mass Spectrom., 2000. 35(7): p. 804-
817. 
26. Gomez, A. and K.Q. Tang, Charge and Fission of Droplets in Electrostatic 
Sprays. Phys. Fluids, 1994.6(1): p. 404-414. 
27. Kebarle, P. and M. Peschke, On the mechanisms by which the charged droplets 
produced by electrospray lead to gas phase ions. Anal. Chim. Acta, 2000. 
406(1): p. 11-35. 
28. Iribarne, J.V. and B.A. Thomson, Evaporation of small ions from charged 
droplets. J. Chern. Phys., 1976.64(6): p. 2287-2294. 
29. Thomson, B.A. and J.V. Iribarne, Field induced ion evaporation from liquid 
surfaces at atmospheric pressure. ). Chern. Phys., 1979. 71(11): p. 4451-4463. 
30. Nguyen, S. and ).B. Fenn, Gas-phase ions of solute species from charged 
droplets of solutions. Proc. Natl. Acad. Sci. USA., 2007.104(4): p. 1111-1117. 
31. Gamero-Castano, M. and ).F. de la Mora, Direct measurement of ion 
evaporation kinetics from electrified liquid surfaces. ). Chern. Phys., 2000. 
113(2): p. 815-832. 
32. Winger, B.E., K.). Lightwahl, R.R.O. Loo, H.R. Udseth, and R.D. Smith, 
Observation and implications of high mass-to-charge ratio ions from 
electrospray-ionization mass spectrometry. J. Am. Soc. Mass Spectrom., 1993. 
4(7): p. 536-545. 
169 
References 
33. de la Mora, J,F., Electrospray ionization of large multiply charged species 
proceeds via Dole's charged residue mechanism. Anal. Chim. Acta, 2000. 
406(1): p. 93-104. 
34. Konermann, L., E. Ahadi, A.D. Rodriguez, and S. Vahidi, Unraveling the 
Mechanism ofElectrospray Ionization. Anal. Chern., 2013.85(1): p. 2-9. 
35. Paul, W. and H. Steinwedel, Ein neues Massenspektrometer ohne Magnetfeld. 
Zeitschrift fUr Naturforschung A, 1953.8(7): p. 448-450. 
36. Douglas, D.J., AJ. Frank, and D.M. Mao, Linear ion traps in mass spectrometry. 
Mass Spectrom. Rev., 2005. 24(1): p. 1-29. 
37. Wolff, M.M. and W.E. Stephens, A Pulsed Mass Spectrometer with Time 
Dispersion. Rev. Sci. Instrum., 1953.24(8): p. 616-617. 
38. Cameron, A.E. and D.F. Eggers, An ion velocitron. Rev. Sci. Instrum., 1948. 
19(9): p. 605-607. 
39. Wiley, W.C. and I.H. McLaren, Time-of-flight mass spectrometer with improved 
resolution. Rev. Sci. Instrum., 1955.26(12): p. 1150-1157. 
40. Wiley, W.C., Bendix Time-of-Flight Mass Spectrometer. Science, 1956. 
124(3226): p. 817-820. 
41. Onnerfjord, P., J. Nilsson, L. Wallman, T. Laurell, and G. Marko-Varga, Picoliter 
Sample Preparation in MALDI-TOF MS Using a Micromachined Silicon Flow-
Through Dispenser. Anal. Chern., 1998. 70(22): p. 4755-4760. 
42. Alikhanov, S.G., A new impulse technique for ion mass measurements. Soviet 
Physics Jetp-Ussr, 1957.4(3): p. 452-453. 
43. Mamyrin, B.A., V.1. Karataev, D.V. Shmikk, and V.A Zagulin, The mass-
reflectron, a new nonmagnetic time-of-flight mass spectrometer with high 
resolution. TrAC, Trends in Anal. Chern., 1973. 37: p. 45-48. 
44. Marshall, AG. Fourier transform ion cyclotron resonance mass spectrometry. 
in 11th International Conference on Fourier Transform Spectroscopy (lCOFTS 
11). 1997. Athens, Ga. 
170 
References 
45. Schmid, D.G., F. von der Mulbe, B. Fleckenstein, T. Weinschenk, and G. jung, 
Broadband detection electrospray ionization fourier transform ion cyclotron 
resonance mass spectrometry to reveal enzymatically and chemically induced 
deamidation reactions within peptides. Anal. Chern., 2001. 73(24): p. 6008-
6013. 
46. Bruins, A.P., Mass spectrometry with ion sources operating at atmospheric 
pressure. Mass Spectrom. Rev., 1991.10(1): p. 53-77. 
47. McLuckey, S.A., Principles of collisional activation in analytical mass 
spectrometry. J. Am. Soc. Mass Spectrom., 1992. 3(6): p. 599-614. 
48. Kanu, A.B., P. Dwivedi, M. Tam, L. Matz, and H.H. Hill, Ion mobility-mass 
spectrometry. j. Mass Spectrom., 2008. 43(1): p. 1-22. 
49. Dwivedi, P., C. Wu, L.M. Matz, B.H. Clowers, W.F. Siems, and H.H. Hill, Gas-
phase chiral separations by ion mobility spectrometry. Anal. Chern., 2006. 
78(24): p. 8200-8206. 
50. Tao, L., j.R. McLean, j.A. McLean, and D.H. Russell, A collision cross-section 
database of singly-charged peptide ions. J. Am. Soc. Mass Spectrom., 2007. 
18(7): p. 1232-1238. 
51. Clemmer, D.E., R.R. Hudgins, and M.F. jarrold, Naked protein conformations-
Cytochrome-c in the gas-phase. j. Am. Chern. Soc., 1995. 117(40): p. 10141-
10142. 
52. Wyttenbach, T., G. vonHelden, and M.T. Bowers, Gas-phase conformation of 
biological molecules: Bradykinin. j. Am. Chern. Soc., 1996. 118(35): p. 8355-
8364. 
53. Clemmer, D.E. and M.F. Jarrold, Ion mobility measurements and their 
applications to clusters and biomolecules. J. Mass Spectrom., 1997. 32(6): p. 
577-592. 
54. Wyttenbach, T. and M. Bowers, Gas-Phase Conformations: The Ion 
Mobility/Ion Chromatography Method, in Modern Mass Spectrometry, C. 
Schalley, Editor 2003, Springer Berlin Heidelberg. p. 207-232. 
171 
References 
55. McLean, )A, B.T. Ruotolo, K). Gillig, and D.H. Russell, Ion mobility-mass 
spectrometry: a new paradigm for proteomics. Int. }. Mass Spectrom., 2005. 
240(3): p. 301-315. 
56. Barran, P.E., N.C. PoIfer, D.}. Campopiano, D.). Clarke, P.RR Langridge-Smith, 
R). Langley, ).RW. Govan, A. Maxwell, }.R. Dorin, RP. Millar, and M.T. Bowers, 
Is it biologically relevant to measure the structures of small peptides in the 
gas-phase? Int. ). Mass Spectrom., 2005. 240(3): p. 273-284. 
57. Ruotolo, B.T., J.L.P. Benesch, A.M. Sandercock, S.J. Hyung, and C.V. Robinson, 
Ion mobility-mass spectrometry analysis of large protein complexes. Nat. 
Protoc., 2008. 3(7): p. 1139-1152. 
58. Benesch, J.L.P., JA Aquilina, B.T. Ruotolo, F. Sobott, and C.V. Robinson, 
Tandem mass spectrometry reveals the quaternary organization of 
macromolecular assemblies. Chern. Biol., 2006. 13(6): p. 597 -605. 
59. Breuker, K. and F.W. McLafferty, Stepwise evolution of protein native 
structure with electrospray into the gas phase, 10(-12) to 10(2) S. Proc. Natl. 
Acad. Sci. USA., 2008.105(47): p.18145-18152 . 
. 
60. Mason, EA and E.W. McDaniel, Transport properties of ions in gases19BB, 
New York: Wiley. 
61. Hoaglund, C.S., S.}. Valentine, and D.E. Clemmer, An ion trap interface for ESI-
ion mobility experiments. Anal. Chern., 1997.69(20): p. 4156-4161. 
62. Giles, K., S.D. Pringle, K.R Worthington, D. Little, }.L. Wildgoose, and RH. 
Bateman, Applications of a travelling wave-based radio-frequencyonly stacked 
ring ion guide. Rapid Commun. Mass Spectrom., 2004.18(20): p. 2401·2414. 
63. Pringle, S.D., K. Giles, J.L. Wildgoose, }.P. Williams, S.E. Slade, K. Thalassinos, 
RH. Bateman, M.T. Bowers, and J.H. Scrivens, An investigation of the mobility 
separation of some peptide and protein ions using a new hybrid 
quadrupole/travelling wave IMS/oa-ToF instrument. Int. }. Mass Spectrom., 
2007.261(1): p. 1-12. 
172 
References 
64. Duijn, E.V., A Barendregt, S. Synowsky, C. Versluis, and AJ.R. Heck, 
Chaperonin Complexes Monitored by Ion Mobility Mass Spectrometry. J. Am. 
Chern. Soc., 2009.131(4): p.1452-1459. 
65. Smith, D.P., T.W. Knapman, I. Campuzano, R.W. Malham, J.T. Berryman, S.E. 
Radford, and AE. Ashcroft, Deciphering drift time measurements from 
travelling wave ion mobility spectrometry-mass spectrometry studies. Eur. J. 
Mass Spectrorn., 2009.15(2): p.113-130. 
66. Smith, D.P., S.E. Radford, and AE. Ashcroft, Elongated oligomers in beta(2)-
microglobulin amyloid assembly revealed by ion mobility spectrometry-mass 
spectrometry. Proc. Natl. Acad. Sci. USA, 2010. 107(15): p. 6794-6798. 
67. Hilton, G.R., K. Thalassinos, M. Grabenauer, N. Sanghera, S.E. Slade, T. 
Wyttenbach, P.J. Robinson, T.J.T. Pinheiro, M.T. Bowers, and J.H. Scrivens, 
Structural Analysis of Prion Proteins by Means of Drift Cell and Traveling Wave 
Ion Mobility Mass Spectrometry. J. Am. Soc. Mass Spectrom., 2010. 21(5): p. 
845-854. 
68. Wyttenbach, T., M. Grabenauer, K. Thalassinos, J.H. Scrivens, and M.T. 
Bowers, The Effect of Calcium Ions and Peptide Ligands on the Relative 
Stabilities of the Calmodulin Dumbbell and Compact Structures. J. Phys. Chern. 
B, 2010.114(1): p. 437-447. 
69. Ruotolo, B.T., K. Giles, I. Campuzano, A.M. Sandercock, R.H. Bateman, and C.V. 
Robinson, Evidence for macromolecular protein rings in the absence of bulk 
water. Science, 2005. 310(5754): p. 1658-1661. 
70. Jenner, M., J. Ellis, W.C. Huang, E.L. Raven, G.C.K. Roberts, and N.J. Oldham, 
Detection of a Protein Conformational Equilibrium by Electrospray lonisation-
Ion Mobility-Mass Spectrometry. Angew. Chern., Int. Ed., 2011. 50(36): p. 
8291-8294. 
71. Bleiholder, C., N.F. Dupuis, T. Wyttenbach, and M.T. Bowers, Ion mobility-
mass spectrometry reveals a conformational conversion from random 
assembly to beta-sheet in amyloid fibril formation. Nat. Chern., 2011. 3(2): p. 
172-177. 
173 
References 
72. De Cecco, M., E.S. Seo, D.J. Clarke, B.J. McCullough, K Taylor, D. Macmillan, J.R. 
Dorin, D.J. Campopiano, and P.E. Barran, Conformational Preferences of 
Linear beta-Defensins Are Revealed by Ion Mobility-Mass Spectrometry. J. Phys. 
Chern. B, 2010. 114(6): p. 2312-2318. 
73. Scarff, C.A., K Thalassinos, G.R. Hilton, and J.H. Scrivens, Travelling wave ion 
mobility mass spectrometry studies of protein structure: biological significance 
and comparison with X-ray crystallography and nuclear magnetic resonance 
spectroscopy measurements. Rapid Commun. Mass Spectrom., 2008. 22(20): 
p.3297-3304. 
74. Mesleh, M.F., J.M. Hunter, A.A. Shvartsburg, G.C. Schatz, and M.F. Jarrold, 
Structural information from ion mobility measurements: Effects of the long-
range potential. J. Phys. Chern., 1996.100(40): p. 16082-16086. 
75. Shvartsburg, A.A. and M.F. Jarrold, An exact hard-spheres scattering model for 
the mobilities ofpolyatomic ions. Chern. Phys. Lett., 1996.261(1-2): p. 86-91. 
76. Hershko, A. and A. Ciechanover, The ubiquitin system. Annu. Rev. Biochem., 
1998. 67: p. 425-479. 
77. Ikeda, F. and I. Dikic, Atypical ubiquitin chains: new molecular signals -
'Protein modifications: Beyond the usual suspects' review series. EMBO Rep., 
2008.9(6): p. 536-542. 
78. Elsasser, S. and D. Finley, Delivery of ubiquitinated substrates to protein-
unfolding machines. Nat. Cell Biol., 2005. 7(8): p. 742-749. 
79. Staub, O. and D. Rotin, Role of ubi quityl at ion in cellular membrane transport. 
Physiol. Rev., 2006.86(2): p. 669-707. 
80. Huang, T.T. and AD. D'Andrea, Regulation of DNA repair by ubiquitylation. 
Nat Rev. Mol. Cell BioI., 2006. 7(5): p. 323-334. 
81. Raiborg, C., KG. Bache, D.J. Gillooly, I.H. Madshush, E. Stang, and H. Stenmark, 
Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early 
endosomes. Nat Cell Biol., 2002. 4(5): p. 394-398. 
174 
References 
82. Hurley, J.H., S. Lee, and G. Prag, Ubiquitin-binding domains. Biochem. J., 2006. 
399: p. 361-372. 
83. Ciechanover, A. and R Ben-Saadon, N-terminal ubiquitination: more protein 
substrates join in. Trends Cell Biol., 2004.14(3): p.103-106. 
84. Ravid, T. and M. Hochstrasser, Autoregulation of an E2 enzyme by ubiquitin-
chain assembly on its catalytic residue. Nat. Cell Biol., 2007. 9(4): p. 422-427. 
85. Wang, X.L., RA. Herr, W.J. Chua, L. Lybarger, E. Wiertz, and T.H. Hansen, 
Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail 
can induce ERAD ofMHC-1 by viral E3ligase mK3. J. Cell Biol., 2007. 177(4): p. 
613-624. 
86. Chau, V., ).W. Tobias, A. Bachmair, D. Marriott, D.). Ecker, D.K. Gonda, and A. 
Varshavsky, A multiubiquitin chain is confined to specific lysise in a targeted 
short-lived protein. Science, 1989. 243(4898): p. 1576-1583. 
87. Cook, W.J., L.C. Jeffrey, M. Carson, Z.J. Chen, and C.M. Pickart, Structure of a 
diubiquitin conjugate and a model for interaction with ubiquitin conjugating 
enzyme (E2).). Biol. Chern., 1992. 267(23): p. 16467-16471. 
88. Sun, L.J. and Z.J. Chen, The novelfunctions of ubi quit in at ion in signaling. Curro 
Opin. Cell Biol., 2004.16(2): p.119-126. 
89. Hicke, L. and R Dunn, Regulation of membrane protein transport by ubiquitin 
and ubiquitin-binding proteins. Annu. Rev. Cell Dev. Biol., 2003. 19: p. 141-
172. 
90. Spence, J., RR Gali, G. Dittmar, F. Sherman, M. Karin, and D. Finley, Cell cycle-
regulated modification of the ribosome by a variant multiubiquitin chain. Cell, 
2000.102(1): p. 67-76. 
91. Komander, D., The emerging complexity of protein ubiquitination. Biochem. 
Soc. Trans., 2009. 37: p. 937-953. 
92. Wu-Baer, F., K. Lagrazon, W. Yuan, and R Baer, The BRCA1/BARDl 
heterodimer assembles polyubiquitin chains through an unconventional 
175 
References 
linkage involving lysine residue K6 of ubi quit in. J. BioI. Chern., 2003. 278(37): 
p.34743-34746. 
93. Morris, J.R. and E. Solomon, BRCAl : BARDl induces the formation of 
conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during 
DNA replication and repair. Hum. Mol. Genet., 2004.13(8): p. 807-817. 
94. Pickart, C.M., Mechanisms underlying ubiquitination. Annu. Rev. Biochem., 
2001. 70: p. 503-533. 
95. Bhoj, V.G. and Z.J. Chen, Ubiquitylation in innate and adaptive immunity. 
Nature, 2009.458(7237): p. 430-437. 
96. Hicke, L., H.L. Schubert, and C.P. Hill, Ubiquitin-binding domains. Nat. Rev. 
Mo1. Cell Bio1., 2005. 6(8): p. 610-621. 
97. Lee, S., Y.C. Tsai, R. Mattera, W.J. Smith, M.S. Kostelansky, A.M. Weissman, J.S. 
Bonifacino, and J.H. Hurley, Structural basis for ubiquitin recognition and 
autoubiquitination by Rabex-5. Nat. Struct. Mol. Biol., 2006. 13(3): p. 264-
271. 
98. Penengo, L., M. Mapelli, A.G. Murachelli, S. Confalonieri, L. Magri, A. 
Musacchio, P.P. Di Fiore, S. Polo, and T.R. Schneider, Crystal structure of the 
ubiquitin binding domains of rabex-5 reveals two modes of interaction with 
ubiquitin. Cell, 2006.124(6): p.1183-1195. 
99. Hirano, S., M. Kawasaki, H. Ura, R. Kato, C. Raiborg, H. Stenmark, and S. 
Wakatsuki, Double-sided ubiquitin binding of Hrs-u/M in endosomal protein 
sorting. Nat. Struct. Mol. BioI., 2006.13(3): p. 272-277. 
100. Varadan, R., M. Assfalg, S. Raasi, C. Pickart, and D. Fushman, Structural 
determinants for selective recognition of a lys48-linked polyubiquitin chain by 
a UBA domain. Mo1. Cen, 2005.18(6): p. 687-698. 
101. Raasi, S., R. Varadan, D. Fushman, and C.M. Pickart, Diverse polyubiquitin 
interaction properties of ubi quit in-associated domains. Nat. Struct. Mol. Bio1., 
2005.12(8): p. 708-714. 
176 
References 
102. Zhang, D., S. Raasi, and D. Fushman, Affinity makes the difference: 
Nonselective interaction of the UBA domain of ubiquilin-l with monomeric 
ubiquitin and polyubiquitin chains. J. Mol. Biol., 200B. 377(1): p. 162-180. 
103. Sundquist, W.l., H.L. Schubert, B.N. Kelly, G.C. Hill, J.M. Holton, and C.P. Hill, 
Ubiquitin recognition by the human TSG10l protein. Mol. Cell, 2004. 13(6): p. 
783-789. 
104. Brzovic, P.S., A. Lissounov, D.E. Christensen, D.W. Hoyt, and RE. KIevit, A 
UbcHS/ubiquitin noncovalent complex is required for processive BRCA1-
directed ubiquitination. Mol. Cell, 2006. 21(6): p. B73-8BO. 
105. Alam, S.L., J. Sun, M. Payne, B.D. Welch, B.K Blake, D.R. Davis, H.H. Meyer, S.D. 
Emr, and W.1. Sundquist, Ubiquitin interactions of NZF zinc fingers. EMBO J., 
2004.23(7): p. 1411-1421. 
106. Reyes-Turcu, F.E., J.R Horton, J.E. Mullally, A. Heroux, X.D. Cheng, and KD. 
Wilkinson, The ubiquitin binding domain ZnFUBP recognizes the C-terminal 
diglycine motifofunanchored ubiquitin. Cell, 2006.124(6): p. 1197-1208. 
107. Wang, Q., A.M. Goh, P.M. Howley, and KJ. Walters, Ubiquitin Recognition by 
the DNA Repair Protein hHR23a. Biochemistry, 2003. 42(46): p. 13529-
13535. 
lOB. Deveraux, Q., V. Ustrell, C. Pickart, and M. Rechsteiner, A 26-5 protease 
subunit that binds ubiquitin conjugates. J. BioI. Chern., 1994. 269(10): p. 
7059-7061. 
109. Fisher, RD., B. Wang, S.L. Alam, D.S. Higginson, H. Robinson, W.l. Sundquist, 
and C.P. Hill, Structure and ubiquitin binding of the ubiquitin-interacting 
motif J. BioI. Chern., 2003. 278(31): p. 2B976-289B4. 
110. Hofmann, K and P. Bucher, The UBA domain: A sequence motif present in 
mUltiple enzyme classes of the ubiquitination pathway. Trends Biochem. Sci., 
1996.21(5): p. 172-173. 
111. Wilkinson, C.RM., M. Seeger, R. Hartmann-Petersen, M. Stone, M. Wallace, C. 
Semple, and C. Gordon, Proteins containing the UBA domain are able to bind 
to mUlti-ubiquitin chains. Nat. Cell Biol., 2001. 3(10): p. 939-943. 
177 
References 
112. Raasi, S. and C.M. Pickart, Rad23 ubiquitin-associated domains (UBA) inhibit 
26 S proteasome-catalyzed proteolysis by sequestering lysine 48-linked 
polyubiquitin chains. J. BioI. Chem., 2003. 278(11): p. 8951-8959. 
113. Mueller, T.D. and J. Feigon, Solution structures of UBA domains reveal a 
conserved hydrophobic surface for protein-protein interactions. J. Mol. BioI., 
2002.319(5): p.1243-1255. 
114. Mah, AL.. G. Perry. M.A. Smith. and M.J. Monteiro, Identification ofubiquilin, a 
novel presenilin interactor that increases presenilin protein accumulation. J. 
Cell BioI., 2000. 151(4): p. 847-862. 
115. Massey. L.K, AL. Mah. D.L. Ford, J. Miller, J. Liang, H. Doong, and M.J. 
Monteiro, Overexpression of ubiquilin decreases ubiquitination and 
degradation ofpresenilin proteins. J. Alzheimers Dis., 2004. 6(1): p. 79-92. 
116. Dikic, I., S. Wakatsuki, and KJ. Walters, Ubiquitin-binding domains - from 
structures to functions. Nat. Rev. Mol. Cell BioI., 2009. 10(10): p. 659-671. 
117. VanDemark, A.P., R.M. Hofmann, C. Tsui, C.M. Pickart, and C. Wolberger, 
Molecular insights into polyubiquitin chain assembly: Crystal structure of the 
Mms2/Ubc13 heterodimer. Cell. 2001. 105(6): p. 711-720. 
118. Strachan, J., L. Roach. K Sokratous, D. Tooth, J. Long, T.P. Garner, M.S. Searle, 
N.J. Oldham, and R. Layfield, Insights into the Molecular Composition of 
Endogenous Unanchored Polyubiquitin Chains. J. Proteome Res., 2012. 11(3): 
p.1969-1980. 
119. Counterman, AE., S.). Valentine, C.A. Srebalus, S.C. Henderson, C.S. Hoaglund, 
and D.E. Clemmer, High-order structure and dissociation of gaseous peptide 
aggregates that are hidden in mass spectra. ). Am. Soc. Mass Spectrom., 1998. 
9(8): p. 743-759. 
120. Salho, R., M.F. Bush, H. Naver, I. Campuzano, C.V. Robinson, I. Pettersson, 
T.J.D. Jorgensen. and KF. Haselmann, Traveling-wave ion mobility mass 
spectrometry of protein complexes: accurate calibrated collision cross-sections 
of human insulin oligomers. Rapid Commun. Mass Spectrom., 2012. 26(10): p. 
1181-1193. 
178 
References 
121. Williams, J.P., J.A. Lough, I. Campuzano, K Richardson, and P.J. Sadler, Use of 
ion mobility mass spectrometry and a collision cross-section algorithm to study 
an organometallic ruthenium anticancer complex and its adducts with a DNA 
oligonucleotide. Rapid Commun. Mass Spectrom., 2009. 23(22): p. 3563-
3569. 
122. Davis, I.W., A Leaver-Fay, V.B. Chen, J.N. Block, G.J. Kapral, X. Wang, L.W. 
Murray, W.B. Arendall, J. Snoeyink, J.S. Richardson, and D.C. Richardson, 
MolProbity: all-atom contacts and structure validation for proteins and nucleic 
acids. Nucleic Acids Res., 2007. 35: p. W375-W383. 
123. Chen, V.B., W.B. Arendall, J.J. Headd, D.A Keedy, RM. Immormino, G.J. Kapral, 
L.W. Murray, J.S. Richardson, and D.C. Richardson, MolProbity: all-atom 
structure validation for macromolecular crystallography. Acta Crystallogr. D 
BioI. Crystallogr., 2010. 66: p. 12-21. 
124. Bertini, I., D.A. Case, L. Ferella, A. Giachetti, and A Rosato, A Grid-enabled web 
portal for NMR structure refinement with AMBER Bioinformatics, 2011. 
27(17): p. 2384-2390. 
125. Case, D.A., T.E. Cheatham, T. Darden, H. Gohlke, R Luo, KM. Merz, A 
Onufriev, C. Simmerling, B. Wang, and RJ. Woods, The Amber biomolecular 
simulation programs. J. Comput. Chern., 2005. 26(16): p.1668-1688. 
126. Benesch, J.L.P. and B.T. Ruotolo, Mass spectrometry: come of age for structural 
and dynamical biology. Curro Opin. Struct. Biol., 2011. 21(5): p. 641-649. 
127. Merrifield, RB., Solid phase peptide synthesis. 1. The synthesis of a 
tetrapeptide. J. Am. Chern. Soc., 1963.85(14): p. 2149-2154. 
128. Iavarone, AT. and E.R. Williams, Mechanism of Charging and Supercharging 
Molecules in Electrospray Ionization. J. Am. Chern. Soc., 2003. 125(8): p. 
2319-2327. 
129. Iavarone, A.T., J.C. Jurchen, and E.R. Williams, Supercharged Protein and 
Peptide Ions Formed by Electrospray Ionization. Anal. Chern., 2001. 73(7): p. 
1455-1460. 
References 
130. Lomeli, S.H., S. Yin, RRO. Loa, and J.A. Loa, Increasing: Charge While 
Preserving Noncovalent Protein Complexes for ESI-MS. J. Am. Soc. Mass 
Spectrom., 2009. 20(4): p. 593-596. 
131. Lomeli, S.H., I.X. Peng, S. Yin, RR.O. Loa, and J.A. Loa, New Reagents for 
Increasing ESI Multiple Charging of Proteins and Protein Complexes. J. Am. 
Soc. Mass Spectrom., 2010. 21(1): p. 127-131. 
132. Scalf, M., M.S. Westphall, J. Krause, S.L. Kaufman, and L.M. Smith, Controlling 
charge states of large ions. Science, 1999. 283(5399): p. 194-197. 
133. Bagal, D., E.N. Kitova, L. Liu, A. EI-Hawiet, P.D. Schnier, and J.S. Klassen, Gas 
Phase Stabilization of Noncovalent Protein Complexes Formed by Electrospray 
Ionization. Anal. Chern., 2009. 81(18): p. 7801-7806. 
134. Zubarev, RA., N.L. Kelleher, and F.W. McLafferty, Electron Capture 
Dissociation of Multiply Charged Protein Cations. A Nonergodic Process. J. Am. 
Chern. Soc., 1998. 120(13): p. 3265-3266. 
135. Xie, Y., J. Zhang, S. Yin, and J.A. Loa, Top-Down ESI-ECD-FT-ICR Mass 
Spectrometry Localizes Noncovalent Protein-Ligand Binding Sites. J. Am. 
Chern. Soc., 2006.128(45): p.14432-14433. 
136. Sterling, H., M. Daly, G. Feld, K. Thoren, A. Kintzer, B. Krantz, and E. Williams, 
Effects of supercharging reagents on noncovalent complex structure in 
electrospray ionization from aqueous solutions. ). Am. Soc. Mass Spectrom., 
2010.21(10): p. 1762-1774. 
137. Kharlamova, A., B.M. Prentice, T.Y. Huang, and S.A. McLuckey, Electrospray 
Droplet Exposure to Gaseous Acids for the Manipulation of Protein Charge 
State Distributions. Anal. Chern., 2010. 82(17): p. 7422-7429. 
138. Shelimov, K.B., D.E. Clemmer, RR Hudgins, and M.F. Jarrold, Protein 
structure in vacuo: Gas-phase confirmations of BPTI and cytochrome c. ). Am. 
Chern. Soc., 1997. 119(9): p. 2240-2248. 
139. Baumketner, A., S.L. Bernstein, T. Wyttenbach, G. Bitan, D.B. Teplow, M.T. 
Bowers, and ).-E. Shea, Amyloid /3-protein monomer structure: A 
computational and experimental study. Protein ScL, 2006. 15(3): p. 420-428. 
180 
References 
140. Lemaire, D., G. Marie, L. Serani, and O. Laprevote, Stabilization of gas-phase 
noncovalent macromolecular complexes in electrospray mass spectrometry 
using aqueous triethylammonium bicarbonate buffer. Anal. Chern., 2001. 
73(8): p.1699-1706. 
141. Halgand, F. and O. Laprevote, Mean charge state and charge state distribution 
of proteins as structural probes. An electrospray ionisation mass spectrometry 
study of lysozyme and ribonuclease A. Eur. J. Mass Spectrom., 2001. 7(6): p. 
433-439. 
142. Pagel, K., S.J. Hyung, B.T. Ruotolo, and C.Y. Robinson, Alternate Dissociation 
Pathways Identified in Charge-Reduced Protein Complex Ions. Anal. Chern., 
2010.82(12): p. 5363-5372. 
143. Catalina, M.l., R.H.H. van den Heuvel, E. van Duijn, and A.I.R. Heck, 
Decharging of Globular Proteins and Protein Complexes in Electrospray. Chern. 
Eur. I., 2005.11(3): p. 960-968. 
144. Sun, I.X., E.N. Kitova, and I.S. Klassen, Method for stabilizing protein-ligand 
complexes in nanoelectrospray ioniZation mass spectrometry. Anal. Chern., 
2007.79(2): p. 416-425. 
145. Sun, N., N. Soya, E.N. Kitova, and }.S. Klassen, Nonspecific Interactions 
Between Proteins and Charged Biomolecules in Electrospray Ionization Mass 
Spectrometry. I. Am. Soc. Mass Spectrom., 2010. 21(3): p. 472-481. 
146. Winger, B.E., K.}. Lightwahl, and R.D. Smith, Gas-phase proton-transfer 
reactions involving multiply charged cytochrome-C ions and water under 
thermal conditions. }. Am. Soc. Mass Spectrom., 1992. 3(6): p. 624-630. 
147. Takats, Z., I.M. Wiseman, B. Gologan, and R.G. Cooks, Electrosonic spray 
ionization. A gentle technique for generating folded proteins and protein 
complexes in the gas phase and for studying ion - Molecule reactions at 
atmospheric pressure. Anal. Chern., 2004. 76(14): p. 4050-4058. 
148. Touboul, D., M.C. lecklin, and R. Zenobi, Rapid and Precise Measurements of 
Gas-Phase Basicity of Pep tides and Proteins at Atmospheric Pressure by 
181 
References 
Electrosonic Spray Ionization-Mass Spectrometry. J. Phys. Chern. B, 2007. 
111(40): p. 11629-11631. 
149. Touboul, D., M.C. Jecklin, and R. Zenobi, Investigation of deprotonation 
reactions on globular and denatured proteins at atmospheric pressure by ESSI-
MS. J. Am. Soc. Mass Spectrom., 2008.19(4): p. 455-466. 
150. Loa, R.R.O., H.R. Udseth, and R.D. Smith, Evidence of charge inversion in the 
reaction of singly charged anions with mUltiply charged macroions. J. Phys. 
Chern., 1991. 95(17): p. 6412-6415. 
151. Ogorzalek Loa, R.R., H.R. Udseth, and R.D. Smith, A new approach for the 
study of gas-phase ion-ion reactions using electrospray ionization. J. Am. Soc. 
Mass Spectrom., 1992. 3(7): p. 695-705. 
152. Zhao, Q., M.W. Soyk, G.M. Schieffer, K. Fuhrer, M.M. Gonin, R.S. Houk, and E.R. 
Badman, An Ion Trap-Ion Mobility-Time of Flight Mass Spectrometer with 
Three Ion Sources for Ion/Ion Reactions. J. Am. Soc. Mass Spectrom., 2009. 
20(8): p. 1549-1561. 
153. Zhao, Q., G.M. Schieffer, M.W. Soyk, T.J. Anderson, R.S. Houk, and E.R. 
Badman, Effects of Ion/Ion Proton Transfer Reactions on Conformation of Gas-
Phase Cytochrome c Ions. J. Am. Soc. Mass Spectrom., 2010. 21(7): p. 1208-
1217. 
154. Clark, S.M. and L. Konermann, Determination of ligand-protein dissociation 
constants by electrospray mass spectrometry-based diffusion measurements. 
Anal. Chern., 2004. 76(23): p. 7077-7083. 
155. Jecklin, M.C., D. Touboul, C. Bovet, A. Wortmann, and R. Zenobi, Which 
electrospray-based ionization method best reflects protein-ligand interactions 
found in solution? A comparison of ESI, nanoESI, and ESSI for the 
determination of dissociation constants with mass spectrometry. J. Am. Soc. 
Mass Spectrom., 2008.19(8): p.1237-1237. 
156. Benkestock, K., G. Sundqvist, P.-D. Edlund, and J. Roeraade, Influence of 
droplet size, capillary-cone distance and selected instrumental parameters for 
182 
References 
the analysis of noncovalent protein-ligand complexes by nano-electrospray 
ionization mass spectrometry. J. Mass Spectrom., 2004. 39(9): p. 1059-1067. 
157. Hunter, E.P.L. and S.G. Lias, Evaluated gas phase basicities and proton 
affinities of molecules: An update. J. Phys. Chern. Ref. Data, 1998. 27(3): p. 
413-656. 
158. Hopper, J.T.S. and N.J. Oldham, Alkali Metal Cation-Induced Destabilization of 
Gas-Phase Protein-Ligand Complexes: Consequences and Prevention. Anal. 
Chern., 2011. 83(19): p. 7472-7479. 
159. Daniel, J.M., S.D. Friess, S. Rajagopalan, S. Wendt, and R Zenobi, Quantitative 
determination of noncovalent binding interactions using soft ionization mass 
spectrometry. Int. J. Mass Spectrom., 2002. 216(1): p. 1-27. 
160. Heck, AJ.R and R.H.H. van den Heuvel, Investigation of intact protein 
complexes by mass spectrometry. Mass Spectrom. Rev., 2004. 23(5): p. 368-
389. 
161. Liu, L., D. Bagal, E.N. Kitova, P.D. Schnier, and J.S. Klassen, Hydrophobic 
Protein-Ligand Interactions Preserved in the Gas Phase. J. Am. Chern. Soc., 
2009.131(44): p. 15980-15981. 
162. Loa, JA, P.F. Hu, P. McConnell, W.T. Mueller, T.K. Sawyer, and V. Thanabal, A 
study of Src SH2 domain protein-phosphopeptide binding interactions by 
electrospray ionization mass spectrometry. J. Am. Soc. Mass Spectrom., 1997. 
8(3): p. 234-243. 
163. Robinson, C.V., E.W. Chung, B.B. Kragelund, J. Knudsen, RT. Aplin, F.M. 
Poulsen, and C.M. Dobson, Probing the nature of noncovalent interactions by 
mass spectrometry. A study of protein-Co A ligand binding and assembly. J. Am. 
Chern. Soc., 1996.118(36): p. 8646-8653. 
164. Rauh, D., G. Klebe, J. Sturzebecher, and M.T. Stubbs, ZZ made EZ: Influence of 
inhibitor configuration on enzyme selectivity. J. Mol. BiOI., 2003. 330(4): p. 
761-770. 
183 
References 
165. Brignone, C., K.E. Bradley, AF. Kisselev, and S.R. Grossman, A post-
ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway. 
Oncogene, 2004. 23(23): p. 4121-4129. 
166. Walters, K.I., P.I. Lech, AM. Goh, Q.H. Wang, and P.M. Howley, DNA-repair 
protein hHR23a alters its protein structure upon binding proteasomal subunit 
S5a. Proc. Natl. Acad. Sci. USA., 2003.100(22): p. 12694-12699. 
167. Raasi, S., I. Orlov, K.G. Fleming, and C.M. Pickart, Binding of polyubiquitin 
chains to ubiquitin-associated (UBA) domains of HHR23A. I. Mol. Biol., 2004. 
341(5): p. 1367-1379. 
168. Hoeller, D. and I. Dikic, Targeting the ubiquitin system in cancer therapy. 
Nature, 2009.458(7237): p. 438-444. 
169. Garner, T.P., I. Long, R. Layfield, and M.S. Searle, Impact ofp62/SQSTMl UBA 
Domain Mutations Linked to Paget's Disease of Bone on Ubiquitin Recognition. 
Biochemistry, 2011. 50(21): p. 4665-4674. 
170. Trempe, I.-F., Reading the ubiquitin postal code. Curro Opin. Struct Biol., 2011. 
21(6): p. 792-801. 
171. Varadan, R., M. Assfalg, A. Haririnia, S. Raasi, C. Pickart, and D. Fushman, 
Solution conformation of Lys(63)-linked di-ubiquitin chain provides clues to 
functional diversity ofpolyubiquitin signaling. I. Biol. Chern., 2004. 279(8): p. 
7055-7063. 
172. Long, I., T.P. Garner, M.J. Pandya, C.J. Craven, P. Chen, B. Shaw, M.P. 
Williamson, R. Layfield, and M.S. Searle, Dimerisation of the UBA Domain of 
p62 Inhibits Ubiquitin Binding and Regulates NF-kappa B Signalling. J. Mol. 
Biol., 2010. 396(1): p. 178-194. 
173. Kulathu, Y., M. Akutsu, A Bremm, K. Hofmann, and D. Komander, Two-sided 
ubiquitin binding explains specificity of the TAB2 NZF domain. Nat Struct Mol. 
BioI., 2009.16(12): p. 1328-1330. 
174. Liu, J.J. and L. Konermann, Protein-Protein Binding Affinities in Solution 
Determined by Electrospray Mass Spectrometry. I. Am. Soc. Mass Spectrom., 
2011.22(3): p. 408-417. 
184 
References 
175. Sims, J.J., A Haririnia, RC. Dickinson, D. Fushman, and RE. Cohen, Avid 
interactions underlie the Lys63-linked polyubiquitin binding specificities 
observed for UBA domains. Nat. Struct. Mol. Biol., 2009.16(8): p. 883-889. 
176. Shin, D., S.Y. Lee, S. Han, S. Ren, S. Kim, Y. Aikawa, and S. Lee, Differential 
polyubiquitin recognition by tandem ubiquitin binding domains of Rabex-S. 
Biochem. Biophys. Res. Commun., 2012. 423(4): p. 757-762. 
177. Garner, T.P., J. Strachan, E.C. Shedden, J.E. Long, J.R. Cavey, B. Shaw, R 
Layfield, and M.S. Searle, Independent Interactions of Ubiquitin-Binding 
Domains in a Ubiquitin-Mediated Ternary Complex. Biochemistry, 2011. 
50(42): p. 9076-9087. 
178. Gabelica, V., F. Rosu, and E. De Pauw, A Simple Method to Determine 
Electrospray Response Factors of Noncovalent Complexes. Anal. Chern., 2009. 
81(16): p. 6708-6715. 
179. Wilcox, J.M., D.L. Rempel, and M.L. Gross, Method of measuring 
oligonucleotide-metal affinities: Interactions of the thrombin binding aptamer 
with K+ and Sr2+. Anal. Chern., 2008. 80(7): p. 2365-2371. 
180. Sun, J., E.N. Kitova, N. Sun, and J.S. Klassen, Methodfor identifying nonspecific 
protein-protein interactions in nanoelectrospray ionization mass 
Spectrometry. Anal. Chern., 2007. 79(21): p. 8301-8311. 
181. Kuprowski, M.C. and L. Konermann, Signal response of coexisting protein 
conformers in electrospray mass spectrometry. Anal. Chern., 2007. 79(6): p. 
2499-2506. 
182. Kaltashov, I.A. and A. Mohimen, Estimates ofprotein surface areas in solution 
by electrospray ionization mass spectrometry. Anal. Chern., 2005. 77(16): p. 
5370-5379. 
183. Kaiser, S.E., B.E. Riley, T.A. Shaler, RS. Trevino, C.H. Becker, H. Schulman, and 
R.R. Kopito, Protein standard absolute quantification (PSAQ) method for the 
measurement of cellular ubiquitin pools. Nat Meth, 2011. 8(8): p. 691-696. 
184. Zhang, N.X., Q.H. Wang, A Ehlinger, L. Randles, J.W. Lary, Y. Kang, A. 
Haririnia, AJ. Storaska, J.L. Cole, D. Fushman, and KJ. Walters, Structure of 
185 
References 
the SSa:K48-Linked Diubiquitin Complex and Its Interactions with Rpn13. Mol. 
Cell, 2009. 35(3): p. 280-290. 
185. Chen, X., B.H. Lee, D. Finley, and KJ. Walters, Structure of Proteasome 
Ubiquitin Receptor hRpn13 and Its Activation by the Scaffolding Protein 
hRpn2. Mol. Cell, 2010. 38(3): p. 404-415. 
186. Piotrowski, J., R Beal, L. Hoffman, KD. Wilkinson, R.E. Cohen, and C.M. 
Pickart, Inhibition of the 26 S proteasome by polyubiquitin chains synthesized 
to have defined lengths. J. BioI. Chern., 1997.272(38): p. 23712-23721. 
187. Dayal, S., A. Sparks, J. Jacob, N. Allende-Vega, D.P. Lane, and M.K. Saville, 
Suppression of the Deubiquitinating Enzyme USPS Causes the Accumulation of 
Unanchored Polyubiquitin and the Activation of p53. J. BioI. Chern., 2009. 
284(8): p. 5030-5041. 
188. Xia, Z.P., L.J. Sun, X. Chen, G. Pineda, X.M. Jiang, A. Adhikari, W.W. Zeng, and 
Z.J. Chen, Direct activation of protein kinases by unanchored polyubiquitin 
chains. Nature, 2009.461(7260): p. 114-119. 
189. Pertel, T., S. Hausmann, D. Morger, S. Zuger, J. Guerra, J. Lascano, C. Reinhard, 
F.A. Santoni, P.D. Uchil, L. Chatel, A. Bisiaux, M.L. Albert, C. Strambio-De-
Castillia, W. Mathes, M. Pizzato, M.G. Grutter, and J. Luban, TRIMS is an innate 
immune sensor for the retrovirus capsid lattice. Nature, 2011. 472(7343): p. 
361-365. 
190. Zeng, W., L. Sun, X. Jiang, X. Chen, F. Hou, A. Adhikari, M. Xu, and Z.J. Chen, 
Reconstitution of the RIG-I pathway reveals a signaling role of unanchored 
polyubiquitin chains in innate immunity. Cell. 141(2): p. 315-30. 
191. Setsuie, R, M. Sakurai, Y. Sakaguchi, and K Wada, Ubiquitin dimers control 
the hydrolase activityofUCH-L3. Neurochem. Int., 2009. 54(5-6): p. 314-321. 
192. Hirano, T., O. Serve, M. Vagi-Utsumi, E. Takemoto, T. Hiromoto, T. Satoh, T. 
Mizushima, and K Kato, Conformational Dynamics of Wild-type Lys-4B-linked 
Diubiquitin in Solution. J. BioI. Chern., 2011. 286(43): p. 37496-502. 
193. Yao, T.T. and RE. Cohen, Cyc1ization ofpo/yubiquitin by the E2-2SK ubiquitin 
conjugating enzyme. J. BioI. Chern., 2000. 275(47): p. 36862-36868. 
186 
References 
194. Satoh, T., E. Sakata, S. Yamamoto, Y. Yamaguchi, A Sumiyoshi, S. Wakatsuki, 
and K. Kato, Crystal structure of cyclic Lys48-linked tetraubiquitin. Biochem. 
Biophys. Res. Commun., 2010. 400(3): p. 329-333. 
195. Peng, J., Evaluation of proteomic strategies for analyzing ubiquitinated 
proteins. Bmb Reports, 2008.41(3): p. 177-183. 
196. Sobott, F., S.J. Watt, J. Smith, M.J. Edelmann, H.B. Kramer, and B.M. Kessler, 
Comparison of CID Versus ETD Based MSjMS Fragmentation for the Analysis of 
Protein Ubiquitination. J. Am. Soc. Mass Spectrom., 2009. 20(9): p. 1652-
1659. 
197. Peng, J.M., D. Schwartz, J.E. Elias, C.C. Thoreen, D.M. Cheng, G. Marsischky, J. 
Roelofs, D. Finley, and S.P. Gygi, A proteomics approach to understanding 
protein ubiquitination. Nat. Biotechnol., 2003. 21(8): p. 921-926. 
198. Meierhofer, D., X. Wang, L. Huang, and P. Kaiser, Quantitative analysis of 
global ubiquitination in HeLa cells by mass spectrometry. J. Proteome Res., 
2008.7(10): p. 4566-4576. 
199. Xu, P. and J.M. Peng, Characterization of polyubiquitin chain structure by 
middle-down mass spectrometry. Anal. Chern., 2008. 80(9): p. 3438-3444. 
200. Kirkpatrick, D.S., N.A. Hathaway, J. Hanna, S. Elsasser, J. Rush, D. Finley, R.W. 
King, and S.P. Gygi, Quantitative analysis of in vitro ubiquitinated cyclin B1 
reveals complex chain topology. Nat. Cell Biol., 2006. 8(7): p. 700-710. 
201. Ziv, I., Y. Matiuhin, D.S. Kirkpatrick, Z. Erpapazoglou, S. Leon, M. 
Pantazopoulou, W. Kim, S.P. Gygi, R. Haguenauer-Tsapis, N. Reis, M.H. 
Glickman, and O. Kleifeld, A Perturbed Ubiquitin Landscape Distinguishes 
Between Ubiquitin in Trafficking and in Proteolysis. Mol. Cell. Proteomics, 
2011. 10(5). 
202. van Dijk, AD.J., D. Fushman, and A Bonvin, Various strategies of using 
residual dipolar couplings in NMR-driven protein docking: Application to 
Lys48-linked Di-ubiquitin and validation against N-15-relaxation data. 
Proteins: Struct., Funct., Bioinf., 2005. 60(3): p. 367-381. 
187 
References 
203. Kaltashov, l.A. and RR Abzalimov, Do ionic charnes in ESI MS provide useful 
information on macromolecular structure? I. Am. Soc. Mass Spectrom., 2008. 
19(9): p. 1239-1246. 
204. Benesch, I.L.P., Collisional Activation of Protein Complexes: Pickinn Up the 
Pieces. I. Am. Soc. Mass Spectrom., 2009. 20(3): p. 341-348. 
205. Wu, C., J. Klasmeier, and H.H. Hill, Atmospheric pressure ion mobility 
spectrometry of protonated and sodiated pep tides. Rapid Commun. Mass 
Spectrom., 1999. 13(12): p.1138-1142. 
206. Rozman, M. and S.I. Gaskell, Non-covalent interactions of alkali metal cations 
with sinnly charned tryptic peptides. I. Mass Spectrom., 2010. 45(12): p. 
1409-1415. 
207. Verkerk, U.H. and P. Kebarle, lon-ion and ion-molecule reactions at the surface 
of proteins produced by nanospray. Information on the number of acidic 
residues and control of the number of ionized acidic and basic residues. I. Am. 
Soc. Mass Spectrom., 2005. 16(8): p. 1325-1341. 
208. lulian, RR and J.L. Beauchamp, The unusually hinh proton affinity of aza-18-
crown-6 ether: Implications for the molecular reconnition of lysine in peptides 
by lariat crown ethers. I. Am. Soc. Mass Spectrom., 2002. 13(5): p. 493-498. 
209. Steinberg, M.Z., REIber, F.W. McLafferty, RB. Gerber, and K. Breuker, Early 
Structural Evolution of Native Cytochrome c after Solvent Removal. 
Chembiochem, 2008.9(15): p. 2417-2423. 
210. Wyttenbach, T., I.E. Bushnell, and M.T. Bowers, Salt Bridne Structures in the 
Absence of Solvent? The Case for the Olin on lycin es. I. Am. Chern. Soc., 1998. 
120(20): p. 5098-5103. 
211. Felitsyn, N., M. Peschke, and P. Kebarle, Origin and number of charges 
observed on multiply-protonated native proteins produced by ESI. Int. I. Mass 
Spectrom., 2002. 219(1): p. 39-62. 
212. Adams, I·, The proteasome: A suitable antineoplastic tarnet. Nat. Rev. Cancer, 
2004.4(5): p. 349-360. 
188 
References 
213. Hoeller, D., C.M. Hecker, and I. Dikic, Ubiquitin and ubiquitin-like proteins in 
cancer pathogenesis. Nat. Rev. Cancer, 2006. 6(10): p. 776-788. 
214. Richardson, P.G., B. Barlogie, J. Berenson, S. Singhal, S. Jagannath, D. Irwin, 
s.v. Rajkumar, G. Srkalovic, M. Alsina, R Alexanian, D. Siegel, R.Z. Orlowski, D. 
Kuter, SA Limentani, S. Lee, T. Hideshima, D.L. Esseltine, M. Kauffman, J. 
Adams, D.P. Schenkein, and KC. Anderson, A phase 2 study of bortezomib in 
relapsed, refractory myeloma. N. Engl. J. Med., 2003. 348(26): p. 2609-2617. 
215. Groll, M., C.R. Berkers, H.L. Ploegh, and H. Ovaa, Crystal structure of the 
boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 
20S proteasome. Structure, 2006. 14(3): p. 451-456. 
216. Nicholson, 8., J.G. Marblestone, T.R. Butt, and M.R Mattern, Deubiquitinating 
enzymes as novel anticancer targets. Future Oncol., 2007. 3(2): p. 191-199. 
217. Chauhan, D., Z. Tian, B. Nicholson, KG.S. Kumar, B. Zhou, R Carrasco, J.L. 
McDermott, CA Leach, M. Fulcinniti, M.P. Kodrasov, J. Weinstock, W.D. 
Kingsbury, T. Hideshima, P.K Shah, S. Minvielle, M. Altun, B.M. Kessler, R 
Orlowski, P. Richardson, N. Munshi, and KC. Anderson, A Small Molecule 
Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple 
Myeloma Cells and Overcomes Bortezomib Resistance. Cancer Cell, 2012. 
22(3): p. 345-358. 
218. Amerik, A.Y., S. Swaminathan, BA Krantz, KD. Wilkinson, and M. 
Hochstrasser, In vivo disassembly of free polyubiquitin chains by yeast Ubp14 
modulates rates of protein degradation by the proteasome. EMBO J., 1997. 
16(16): p. 4826-4838. 
219. Lindsey, D.F., A. Amerik, W.J. Deery, J.D. Bishop, M. Hochstrasser, and RH. 
Gomer, A deubiquitinating enzyme that disassembles free polyubiquitin chains 
is required for development but not growth in Dictyostelium. J. BioI. Chern., 
1998.273(44): p. 29178-29187. 
220. Lam, Y.A., C.M. Pickart, A. Alban, M. Landon, C. Jamieson, R Ramage, R.J. 
Mayer, and R Layfield, Inhibition of the ubiquitin-proteasome system in 
Alzheimer's disease. Proc. Natl. Acad. Sci. USA., 2000. 97(18): p. 9902-9906. 
189 
References 
221. Wilkinson, K.D., V.L. Tashayev, L.B. Oconnor, C.N. Larsen, E. Kasperek, and 
C.M. Pickart, Metabolism of the polyubiquitin signal - Structure, mechanism, 
and role of Isopeptidase-T. Biochemistry, 1995. 34(44): p. 14535-14546. 
190 
APPENDIX 
The fi gure below shows the Windows form application designed using the Microsoft 
Visual Studio 2010 (.NET framework 4.0). The calculator is available on request 
(kleitos.sokratous@gmail.com). 
Instrument Concernratlon uMS 
SYNAPT HDMS • M mM " ~ M M
Protem Concentration IP.I 0 5 
ltgand Concentration [ ~ M M
P.'Qlein • ligand Unbound Protein 
Charge IntenSity Cha'ge IntenSity 
13 
31 
'n 6590909090909 
471 
488 
38 
Calculate Ll 
N arAiI 
Ka = 4 5E+04 MO' 
Kd = 22180llM 
The source code of the calculator is given below. 
Public Class Kd_Cal 
Di m scientific As String 
so 
( S I 
+ 
1 
Private Sub Forml_Load(ByVal sender As System. Object, ByVal e As 
System.EventArgs) Handles MyBase.Load 
PLchl.Enabled False 
PLch2.Enabled False 
PLch3.Enabled False 
PLch4 . Enabled False 
UPchl.Enabled False 
UPch2.Enabled False 
UPch3.Enabled False 
UPch4.Enabled False 
Labe112.Visible 
Label13.Visible 
Labe115.Visible 
Label17.Visible = 
False 
False 
False 
False 
I 
\ 
\ 
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Label19.Visible = False 
Avg.Visible = False 
StDev.Visible = False 
StdError.Visible = False 
Ka.Visible = False 
Kd.Visible = False 
PrCon.Visible = False 
LiCon.Visible = False 
Leone.Enabled = False 
Peonc.Enabled = False 
End Sub 
Private Sub KdCal_Cliek(ByVal sender As System.Object, ByVal e As 
System.EventArgs) Handles KdCal.Click 
Dim R As Double 
'R = (Val(PLint1.Text) + Val(PLint2.Text) + Val(PLint3.Text) + 
Val(PLint4.Text» / (Val(UPint1.Text) + Val(UPint2.Text) + Val(UPint3.Text) 
+ Val(UPint4.Text» 
R = (Val(UPint1.Text) + Val(UPint2.Text) + Val(UPint3.Text) + 
Val(UPint4.Text» / (Val(PLint1.Text) + Val(PLint2.Text) + Val(PLint3.Text) 
+ Val(PLint4.Text» 
R» ) 
1eeeeee 
Ratio.Text = R 
Label12.Visible = True 
Label13.Visible = True 
Ka.Visible = True 
Kd.Visible = True 
'Ka.Text = R / (Val(LiCon.Text) - «R * Val(prCon.Text» / (1 + 
'Kd.Text = (1 / Val(Ka.Text» * 1eeeeee 
Kd.Text = (R * (Val(LiCon.Text) - (Val(prCon.Text) / (1 + R»» * 
Ka.Text = (1 / Val(Kd.Text» * 1eeeeee 
Ka.Text = Format(Val(Ka.Text), "G2") & " M %" 
Kd.Text = Format(Val(Kd.Text), "F3") & " \.lM" 
Dim Kds As String = Val(Kd.Text) 
ListBoxKd.Items.Add(Kds & " \.lM") 
End Sub 
Private Sub Pconc_Click(ByVal sender As Object, ByVal e As 
System.EventArgs) Handles Pcone.Click 
If RadioButtonl.Checked = True Then 
PrCon.Text = Val(Pconc.Text) 
Elself RadioButton2.Checked = True Then 
PrCon.Text = Val(Pconc.Text) / ieee 
ElseIf RadioButton3.Checked = True Then 
PrCon.Text = Val(Peone.Text) / 1eeeeee 
End If 
End Sub 
Private Sub Peonc_KeyPress(BYVal sender As Object, ByVal e As 
System.Windows.Forms.KeypressEventArgs) Handles Peone,KeyPress 
If Not Ase(e.KeyChar) = 8 AndAlso Not Asc(e.KeyChar) = 46 AndAlso 
Not Ase(e.KeyChar) = 13 AndAlso Not ISNumeric(e.KeyChar) Then 
MessageBox.Show("Please enter numbers only") 
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e.Handled = True 
End If 
End Sub 
Private Sub Lconc_Click(ByVal sender As Object. ByVal e As 
system.EventArgs) Handles Lconc.Click 
If RadioButton1.Checked = True Then 
LiCon.Text = Val(Lconc.Text) 
EIseIf RadioButton2.Checked = True Then 
LiCon.Text = Val(Lconc.Text) /leee 
EIseIf RadioButton3.Checked = True Then 
LiCon.Text = Val(Lconc.Text) / 1eeeeee 
End If 
End Sub 
Private Sub LeOne_KeyPress(ByVal sender As Object. ByVal e As 
system.Windows.Forms.KeypressEventArgs) Handles Leone.KeyPress 
If Not Ase(e.KeyChar) = 8 AndAIso Not Asc(e.KeyChar) = 46 AndAIso 
Not Ase(e.KeyChar) = 13 AndAIso Not IsNumeric(e.KeyChar) Then 
MessageBox.Show("Please enter numbers only") 
e.Handled = True 
End If 
End Sub 
Private Sub RadioButton1_CheckedChanged(Byval sender As System. Object. 
ByVal e As System.EventArgs) Handles RadioButtonl.CheekedChanged 
Label4.Text = "M" 
LabelS.Text • "M" 
PrCon.Text = Val(Peone.Text) 
LiCon.Text = Val(Leonc.Text) 
LabelPunit.Text = "(M)" 
LabelLunit.Text = "(M)" 
Leone.Enabled = True 
Pconc.Enabled = True 
End Sub 
Private Sub RadioButton2_CheekedChanged(ByVal sender As System.Object. 
ByVal e As System.EventArgs) Handles RadioButton2.CheckedChanged 
Label4.Text = "111M" 
LabelS.Text = "mM" 
PrCon.Text = Val(Peone.Text) / leee 
LiCon.Text • Val(Lconc.Text) / 1eee 
LabelPunit.Text = "(mM)" 
LabelLunit.Text = "(mM)" 
Leone.Enabled = True 
Peone.Enabled = True 
End Sub 
Private Sub RadioButton3_CheckedChanged{ByVal sender As System. Object, 
ByVal e As System.EventArgs) Handles RadioButton3.CheekedChanged 
Label4.Text = "j.iM" 
LabelS.Text = "!!Mil 
PrCon.Text = Val(Peone.Text) I leeeeee 
LiCon.Text = Val(Lcone.Text) I leeeeee 
LabelPunit.Text = "(j.iM)" 
LabelLunit.Text = " ( ~ M ) " "
Leone.Enabled = True 
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Pconc.Enabled = True 
End Sub 
Private Sub Pconc_TextChanged(ByVal sender As System.Object. ByVal e As 
System.EventArgs) Handles Pconc.TextChanged 
If RadioButtonl.Checked = True Then 
PrCon.Text = Val(Pconc.Text) 
ElseIf RadioButton2.Checked = True Then 
PrCon.Text = Val(Pconc.Text) / leee 
ElseIf RadioButton3.Checked = True Then 
PrCon.Text = Val(Pconc.Text) / leeeeee 
End If 
End Sub 
Private Sub Lconc_TextChanged(ByVal sender As System.Object. ByVal e As 
System.EventArgs) Handles Lconc.TextChanged 
If RadioButtonl.Checked = True Then 
LiCon.Text = Val(lconc.Text) 
ElseIf RadioButton2.Checked = True Then 
LiCon.Text • Val(Lconc.Text) / leee 
ElseIf RadioButton3.Checked = True Then 
liCon.Text • Val(lconc.Text) / leeeeee 
End If 
End Sub 
Private Sub ButtonAvg_Click(ByVal sender As System. Object. ByVal e As 
System.EventArgs) Handles ButtonAvg.Click 
Dim i As Integer 
Dim m As Double 
Dim squares As Double 
Dim mean As Double 
Dim SampleSize As Double 
Dim SampleSizel As Double 
Labells.Visible = True 
Label17.Visible = True 
Label19.Visible = True 
Avg.Visible = True 
StDev.Visible = True 
StdError.Vlslble = True 
For i·e To ListBoxKd.Items.Count - 1 
m = m + Val(ListBoxKd.ltems(i» 
Next 
mean • (m / ListBoxKd.ltems.Count) 
SampleSize • 1 / (Val(listBoxKd.Items.Count) _ 1) 
Avg.Text • Format(mean. HF2") 
For i • 9 To ListBoxKd.Items.Count - 1 
squares • squares + «Val(ListBoxKd.ltems.ltem(i» _ mean) A 2) Next 
StDev.Text • Format«(squares • SampleSize) A 9.5). "F3") 
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StdError.Text = Format«Val(StDev.Text) / «ListBoxKd.ltems.Count) 
1\ 13.5». "F4") 
ListBoxP.ltems.Add(Pconc.Text) 
ListBoxL.ltems.Add(Lconc.Text) 
listBoxSD.ltems.Add(StDev.Text) 
listBoxAvg.ltems.Add(Avg.Text & " ± " & Format«Val(StdError.Text) 
* 1.96), "F2") & " 11M") 
ListBoxKd.ltems.Clear() 
Ka.Text = 13 
Kd.Text = 13 
End Sub 
Private Sub Reset_Click(ByVal sender As System.Object, ByVal e As 
System.EventArgs) Handles Reset.Click 
listBoxKd.ltems.Clear() 
Ka.Text = e 
Kd.Text = e 
End Sub 
Private Sub Remove_Click(ByVal sender As System.Object, ByVal e As 
System.EventArgs) Handles Remove.Click 
listBoxKd.ltems.Remove(listBoxKd.Selectedltem) 
End Sub 
Private Sub listBox4_SelectedlndexChanged(ByVal sender As 
System.Object, ByVal e As System.EventArgs) Handles 
listBoxAvg.SelectedlndexChanged 
End Sub 
Private Sub listBoxKd_SelectedlndexChanged(ByVal sender As 
System.Object, ByVal e As System.EventArgs) Handles 
ListBoxKd.SelectedlndexChanged 
End Sub 
End Class 
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